<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073337115-3174892f-db38-4f75-8669-c47cdab3dd7b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202012071</link>
            <description><![CDATA[<p class="para" id="N65540">Deliz-Aguirre et al. examine the molecular dynamics of interleukin 1 receptor signaling. Receptor sensing of IL-1 triggers the oligomerization of MyD88 and formation of the Myddosome signaling complex. The formation of a MyD88 oligomer of a requisite size serves as a threshold to active downstream signaling.</p><p class="para" id="N65539">A recurring feature of innate immune receptor signaling is the self-assembly of signaling proteins into oligomeric complexes. The Myddosome is an oligomeric complex that is required to transmit inflammatory signals from TLR/IL1Rs and consists of MyD88 and IRAK family kinases. However, the molecular basis for how Myddosome proteins self-assemble and regulate intracellular signaling remains poorly understood. Here, we developed a novel assay to analyze the spatiotemporal dynamics of IL1R and Myddosome signaling in live cells. We found that MyD88 oligomerization is inducible and initially reversible. Moreover, the formation of larger, stable oligomers consisting of more than four MyD88s triggers the sequential recruitment of IRAK4 and IRAK1. Notably, genetic knockout of IRAK4 enhanced MyD88 oligomerization, indicating that IRAK4 controls MyD88 oligomer size and growth. MyD88 oligomer size thus functions as a physical threshold to trigger downstream signaling. These results provide a mechanistic basis for how protein oligomerization might function in cell signaling pathways.</p>]]></description>
            <pubDate><![CDATA[2021-05-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Retroactivity induced operating regime transition in an enzymatic futile cycle]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766071505386-a856c32a-a6b5-4e19-bd72-f3ed87eb9dd1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0250830</link>
            <description><![CDATA[<p class="para" id="N65539">Activated phosphorylation-dephosphorylation biochemical reaction cycles are a class of enzymatic futile cycles. A futile cycle such as a single MAPK cascade governed by two underlying enzymatic reactions permits Hyperbolic (H), Signal transducing (ST), Threshold-hyperbolic (TH) and Ultrasensitive (U) operating regimes that characterize input-output behaviour. Retroactive signalling caused by load due to sequestration of phosphorylated or unphosphorylated form of the substrate in a single enzymatic cascade without explicit feedback can introduce two-way communication, a feature not possible otherwise. We systematically characterize the operating regimes of a futile cycle subject to retroactivity in either of the substrate forms. We demonstrate that increasing retroactivity strength, which quantifies the downstream load, can trigger five possible regime transitions. Retroactivity strength is a reflection of the fraction of the substrate sequestered by its downstream target. Remarkably, the minimum required retroactivity strength to evidence any sequestration triggered regime transition demands 23% of the substrate bound to its downstream target. This minimum retroactivity strength corresponds to the transition of the dose-response curve from ST to H regime. We show that modulation of the saturation and unsaturation levels of the enzymatic reactions by retroactivity is the fundamental mechanism governing operating regime transition.</p>]]></description>
            <pubDate><![CDATA[2021-04-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766069411418-a6c91ca8-850e-43eb-9930-c4cf0808e5a3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0240145</link>
            <description><![CDATA[<p class="para" id="N65539">Ovarian cancer is the fifth most common cause of cancer deaths among American women. Platinum and taxane combination chemotherapy represents the first-line approach for ovarian cancer, but treatment success is often limited by chemoresistance. Therefore, it is necessary to find new drugs to sensitize ovarian cancer cells to chemotherapy. Persistent activation of Signal Transducer and Activator of Transcription 3 (STAT3) signaling plays an important role in oncogenesis. Using a novel approach called advanced multiple ligand simultaneous docking (AMLSD), we developed a novel nonpeptide small molecule, LLL12B, which targets the STAT3 pathway. In this study, LLL12B inhibited STAT3 phosphorylation (tyrosine 705) and the expression of its downstream targets, which are associated with cancer cell proliferation and survival. We showed that LLL12B also inhibits cell viability, migration, and proliferation in human ovarian cancer cells. LLL12B combined with either paclitaxel or with cisplatin demonstrated synergistic inhibitory effects relative to monotherapy in inhibiting cell viability and LLL12B-paclitaxel or LLL12B-cisplatin combination exhibited greater inhibitory effects than cisplatin-paclitaxel combination in ovarian cancer cells. Furthermore, LLL12B-paclitaxel or LLL12B-cisplatin combination showed more significant in inhibiting cell migration and growth than monotherapy in ovarian cancer cells. In summary, our results support the novel small molecule LLL12B as a potent STAT3 inhibitor in human ovarian cancer cells and suggest that LLL12B in combination with the current front-line chemotherapeutic drugs cisplatin and paclitaxel may represent a promising approach for ovarian cancer therapy.</p>]]></description>
            <pubDate><![CDATA[2021-04-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766068903241-d9ce6f64-092a-4d35-b381-a1a946500b99/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0249759</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Purpose</h3><p class="para" id="N65543">Pseudoexfoliation (PXF) is a unique form of glaucoma characterized by accumulation of exfoliative material in the eyes. Changes in tear profile in disease stages may give us insights into molecular mechanisms involved in causing glaucoma in the eye.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">All patients were categorized into three main categories; pseudoexfoliation (PXF), pseudoexfoliation glaucoma (PXG) and cataract, which served as control. Cytokines, transforming growth factor β1 (TGFβ1), matrix metalloproteases (MMPs) and fibronectin (FN1) were assessed with multiplex bead assay, enzyme-linked immunosorbent assay (ELISA), gelatin zymography, and immunohistochemistry (IHC) respectively in different ocular tissues such as tears, tenon’s capsule, aqueous humor (AH) and serum samples of patients with PXF stages.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">We found that TGFβ1, MMP-9 and FN1 protein expression were upregulated in tears, tenon’s capsule and AH samples in PXG compared to PXF, though the MMP-9 protein activity was downregulated in PXG compared with control or PXF. We have also found that in PXG tears sample the fold change of TGF-α (Transforming Growth Factor-α), MDC (Macrophage Derived Chemokine), IL-8 (Interleukin-8), VEGF (Vascular Endothelial Growth Factor) were significantly downregulated and the levels of GM-CSF (Granulocyte Macrophage Colony Stimulating Factor), IP-10 (Interferon- γ produced protein-10) were significant upregulated. While in AH; IL-6 (Interleukin-6), IL-8, VEGF, IFN-a2 (Interferon- α2), GRO (Growth regulated alpha protein) levels were found lower and IL1a (Interleukin-1α) level was higher in PXG compared to PXF. And in serum; IFN-a2, Eotaxin, GM-CSF, Fractalkine, IL-10 (Interleukin-10), IL1Ra (Interleukin-1 receptor antagonist), IL-7 (Interleukin-7), IL-8, MIP1β (Macrophage Inflammatory Protein-1β), MCP-1 (Monocyte Chemoattractant Protein-1) levels were significantly upregulated and PDGF-AA (Platelet Derived Growth Factor-AA) level was downregulated in the patients with PXG compared to PXF.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusions</h3><p class="para" id="N65561">Altered expression of these molecules in tears may therefore be used as a signal for onset of glaucoma or for identifying eyes at risk of developing glaucoma in PXF.</p></div>]]></description>
            <pubDate><![CDATA[2021-04-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MAUI (MBI Analysis User Interface)—An image processing pipeline for Multiplexed Mass Based Imaging]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766068546309-2bf69b76-5290-47a2-8981-606c5a794dfe/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008887</link>
            <description><![CDATA[<p class="para" id="N65539">Mass Based Imaging (MBI) technologies such as Multiplexed Ion Beam Imaging by time of flight (MIBI-TOF) and Imaging Mass Cytometry (IMC) allow for the simultaneous measurement of the expression levels of 40 or more proteins in biological tissue, providing insight into cellular phenotypes and organization <i>in situ</i>. Imaging artifacts, resulting from the sample, assay or instrumentation complicate downstream analyses and require correction by domain experts. Here, we present MBI Analysis User Interface (MAUI), a series of graphical user interfaces that facilitate this data pre-processing, including the removal of channel crosstalk, noise and antibody aggregates. Our software streamlines these steps and accelerates processing by enabling real-time and interactive parameter tuning across multiple images.</p><p class="para" id="N65542">High-dimensional Imaging technologies allow to simultaneously measure the expression levels of dozens of proteins in biological tissue, providing insight into single-cell phenotypes and organization <i>in situ</i>. Imaging artifacts, resulting from the sample, assay or instrumentation complicate downstream analyses and require correction by domain experts. Here, we present MAUI, a series of graphical user interfaces that facilitate this data pre-processing, including the removal of channel crosstalk, noise and antibody aggregates. MAUI accelerates and automates these steps, such that reproducible, high-quality data will be the input for subsequent stages of analysis.</p>]]></description>
            <pubDate><![CDATA[2021-04-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RhoGTPases and inflammasomes: Guardians of effector-triggered immunity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766068106701-84dd0b4b-1d6f-4d18-a286-6317c1169a65/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009504</link>
            <description><![CDATA[<p class="para" id="N65539">Pathogens have evolved smart strategies to invade hosts and hijack their immune responses. One such strategy is the targeting of the host RhoGTPases by toxins or virulence factors to hijack the cytoskeleton dynamic and immune processes. In response to this microbial attack, the host has evolved an elegant strategy to monitor the function of virulence factors and toxins by sensing the abnormal activity of RhoGTPases. This innate immune strategy of sensing bacterial effector targeting RhoGTPase appears to be a bona fide example of effector-triggered immunity (ETI). Here, we review recently discovered mechanisms by which the host can sense the activity of these toxins through NOD and NOD-like receptors (NLRs).</p>]]></description>
            <pubDate><![CDATA[2021-04-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766067331865-eae8d7a6-8a6d-4552-9fbb-78086b8315db/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0243336</link>
            <description><![CDATA[<p class="para" id="N65539">A joint analysis of the NCI60 small molecule screening data, their genetically defective genes, and mechanisms of action (MOA) of FDA approved cancer drugs screened in the NCI60 is proposed for identifying links between chemosensitivity, genomic defects and MOA. Self-Organizing-Maps (SOMs) are used to organize the chemosensitivity data. Student’s t-tests are used to identify SOM clusters with enhanced chemosensitivity for tumor cell lines with versus without genetically defective genes. Fisher’s exact and chi-square tests are used to reveal instances where defective gene to chemosensitivity associations have enriched MOAs. The results of this analysis find a relatively small set of defective genes, inclusive of <i>ABL1</i>, <i>AXL</i>, <i>BRAF</i>, <i>CDC25A</i>, <i>CDKN2A</i>, <i>IGF1R</i>, <i>KRAS</i>, <i>MECOM</i>, <i>MMP1</i>, <i>MYC</i>, <i>NOTCH1</i>, <i>NRAS</i>, <i>PIK3CG</i>, <i>PTK2</i>, <i>RPTOR</i>, <i>SPTBN1</i>, <i>STAT2</i>, <i>TNKS</i> and <i>ZHX2</i>, as possible candidates for roles in chemosensitivity for compound MOAs that target primarily, but not exclusively, kinases, nucleic acid synthesis, protein synthesis, apoptosis and tubulin. These results find exploitable instances of enhanced chemosensitivity of compound MOA’s for selected defective genes. Collectively these findings will advance the interpretation of pre-clinical screening data as well as contribute towards the goals of cancer drug discovery, development decision making, and explanation of drug mechanisms.</p>]]></description>
            <pubDate><![CDATA[2021-04-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genetic analysis of the septal peptidoglycan synthase FtsWI complex supports a conserved activation mechanism for SEDS-bPBP complexes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766066739261-99b8418f-9294-4953-96eb-0904d571f19a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009366</link>
            <description><![CDATA[<p class="para" id="N65539">SEDS family peptidoglycan (PG) glycosyltransferases, RodA and FtsW, require their cognate transpeptidases PBP2 and FtsI (class B penicillin binding proteins) to synthesize PG along the cell cylinder and at the septum, respectively. The activities of these SEDS-bPBPs complexes are tightly regulated to ensure proper cell elongation and division. In <i>Escherichia coli</i> FtsN switches FtsA and FtsQLB to the active forms that synergize to stimulate FtsWI, but the exact mechanism is not well understood. Previously, we isolated an activation mutation in <i>ftsW</i> (M269I) that allows cell division with reduced FtsN function. To try to understand the basis for activation we isolated additional substitutions at this position and found that only the original substitution produced an active mutant whereas drastic changes resulted in an inactive mutant. In another approach we isolated suppressors of an inactive FtsL mutant and obtained FtsW<sup>E289G</sup> and FtsI<sup>K211I</sup> and found they bypassed FtsN. Epistatic analysis of these mutations and others confirmed that the FtsN-triggered activation signal goes from FtsQLB to FtsI to FtsW. Mapping these mutations, as well as others affecting the activity of FtsWI, on the RodA-PBP2 structure revealed they are located at the interaction interface between the extracellular loop 4 (ECL4) of FtsW and the pedestal domain of FtsI (PBP3). This supports a model in which the interaction between the ECL4 of SEDS proteins and the pedestal domain of their cognate bPBPs plays a critical role in the activation mechanism.</p><p class="para" id="N65542">Bacterial cell division requires the synthesis of septal peptidoglycan by the widely conserved SEDS-bPBP protein complex FtsWI, but how the complex is activated during cell division is still poorly understood. Previous studies suggested that FtsN initiates a signaling cascade in the periplasm to activate FtsWI. Here we isolated and characterized activated FtsW and FtsI mutants and confirmed that the signaling cascade for FtsW activation goes from FtsN to FtsQLB to FtsI and then to FtsW. The residues corresponding to mutations affecting FtsWI activation are clustered to a small region of the interaction interface between the pedestal domain of FtsI and the extracellular loop 4 of FtsW, suggesting that this interaction mediates activation of FtsW. This is strikingly similar to the proposed activation mechanism for the RodA-PBP2 complex, another SEDS-bPBP complex required for cell elongation. Thus, the two homologous SEDS-bPBP complexes are activated similarly by completely unrelated activators that modulate the interaction interface between the SEDS proteins and the bPBPs.</p>]]></description>
            <pubDate><![CDATA[2021-04-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Effect of high-frequency low-intensity pulsed electric field on protecting SH-SY5Y cells against hydrogen peroxide and β-amyloid-induced cell injury via ERK pathway]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766066244725-d850d696-a3a9-4729-a89c-55dc0cf6286f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0250491</link>
            <description><![CDATA[<p class="para" id="N65539">As the most common type of neurodegenerative diseases (NDDs), Alzheimer’s disease (AD) is thought to be caused mainly by the excessive aggregation of β-amyloid protein (Aβ). However, a growing number of studies have found that reactive oxygen species (ROS) play a key role in the onset and progression of AD. The present study aimed to probe the neuroprotective effect of high-frequency low-intensity pulsed electric field (H-LIPEF) for SH-SY5Y cells against hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and Aβ-induced cytotoxicity. By looking in a systematic way into the frequency- and amplitude-dependent neuroprotective effect of pulsed electric field (PEF), the study finds that H-LIPEF at 200 Hz produces the optimal protective effect for SH-SY5Y cells. The underlying mechanisms were confirmed to be due to the activation of extracellular signal-regulated kinase (ERK) pathway and the downstream prosurvival and antioxidant proteins. Because the electric field can be modified to focus on specific area in a non-contact manner, the study suggests that H-LIPEF holds great potential for treating NDDs, whose effect can be further augmented with the administering of drugs or natural compounds at the same time.</p>]]></description>
            <pubDate><![CDATA[2021-04-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766066015229-3e436452-bff7-4b2b-95e4-72c79fed5b5e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0250603</link>
            <description><![CDATA[<p class="para" id="N65539">The pathogenesis of GC involves the complex networking of multiple signaling pathways; however, the detailed mechanisms of tumorigenesis of GC remains largely unknown. Therefore, it is necessary to explore novel diagnostic/prognostic biomarkers for GC. In this study, the levels of hsa_circRNA_100269 in gastric cancer (GC) samples and cells were examined, and its effects on the biological functions of GC cells were elucidated. The levels of hsa_circRNA_100269 in specimens/cell lines were examined using RT-qPCR. Cell models with hsa_circRNA_100269 overexpression or knockdown were generated using lentiviral vectors. Cell viability was determined by MTT assay; cell migratory/invasive activity was evaluated using wound healing/Transwell assay. Cell cycle arrest and apoptosis were assessed by flow cytometry; expression of associated markers involved in cell apoptosis, EMT and the PI3K/Akt signaling were determined by RT-qPCR/immunoblotting. In vivo study was also performed using hsa_circRNA_100269 knockout mice. Our findings revealed downregulation of hsa_circRNA_100269 in GC tissues compared to non-cancerous control. Additionally, the levels of PI3K were remarkably elevated in GC tissues, where hsa_circRNA_100269 and PI3K was negatively correlated. Moreover, the expression of hsa_circRNA_100269 was associated with histology grade and occurrence of metastasis in GC patients. In addition, hsa_circRNA_100269 was downregulated in GC cells compared to normal gastric epithelial cells. Overexpressed hsa_circRNA_100269 notably inhibited the proliferation, migration, invasion and EMT of GC cells, whereas cell cycle arrest at G0/G1 phase was promoted and cell apoptosis was enhanced. Moreover, the PI3K/Akt signaling was involved in hsa_circRNA_100269-regulated GC cell proliferation, migration, invasion, EMT and apoptosis. Knockdown of hsa_circRNA_100269 also remarkably induced tumor growth in mouse model. In summary, our findings indicated that the levels of hsa_circRNA_100269 were reduced in GC. Furthermore, hsa_circRNA_100269 could suppress the development of GC by inactivating the PI3K/Akt pathway. More importantly, hsa_circRNA_100269/PI3K/Akt axis may be a novel therapeutic candidate for GC treatment.</p>]]></description>
            <pubDate><![CDATA[2021-04-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Farnesyl pyrophosphate is a new danger signal inducing acute cell death]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766065748495-277fcb58-19f1-4c0c-bbbc-382717f1ecc7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001134</link>
            <description><![CDATA[<p class="para" id="N65539">Cell death is a vital event in life. Infections and injuries cause lytic cell death, which gives rise to danger signals that can further induce cell death, inflammation, and tissue damage. The mevalonate (MVA) pathway is an essential, highly conserved and dynamic metabolic pathway. Here, we discover that farnesyl pyrophosphate (FPP), a metabolic intermediate of the MVA pathway, functions as a newly identified danger signal to trigger acute cell death leading to neuron loss in stroke. Harboring both a hydrophobic 15-carbon isoprenyl chain and a heavily charged pyrophosphate head, FPP leads to acute cell death independent of its downstream metabolic pathways. Mechanistically, extracellular calcium influx and the cation channel transient receptor potential melastatin 2 (TRPM2) exhibit essential roles in FPP-induced cell death. FPP activates TRPM2 opening for ion influx. Furthermore, in terms of a mouse model constructing by middle cerebral artery occlusion (MCAO), FPP accumulates in the brain, which indicates the function of the FPP and TRPM2 danger signal axis in ischemic injury. Overall, our data have revealed a novel function of the MVA pathway intermediate metabolite FPP as a danger signal via transient receptor potential cation channels.</p><p class="para" id="N65540">Farnesyl pyrophosphate, a metabolic intermediate of the cholesterol synthesis pathway, functions as a novel danger signal to trigger acute cell necrosis, and collaborates with activation of the cation channel TRPM2 to play an important role in brain ischemic injury.</p>]]></description>
            <pubDate><![CDATA[2021-04-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[VolPy: Automated and scalable analysis pipelines for voltage imaging datasets]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766065491951-530609f8-53f0-4ad8-b689-c908a084e56a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008806</link>
            <description><![CDATA[<p class="para" id="N65539">Voltage imaging enables monitoring neural activity at sub-millisecond and sub-cellular scale, unlocking the study of subthreshold activity, synchrony, and network dynamics with unprecedented spatio-temporal resolution. However, high data rates (&gt;800MB/s) and low signal-to-noise ratios create bottlenecks for analyzing such datasets. Here we present <i>VolPy</i>, an automated and scalable pipeline to pre-process voltage imaging datasets. <i>VolPy</i> features motion correction, memory mapping, automated segmentation, denoising and spike extraction, all built on a highly parallelizable, modular, and extensible framework optimized for memory and speed. To aid automated segmentation, we introduce a corpus of 24 manually annotated datasets from different preparations, brain areas and voltage indicators. We benchmark <i>VolPy</i> against ground truth segmentation, simulations and electrophysiology recordings, and we compare its performance with existing algorithms in detecting spikes. Our results indicate that <i>VolPy</i>’s performance in spike extraction and scalability are state-of-the-art.</p><p class="para" id="N65542">Roughly 290 million electrical action potentials occur every second in the human brain, facilitating the propagation of signals among cells in the nervous system and driving most of our daily operations. New methods in brain imaging are emerging that have the speed and resolution to capture events in the brain at the pace at which neurons typically communicate. These methods measure voltage in neurons by using light, and therefore can access very detailed brain signaling patterns. However, the adoption of these methods by a larger community, and not a restricted set of experts, is limited by the lack of computational tools, thereby greatly hindering progress in this field. In this paper, we present <i>VolPy</i>, a software framework that greatly facilitates the preprocessing of this new type of imaging datasets. This pipeline incorporates efficient and optimized algorithms that can identify neurons and extract their activity with great accuracy. The presented software will make this new imaging modality accessible to a wide audience.</p>]]></description>
            <pubDate><![CDATA[2021-04-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Constitutive G protein coupling profiles of understudied orphan GPCRs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766064720876-d55a79e6-f8cd-434a-af1d-9d199b8e66ff/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247743</link>
            <description><![CDATA[<p class="para" id="N65539">A large number of GPCRs are potentially valuable drug targets but remain understudied. Many of these lack well-validated activating ligands and are considered “orphan” receptors, and G protein coupling profiles have not been defined for many orphan GPCRs. Here we asked if constitutive receptor activity can be used to determine G protein coupling profiles of orphan GPCRs. We monitored nucleotide-sensitive interactions between 48 understudied orphan GPCRs and five G proteins (240 combinations) using bioluminescence resonance energy transfer (BRET). No receptor ligands were used, but GDP was used as a common G protein ligand to disrupt receptor-G protein complexes. Constitutive BRET between the same receptors and β-arrestins was also measured. We found sufficient GDP-sensitive BRET to generate G protein coupling profiles for 22 of the 48 receptors we studied. Altogether we identified 48 coupled receptor-G protein pairs, many of which have not been described previously. We conclude that receptor-G protein complexes that form spontaneously in the absence of guanine nucleotides can be used to profile G protein coupling of constitutively-active GPCRs. This approach may prove useful for studying G protein coupling of other GPCRs for which activating ligands are not available.</p>]]></description>
            <pubDate><![CDATA[2021-04-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A phylogenetic study of the members of the MAPK and MEK families across Viridiplantae]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766062710279-887cb295-6693-413d-beab-30ba51f76b4d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0250584</link>
            <description><![CDATA[<p class="para" id="N65539">Protein phosphorylation is regulated by the activity of enzymes generically known as kinases. One of those kinases is Mitogen-Activated Protein Kinases (MAPK), which operate through a phosphorylation cascade conformed by members from three related protein kinase families namely MAPK kinase kinase (MEKK), MAPK kinase (MEK), and MAPK; these three acts hierarchically. Establishing the evolution of these proteins in the plant kingdom is an interesting but complicated task because the current MAPK, MAPKK, and MAPKKK subfamilies arose from duplications and subsequent sub-functionalization during the early stage of the emergence of Viridiplantae. Here, an <i>in silico</i> genomic analysis was performed on 18 different plant species, which resulted in the identification of 96 genes not previously annotated as components of the MAPK (70) and MEK (26) families. Interestingly, a deeper analysis of the sequences encoded by such genes revealed the existence of putative domains not previously described as signatures of MAPK and MEK kinases. Additionally, our analysis also suggests the presence of conserved activation motifs besides the canonical TEY and TDY domains, which characterize the MAPK family.</p>]]></description>
            <pubDate><![CDATA[2021-04-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766062523303-d9e86678-e744-4358-863e-baf6e3eaa6c9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0248380</link>
            <description><![CDATA[<p class="para" id="N65539">Inactivating mutations in either <i>TSC1</i> or <i>TSC2</i> cause Tuberous Sclerosis Complex, an autosomal dominant disorder, characterized by multi-system tumor and hamartoma development. Mutation and loss of function of <i>TSC1</i> and/or <i>TSC2</i> also occur in a variety of sporadic cancers, and rapamycin and related drugs show highly variable treatment benefit in patients with such cancers. The TSC1 and TSC2 proteins function in a complex that inhibits mTORC1, a key regulator of cell growth, which acts to enhance anabolic biosynthetic pathways. In this study, we identified and validated five cancer cell lines with <i>TSC1</i> or <i>TSC2</i> mutations and performed a kinase inhibitor drug screen with 197 compounds. The five cell lines were sensitive to several mTOR inhibitors, and cell cycle kinase and HSP90 kinase inhibitors. The IC50 for Torin1 and INK128, both mTOR kinase inhibitors, was significantly increased in three TSC2 null cell lines in which TSC2 expression was restored. Rapamycin was significantly more effective than either INK128 or ganetespib (an HSP90 inhibitor) in reducing the growth of TSC2 null SNU-398 cells in a xenograft model. Combination ganetespib-rapamycin showed no significant enhancement of growth suppression over rapamycin. Hence, although HSP90 inhibitors show strong inhibition of TSC1/TSC2 null cell line growth in vitro, ganetespib showed little benefit at standard dosage in vivo. In contrast, rapamycin which showed very modest growth inhibition in vitro was the best agent for in vivo treatment, but did not cause tumor regression, only growth delay.</p>]]></description>
            <pubDate><![CDATA[2021-04-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A novel yeast hybrid modeling framework integrating Boolean and enzyme-constrained networks enables exploration of the interplay between signaling and metabolism]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766061756888-54d4aec9-4de1-4e0f-89ca-a062f482895b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008891</link>
            <description><![CDATA[<p class="para" id="N65539">The interplay between nutrient-induced signaling and metabolism plays an important role in maintaining homeostasis and its malfunction has been implicated in many different human diseases such as obesity, type 2 diabetes, cancer, and neurological disorders. Therefore, unraveling the role of nutrients as signaling molecules and metabolites together with their interconnectivity may provide a deeper understanding of how these conditions occur. Both signaling and metabolism have been extensively studied using various systems biology approaches. However, they are mainly studied individually and in addition, current models lack both the complexity of the dynamics and the effects of the crosstalk in the signaling system. To gain a better understanding of the interconnectivity between nutrient signaling and metabolism in yeast cells, we developed a hybrid model, combining a Boolean module, describing the main pathways of glucose and nitrogen signaling, and an enzyme-constrained model accounting for the central carbon metabolism of <i>Saccharomyces cerevisiae</i>, using a regulatory network as a link. The resulting hybrid model was able to capture a diverse utalization of isoenzymes and to our knowledge outperforms constraint-based models in the prediction of individual enzymes for both respiratory and mixed metabolism. The model showed that during fermentation, enzyme utilization has a major contribution in governing protein allocation, while in low glucose conditions robustness and control are prioritized. In addition, the model was capable of reproducing the regulatory effects that are associated with the Crabtree effect and glucose repression, as well as regulatory effects associated with lifespan increase during caloric restriction. Overall, we show that our hybrid model provides a comprehensive framework for the study of the non-trivial effects of the interplay between signaling and metabolism, suggesting connections between the Snf1 signaling pathways and processes that have been related to chronological lifespan of yeast cells.</p><p class="para" id="N65542">Elucidating the complex relationship between nutrient-induced signaling and metabolism represents a key in understanding the onset of many different human diseases like obesity, type 3 diabetes, cancer, and many neurological disorders. In this work we proposed a hybrid modeling approach, combining Boolean representation of signaling pathways, like Snf1, TORC1, and PKA with the enzyme constrained model of metabolism linking them via the regulatory network. This allowed us to improve individual model predictions and elucidate how single components in the dynamic signaling layer affect steady-state metabolism. The model has been tested under respiration and fermentation, revealing novel connections and further reproducing the regulatory effects that are associated with the Crabtree effect and glucose repression. Finally, we show a connection between Snf1 signaling and chronological lifespan.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ubiquitin-protein ligase <i>Ubr5</i> cooperates with hedgehog signalling to promote skeletal tissue homeostasis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766061228075-2b7b0b5b-9643-4c17-82ef-227d2fdecd40/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009275</link>
            <description><![CDATA[<p class="para" id="N65539">Mammalian Hedgehog (HH) signalling pathway plays an essential role in tissue homeostasis and its deregulation is linked to rheumatological disorders. UBR5 is the mammalian homologue of the E3 ubiquitin-protein ligase Hyd, a negative regulator of the Hh-pathway in <i>Drosophila</i>. To investigate a possible role of UBR5 in regulation of the musculoskeletal system through modulation of mammalian HH signaling, we created a mouse model for specific loss of <i>Ubr5</i> function in limb bud mesenchyme. Our findings revealed a role for UBR5 in maintaining cartilage homeostasis and suppressing metaplasia. <i>Ubr5</i> loss of function resulted in progressive and dramatic articular cartilage degradation, enlarged, abnormally shaped sesamoid bones and extensive heterotopic tissue metaplasia linked to calcification of tendons and ossification of synovium. Genetic suppression of smoothened (<i>Smo</i><b>),</b> a key mediator of HH signalling, dramatically enhanced the <i>Ubr5</i> mutant phenotype. Analysis of HH signalling in both mouse and cell model systems revealed that loss of <i>Ubr5</i> stimulated canonical HH-signalling while also increasing PKA activity. In addition, human osteoarthritic samples revealed similar correlations between <i>UBR5</i> expression, canonical HH signalling and PKA activity markers. Our studies identified a crucial function for the <i>Ubr5</i> gene in the maintenance of skeletal tissue homeostasis and an unexpected mode of regulation of the HH signalling pathway.</p><p class="para" id="N65542">Ubiquitin ligases modify proteins post-translationally which is essential for a variety of cellular processes. UBR5 is an E3 ubiquitin ligase and in <i>Drosophila</i> is a regulator of Hedgehog signaling. In mammals, the Hedgehog (HH) signalling pathway, among many other roles, plays an essential role in tissue maintenance, a process called homeostasis. A murine genetic system was developed to specifically eliminate UBR5 function from embryonic limb tissue that subsequently forms bone and connective tissue (ligaments and tendons). This approach revealed that UBR5 operates as a potent suppressor of excessive growth of normal cartilage and bone and prevents formation of bone in ectopic sites in connective tissue near the knees and ankle joints. In contrast to abnormal growth, UBR5 inhibits degradation of the articular cartilage that cushions the knee joint leading to extensive exposure of underlying bone. Furthermore, Ubr5 interacts with smoothened, a component of the HH pathway, identifying UBR5 as a regulator of mammalian HH signaling in the postnatal musculoskeletal system. In summary, this work shows that UBR5 interacts with the HH pathway to regulate skeletal homeostasis in and around joints of the legs and identifies targets that may be harnessed for biomedical engineering and clinical applications.</p>]]></description>
            <pubDate><![CDATA[2021-04-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[STRIPAK regulates Slik localization to control mitotic morphogenesis and epithelial integrity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766056385428-9442df2d-6431-405a-b88c-dcb3db4d4358/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201911035</link>
            <description><![CDATA[<p class="para" id="N65540">Cell and tissue morphogenesis are fundamental during development. The authors previously characterized Slik kinase and its effector, moesin, as regulators of mitotic morphogenesis and epithelial integrity. Here, they identify dSTRIPAK as a new regulator of Slik localization to promote moesin activation and functions.</p><p class="para" id="N65539">Proteins of the ezrin, radixin, and moesin (ERM) family control cell and tissue morphogenesis. We previously reported that moesin, the only ERM in <i>Drosophila</i>, controls mitotic morphogenesis and epithelial integrity. We also found that the Pp1-87B phosphatase dephosphorylates moesin, counteracting its activation by the Ste20-like kinase Slik. To understand how this signaling pathway is itself regulated, we conducted a genome-wide RNAi screen, looking for new regulators of moesin activity. We identified that Slik is a new member of the striatin-interacting phosphatase and kinase complex (STRIPAK). We discovered that the phosphatase activity of STRIPAK reduces Slik phosphorylation to promote its cortical association and proper activation of moesin. Consistent with this finding, inhibition of STRIPAK phosphatase activity causes cell morphology defects in mitosis and impairs epithelial tissue integrity. Our results implicate the Slik–STRIPAK complex in the control of multiple morphogenetic processes.</p>]]></description>
            <pubDate><![CDATA[2020-09-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Keeping track of time: The fundamentals of cellular clocks]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766056352662-c1944435-3425-4db2-8e2d-c7356c65c1ac/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202005136</link>
            <description><![CDATA[<p class="para" id="N65540">Gliech and Holland discuss the guiding design principles of biological clocks across a variety of model systems.</p><p class="para" id="N65539">Biological timekeeping enables the coordination and execution of complex cellular processes such as developmental programs, day/night organismal changes, intercellular signaling, and proliferative safeguards. While these systems are often considered separately owing to a wide variety of mechanisms, time frames, and outputs, all clocks are built by calibrating or delaying the rate of biochemical reactions and processes. In this review, we explore the common themes and core design principles of cellular clocks, giving special consideration to the challenges associated with building timers from biochemical components. We also outline how evolution has coopted time to increase the reliability of a diverse range of biological systems.</p>]]></description>
            <pubDate><![CDATA[2020-09-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The DNA damage response links human squamous proliferation with differentiation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766056343555-90151a13-de11-479d-8ee0-5ac804e38b52/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202001063</link>
            <description><![CDATA[<p class="para" id="N65540">Molinuevo et al. show a novel control of epidermoid differentiation by the DNA damage response signals and propose a model for automatic cleansing of stratified self-renewal epithelia facing genotoxic agents.</p><p class="para" id="N65539">How rapid cell multiplication leads to cell differentiation in developing tissues is still enigmatic. This question is central to morphogenesis, cell number control, and homeostasis. Self-renewal epidermoid epithelia are continuously exposed to mutagens and are the most common target of cancer. Unknown mechanisms commit rapidly proliferating cells to post-mitotic terminal differentiation. We have over-activated or inhibited the endogenous DNA damage response (DDR) pathways by combinations of activating TopBP1 protein, specific shRNAs, or chemical inhibitors for ATR, ATM, and/or DNA-PK. The results dissect and demonstrate that these signals control keratinocyte differentiation in proliferating cells independently of actual DNA damage. The DDR limits keratinocyte multiplication upon hyperproliferative stimuli. Moreover, knocking down H2AX, a common target of the DDR pathways, inhibits the epidermoid phenotype. The results altogether show that the DDR is required to maintain the balance proliferation differentiation and suggest that is part of the squamous program. We propose a homeostatic model where genetic damage is automatically and continuously cleansed by cell-autonomous mechanisms.</p>]]></description>
            <pubDate><![CDATA[2020-10-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Novel phospho-switch function of delta-catenin in dendrite development]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766056218354-79b9b744-dec7-48d6-b96d-5de15c01d989/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201909166</link>
            <description><![CDATA[<p class="para" id="N65540">Baumert et al. identify a novel “phospho-switch” within the neuronal protein delta-catenin. This phospho-switch, located at delta-catenin’s C-terminus, is sensitive to upstream glutamate signaling and instructs dendrites to branch versus extend during development by determining delta-catenin’s neuronal binding partners and subsequent modulation of actin-associated proteins.</p><p class="para" id="N65539">In neurons, dendrites form the major sites of information receipt and integration. It is thus vital that, during development, the dendritic arbor is adequately formed to enable proper neural circuit formation and function. While several known processes shape the arbor, little is known of those that govern dendrite branching versus extension. Here, we report a new mechanism instructing dendrites to branch versus extend. In it, glutamate signaling activates mGluR5 receptors to promote Ckd5-mediated phosphorylation of the C-terminal PDZ-binding motif of delta-catenin. The phosphorylation state of this motif determines delta-catenin’s ability to bind either Pdlim5 or Magi1. Whereas the delta:Pdlim5 complex enhances dendrite branching at the expense of elongation, the delta:Magi1 complex instead promotes lengthening. Our data suggest that these complexes affect dendrite development by differentially regulating the small-GTPase RhoA and actin-associated protein Cortactin. We thus reveal a “phospho-switch” within delta-catenin, subject to a glutamate-mediated signaling pathway, that assists in balancing the branching versus extension of dendrites during neural development.</p>]]></description>
            <pubDate><![CDATA[2020-10-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mitogen-activated protein kinase 6 negatively regulates secondary wall biosynthesis by modulating MYB46 protein stability in <i>Arabidopsis thaliana</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766054418095-c8bb9246-6c07-4208-94a2-9db9141ad764/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009510</link>
            <description><![CDATA[<p class="para" id="N65539">The R2R3-MYB transcription factor MYB46 functions as a master switch for secondary cell wall biosynthesis, ensuring the exquisite expression of the secondary wall biosynthetic genes in the tissues where secondary walls are critical for growth and development. At the same time, suppression of its function is needed when/where formation of secondary walls is not desirable. Little is known about how this opposing control of secondary cell wall formation is achieved. We used both transient and transgenic expression of MYB46 and mitogen-activated protein kinase 6 (MPK6) to investigate the molecular mechanism of the post-translational regulation of MYB46. We show that MYB46 is phosphorylated by MPK6, leading to site specific phosphorylation-dependent degradation of MYB46 by the ubiquitin-mediated proteasome pathway. In addition, the MPK6-mediated MYB46 phosphorylation was found to regulate <i>in planta</i> secondary wall forming function of MYB46. Furthermore, we provide experimental evidences that MYB83, a paralog of MYB46, is not regulated by MPK6. The coupling of MPK signaling to MYB46 function provides insights into the tissue- and/or condition-specific activity of MYB46 for secondary wall biosynthesis.</p><p class="para" id="N65542">Secondary cell walls are critical for plant growth and of economic importance to humans as fiber, pulp for paper, and as a renewable source of energy. A master switch for secondary wall biosynthesis, MYB46, ensures the exquisite expression of the biosynthetic genes in the tissues where secondary walls are critical. However, suppression of secondary wall formation is needed during impermanent cessation of vegetative growth triggered by environmental stresses. Although the expression of <i>MYB46</i> is upregulated by abiotic stresses, secondary wall formation may not occur. How is this opposing control achieved? The mitogen-activated protein kinase (MPK) cascade is among the most conserved signal transduction systems in eukaryotes and plays a crucial role in the regulation of biochemical and physiological changes associated with environmental stimuli and phytohormones. In this report, we show that MYB46 is negatively regulated by MPK6 during salt stress, providing a novel insight into a mechanism by which plants incorporate environmental signals into differential regulation of secondary wall biosynthesis.</p>]]></description>
            <pubDate><![CDATA[2021-04-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[<i>activin-2</i> is required for regeneration of polarity on the planarian anterior-posterior axis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766053681860-aaa1636a-e39f-43fb-87ca-4e273dfb211e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009466</link>
            <description><![CDATA[<p class="para" id="N65539">Planarians are flatworms and can perform whole-body regeneration. This ability involves a mechanism to distinguish between anterior-facing wounds that require head regeneration and posterior-facing wounds that require tail regeneration. How this head-tail regeneration polarity decision is made is studied to identify principles underlying tissue-identity specification in regeneration. We report that inhibition of <i>activin-2</i>, which encodes an Activin-like signaling ligand, resulted in the regeneration of ectopic posterior-facing heads following amputation. During tissue turnover in uninjured planarians, positional information is constitutively expressed in muscle to maintain proper patterning. Positional information includes Wnts expressed in the posterior and Wnt antagonists expressed in the anterior. Upon amputation, several wound-induced genes promote re-establishment of positional information. The head-versus-tail regeneration decision involves preferential wound induction of the Wnt antagonist <i>notum</i> at anterior-facing over posterior-facing wounds. Asymmetric activation of <i>notum</i> represents the earliest known molecular distinction between head and tail regeneration, yet how it occurs is unknown. <i>activin-2</i> RNAi animals displayed symmetric wound-induced activation of <i>notum</i> at anterior- and posterior-facing wounds, providing a molecular explanation for their ectopic posterior-head phenotype. <i>activin-2</i> RNAi animals also displayed anterior-posterior (AP) axis splitting, with two heads appearing in anterior blastemas, and various combinations of heads and tails appearing in posterior blastemas. This was associated with ectopic nucleation of anterior poles, which are head-tip muscle cells that facilitate AP and medial-lateral (ML) pattern at posterior-facing wounds. These findings reveal a role for Activin signaling in determining the outcome of AP-axis-patterning events that are specific to regeneration.</p><p class="para" id="N65542">A central problem in animal regeneration is how animals determine what body part to regenerate. Planarians are flatworms that can regenerate any missing body region, and are studied to identify mechanisms underlying regeneration. At transverse amputation planes, a poorly understood mechanism specifies regeneration of either a head or a tail. This head-versus-tail regeneration decision-making process is referred to as regeneration polarity and has been studied for over a century to identify mechanisms that specify what to regenerate. The gene <i>notum</i>, which encodes a Wnt antagonist, is induced within hours after injury preferentially at anterior-facing wounds, where it specifies head regeneration. We report that Activin signaling is required for regeneration polarity, and the underlying asymmetric activation of <i>notum</i> at anterior- over posterior-facing wounds. We propose that Activin signaling is involved in regeneration-specific responses broadly in the animal kingdom.</p>]]></description>
            <pubDate><![CDATA[2021-03-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[<i>CSNK1G2</i> differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766045472953-2336b4f9-b5cf-46b9-8d3f-ee0119f18d52/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246264</link>
            <description><![CDATA[<p class="para" id="N65539">Tamoxifen (TAM) is a selective estrogen receptor modulator used for breast cancer patients. Prolonged use of tamoxifen is not recommended for some patients. In this study, we aimed to identify molecular targets sensitive to TAM using a genome-wide gene deletion library screening of fission yeast heterozygous mutants. From the screening, <i>casein kinase 1 gamma 2</i> (<i>CSNK1G2</i>), a serine-/threonine protein kinase, was the most sensitive target to TAM with a significant cytotoxicity in estrogen receptor-positive (ER<sup>+</sup>) breast cancer cells but with only a slight toxicity in the case of ER<sup>-</sup> cells. In addition, tumor sphere formation and expression of breast stem cell marker genes such as <i>CD44</i>/<i>CD2</i> were greatly inhibited by <i>CSNK1G2</i> knockdown in ER<sup>+</sup> breast cancer cells. Consistently, <i>CSNK1G2</i> altered ERα activity via phosphorylation, specifically at serine (Ser)<sup>167</sup>, as well as the regulation of estrogen-responsive element (ERE) of estrogen-responsive genes such as <i>CTSD</i> and <i>GREB1</i>. However, <i>ERα</i> silencing almost completely blocked <i>CSNK1G2</i>-induced TAM sensitivity. In ER<sup>+</sup> breast cancer cells, combined treatment with TAM and <i>CSNK1G2</i> knockdown further enhanced the TAM-mediated decrease in phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase (S6K) signaling but not extracellular signal-regulated kinase (ERK) signaling. Inversely, in ER<sup>-</sup> cells treated with TAM, only ERK and PI3K signaling was altered by <i>CSNK1G2</i> knockdown. The CK1 inhibitor, D4476, partly mimicked the <i>CSNK1G2</i> knockdown effect in ER<sup>+</sup> breast cancer cells, but with a broader repression ranging from PI3K/AKT/mTOR/S6K to ERK signaling. Collectively, these results suggest that <i>CSNK1G2</i> plays a key role in sensitizing TAM toxicity in ER<sup>+</sup> and ER<sup>-</sup> breast cancer cells via differently regulating PI3K/AKT/mTOR/S6K and ERK signaling.</p>]]></description>
            <pubDate><![CDATA[2021-04-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Two transcriptionally distinct pathways drive female development in a reptile with both genetic and temperature dependent sex determination]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036867887-50bffe5e-c422-4177-a09f-a39decc629ca/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009465</link>
            <description><![CDATA[<p class="para" id="N65539">How temperature determines sex remains unknown. A recent hypothesis proposes that conserved cellular mechanisms (calcium and redox; ‘CaRe’ status) sense temperature and identify genes and regulatory pathways likely to be involved in driving sexual development. We take advantage of the unique sex determining system of the model organism, <i>Pogona vitticeps</i>, to assess predictions of this hypothesis. <i>P</i>. <i>vitticeps</i> has ZZ male: ZW female sex chromosomes whose influence can be overridden in genetic males by high temperatures, causing male-to-female sex reversal. We compare a developmental transcriptome series of ZWf females and temperature sex reversed ZZf females. We demonstrate that early developmental cascades differ dramatically between genetically driven and thermally driven females, later converging to produce a common outcome (ovaries). We show that genes proposed as regulators of thermosensitive sex determination play a role in temperature sex reversal. Our study greatly advances the search for the mechanisms by which temperature determines sex.</p><p class="para" id="N65542">In many reptiles and fish, environment can determine, or influence, the sex of developing embryos. How this happens at a molecular level that has eluded resolution for half a century of intensive research. We studied the bearded dragon, a lizard that has sex chromosomes (ZZ male and ZW female), but in which that temperature can override ZZ sex chromosomes to cause male to female sex reversal. This provides an unparalleled opportunity to disentangle, in the same species, the biochemical pathways required to make a female by these two different routes. We sequenced the transcriptomes of gonads from developing ZZ reversed and normal ZW dragon embryos and discovered that different sets of genes are active in ovary development driven by genotype or temperature. Females whose sex was initiated by temperature showed a transcriptional profile consistent with the recently-proposed Calcium-Redox hypotheses of cellular temperature sensing. These findings are an important for understanding how the environment influences the development of sex, and more generally how the environment can epigenetically modify the action of genes.</p>]]></description>
            <pubDate><![CDATA[2021-04-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Extracellular spreading of Wingless is required for <i>Drosophila</i> oogenesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766035624887-f15cbe43-ae52-40a6-8c34-982ef33ad35e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009469</link>
            <description><![CDATA[<p class="para" id="N65539">Recent studies have investigated whether the Wnt family of extracellular ligands can signal at long range, spreading from their source and acting as morphogens, or whether they signal only in a juxtacrine manner to neighboring cells. The original evidence for long-range Wnt signaling arose from studies of Wg, a <i>Drosophila</i> Wnt protein, which patterns the wing disc over several cell diameters from a central source of Wg ligand. However, the requirement of long-range Wg for patterning was called into question when it was reported that replacing the secreted protein Wg with a membrane-tethered version, NRT-Wg, results in flies with normally patterned wings. We and others previously reported that Wg spreads in the ovary about 50 μm or 5 cell diameters, from the cap cells to the follicle stem cells (FSCs) and that Wg stimulates FSC proliferation. We used the <i>NRT-wg</i> flies to analyze the consequence of tethering Wg to the cap cells. <i>NRT-wg</i> homozygous flies are sickly, but we found that hemizygous <i>NRT-wg/null</i> flies, carrying only one copy of tethered Wingless, were significantly healthier. Despite their overall improved health, these hemizygous flies displayed dramatic reductions in fertility and in FSC proliferation. Further, FSC proliferation was nearly undetectable when the <i>wg</i> locus was converted to <i>NRT-wg</i> only in adults, and the resulting germarium phenotype was consistent with a previously reported <i>wg</i> loss-of-function phenotype. We conclude that Wg protein spreads from its source cells in the germarium to promote FSC proliferation.</p><p class="para" id="N65542">Wingless (Wg)/Wnt proteins act as important signals between cells in many contexts. For decades, studies in the <i>Drosophila</i> wing established that Wg signals to distant cells, implying that Wg spreads extracellularly. However, studies in other tissues and organisms have found Wnt ligands signal in a juxtacrine manner, to neighboring cells. Recently the importance of Wg spreading was re-evaluated in the fly wing, spurred by the finding that membrane-tethered Wg, unable to spread from its source cell, can substitute for Wg. These findings fueled a search for other tissues where Wg extracellular spreading is required. The nature of Wg signaling in <i>Drosophila</i> oogenesis has been unclear. In the germarium a visible gradient of Wg spans ~50 μm, reaching from its source to follicle stem cells, but it has been argued that Wg signals from neighboring cells to the stem cells. In this study, we tested the role of Wg spreading by analyzing oogenesis in the tethered-Wg flies. Two copies of tethered Wg cause a non-specific Wg toxicity; however, even when the dose tethered Wg is reduced, ovaries have negligible follicle stem cell proliferation and produce few eggs. Thus, extracellular Wg spreading is essential for follicle stem cell proliferation and oogenesis.</p>]]></description>
            <pubDate><![CDATA[2021-04-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Extracellular vesicles secreted by <i>Giardia duodenalis</i> regulate host cell innate immunity via TLR2 and NLRP3 inflammasome signaling pathways]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766035209223-28e6a4a8-194a-4c49-a522-958b230f41ab/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pntd.0009304</link>
            <description><![CDATA[<p class="para" id="N65539"><i>Giardia duodenalis</i>, also known as <i>G</i>. <i>intestinalis</i> or <i>G</i>. <i>lamblia</i>, is the major cause of giardiasis leading to diarrheal disease with 280 million people infections annually worldwide. Extracellular vesicles (EVs) have emerged as a ubiquitous mechanism participating in cells communications. The aim of this study is to explore the roles of <i>G</i>. <i>duodenalis</i> EVs (GEVs) in host-pathogen interactions using primary mouse peritoneal macrophages as a model. Multiple methods of electron microscopy, nanoparticle tracking analysis, proteomic assays, flow cytometry, immunofluorescence, qPCR, western blot, ELISA, inhibition assays, were used to characterize GEVs, and explore its effects on the host cell innate immunity as well as the underlying mechanism using primary mouse peritoneal macrophages. Results showed that GEVs displayed typical cup-shaped structure with 150 nm in diameter. GEVs could be captured by macrophages and triggered immune response by increasing the production of inflammatory cytokines Il1β, Il6, Il10, Il12, Il17, Ifng, Tnf, Il18, Ccl20 and Cxcl2. Furthermore, activation of TLR2 and NLRP3 inflammasome signaling pathways involved in this process. In addition, CA-074 methyl ester (an inhibitor of cathepsin B) or zVAD-fmk (an inhibitor of pan-caspase) pretreatment entirely diminished these effects triggered by GEVs exposure. Taken together, these findings demonstrated that GEVs could be internalized into mouse peritoneal macrophages and regulate host cell innate immunity via TLR2 and NLRP3 inflammasome signaling pathways.</p><p class="para" id="N65542"><i>G</i>. <i>duodenalis</i>, one of the most common cause of diarrheal diseases, is widely existed in the contaminated water and threatening the public health especially in developing countries. Along with the increasing resistance to anti-<i>G</i>. <i>duodenalis</i> drugs occurs, new targets against giardiasis are of urgently needed. The innate immune system is the first defense line of organism to resist multiple pathogens invasion through recognizing pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs), termed Toll-like receptors (TLRs) on the surface of cell membrane and nucleotide oligomerization domain (Nod)-like receptors (NLRs) inside immune cells. Recently, extracellular vesicles have emerged as a ubiquitous mechanism participating in cells communications. In this study, EVs secreted by extracellular protozoan <i>G</i>. <i>duodenalis</i> were obtained and displayed typical cup-shaped structure with 150 nm in diameter. Moreover, GEVs could enter into primary mouse peritoneal macrophages and regulate host cell innate immunity by up-regulation of various inflammatory cytokines expression. Furthermore, TLR2 and NLRP3 inflammasome signaling pathways involved in this process. This study demonstrated that GEVs could be internalized into primary mouse peritoneal macrophages, regulate host cell innate immunity via TLR2 and NLRP3 inflammasome signaling pathways, and may provide new targets against giardiasis.</p>]]></description>
            <pubDate><![CDATA[2021-04-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Coordinated changes in the expression of Wnt pathway genes following human and rat peripheral nerve injury]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766032949325-55e589ac-ca50-4f3b-a8e2-d4d68b70773f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0249748</link>
            <description><![CDATA[<p class="para" id="N65539">A human neuroma-in continuity (NIC), formed following a peripheral nerve lesion, impedes functional recovery. The molecular mechanisms that underlie the formation of a NIC are poorly understood. Here we show that the expression of multiple genes of the Wnt family, including Wnt5a, is changed in NIC tissue from patients that underwent reconstructive surgery. The role of Wnt ligands in NIC pathology and nerve regeneration is of interest because Wnt ligands are implicated in tissue regeneration, fibrosis, axon repulsion and guidance. The observations in NIC prompted us to investigate the expression of Wnt ligands in the injured rat sciatic nerve and in the dorsal root ganglia (DRG). In the injured nerve, four gene clusters were identified with temporal expression profiles corresponding to particular phases of the regeneration process. In the DRG up- and down regulation of certain Wnt receptors suggests that nerve injury has an impact on the responsiveness of injured sensory neurons to Wnt ligands in the nerve. Immunohistochemistry showed that Schwann cells in the NIC and in the injured nerve are the source of Wnt5a, whereas the Wnt5a receptor Ryk is expressed by axons traversing the NIC. Taken together, these observations suggest a central role for Wnt signalling in peripheral nerve regeneration.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TcpC inhibits toll-like receptor signaling pathway by serving as an E3 ubiquitin ligase that promotes degradation of myeloid differentiation factor 88]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030961851-c74240c0-14c5-4a1a-9e42-47f8e7dfc7d3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009481</link>
            <description><![CDATA[<p class="para" id="N65539">TcpC is a virulence factor of uropathogenic <i>E</i>. <i>coli</i> (UPEC). It was found that TIR domain of TcpC impedes TLR signaling by direct association with MyD88. It has been a long-standing question whether bacterial pathogens have evolved a mechanism to manipulate MyD88 degradation by ubiquitin-proteasome pathway. Here, we show that TcpC is a MyD88-targeted E3 ubiquitin ligase. Kidney macrophages from mice with pyelonephritis induced by TcpC-secreting UPEC showed significantly decreased MyD88 protein levels. Recombinant TcpC (rTcpC) dose-dependently inhibited protein but not mRNA levels of MyD88 in macrophages. Moreover, rTcpC significantly promoted MyD88 ubiquitination and accumulation in proteasomes in macrophages. Cys12 and Trp106 in TcpC are crucial amino acids in maintaining its E3 activity. Therefore, TcpC blocks TLR signaling pathway by degradation of MyD88 through ubiquitin-proteasome system. Our findings provide not only a novel biochemical mechanism underlying TcpC-medicated immune evasion, but also the first example that bacterial pathogens inhibit MyD88-mediated signaling pathway by virulence factors that function as E3 ubiquitin ligase.</p><p class="para" id="N65542">Toll/interleukin-1 receptor domain-containing protein encoded by <i>E</i>. <i>coli</i> (TcpC) is an important virulence factor in many strains of uropathogenic <i>E</i>. <i>coli</i> (UPEC). TcpC-mediated evasion of innate immunity plays an important role in the pathogenesis of UPEC caused urinary tract infection (UTI) including pyelonephritis. In the present study, we show TcpC is an E3 ubiquitin ligase that promotes ubiquitination and degradation of MyD88, hereby blocking the TLR signaling pathway. Our findings not only illuminate the novel biochemical mechanisms underlying TcpC-mediated evasion of innate immunity, but also provide the first example that bacterial pathogens can subvert TLR signaling pathway through virulence factors that function as MyD88-targeted E3 ubiquitin ligase.</p>]]></description>
            <pubDate><![CDATA[2021-03-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cytotoxicity of <i>Vibrio parahaemolyticus</i> AHPND toxin on shrimp hemocytes, a newly identified target tissue, involves binding of toxin to aminopeptidase N1 receptor]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030914939-8765cf22-2dbf-46e2-b2e1-156bac7edc2a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009463</link>
            <description><![CDATA[<p class="para" id="N65539">Acute hepatopancreatic necrosis disease (AHPND) caused by PirAB<sup>VP</sup>-producing strain of <i>Vibrio parahaemolyticus</i>, VP<sub>AHPND</sub>, has seriously impacted the shrimp production. Although the VP<sub>AHPND</sub> toxin is known as the VP<sub>AHPND</sub> virulence factor, a receptor that mediates its action has not been identified. An in-house transcriptome of <i>Litopenaeus vannamei</i> hemocytes allows us to identify two proteins from the aminopeptidase N family, <i>Lv</i>APN1 and <i>Lv</i>APN2, the proteins of which in insect are known to be receptors for Cry toxin. The membrane-bound APN, <i>Lv</i>APN1, was characterized to determine if it was a VP<sub>AHPND</sub> toxin receptor. The increased expression of <i>Lv</i>APN1 was found in hemocytes, stomach, and hepatopancreas after the shrimp were challenged with either VP<sub>AHPND</sub> or the partially purified VP<sub>AHPND</sub> toxin. <i>Lv</i>APN1 knockdown reduced the mortality, histopathological signs of AHPND in the hepatopancreas, and the number of virulent VP<sub>AHPND</sub> bacteria in the stomach after VP<sub>AHPND</sub> toxin challenge. In addition, <i>Lv</i>APN1 silencing prevented the toxin from causing severe damage to the hemocytes and sustained both the total hemocyte count (THC) and the percentage of living hemocytes. We found that the r<i>Lv</i>APN1 directly bound to both rPirA<sup>VP</sup> and rPirB<sup>VP</sup> toxins, supporting the notion that silencing of <i>Lv</i>APN1 prevented the VP<sub>AHPND</sub> toxin from passing through the cell membrane of hemocytes. We concluded that the <i>Lv</i>APN1 was involved in AHPND pathogenesis and acted as a VP<sub>AHPND</sub> toxin receptor mediating the toxin penetration into hemocytes. Besides, this was the first report on the toxic effect of VP<sub>AHPND</sub> toxin on hemocytes other than the known target tissues, hepatopancreas and stomach.</p><p class="para" id="N65542">A specific strain of <i>Vibrio parahaemolyticus</i> causing acute hepatopancreatic necrosis disease (AHPND) in shrimp or VP<sub>AHPND</sub> produces a binary toxin (PirAB<sup>vp</sup> toxin) that is previously known to induce cell death of stomach and hepatopancreas but the molecular mechanism has not been defined. Similar to Cry toxin receptor in insects, a novel aminopeptidase N1 protein from <i>L</i>. <i>vannamei</i> (<i>Lv</i>APN1) was identified as a putative receptor of VP<sub>AHPND</sub> toxin. Suppression of <i>Lv</i>APN1 reduced the number of AHPND virulence plasmids in stomach and occurrence of AHPND clinical sign, sustained the number of total hemocyte count, and elevated the number of viable hemocyte. We demonstrated that VP<sub>AHPND</sub> toxin challenge induces hemocyte cell damage and it interacts with <i>Lv</i>APN1 <i>in vitro</i>. Collectively, our finding suggested that not only stomach and hepatopancreas but also hemocyte are the VP<sub>AHPND</sub> target tissues where <i>Lv</i>APN1 serves as a VP<sub>AHPND</sub> toxin receptor. This study provides novel insight into the contributions of <i>Lv</i>APN1 receptor towards the AHPND pathogenesis in shrimp and may extend to the development of AHPND preventive measure in shrimp.</p>]]></description>
            <pubDate><![CDATA[2021-03-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766024118799-ce6f1cae-a5fb-42ca-bbba-76e72ae09e67/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008870</link>
            <description><![CDATA[<p class="para" id="N65539">The emerging tumor-on-chip (ToC) approaches allow to address biomedical questions out of reach with classical cell culture techniques: in biomimetic 3D hydrogels they partially reconstitute <i>ex vivo</i> the complexity of the tumor microenvironment and the cellular dynamics involving multiple cell types (cancer cells, immune cells, fibroblasts, <i>etc</i>.). However, a clear bottleneck is the extraction and interpretation of the rich biological information contained, sometime hidden, in the cell co-culture videos. In this work, we develop and apply novel video analysis algorithms to automatically measure the cytotoxic effects on human cancer cells (lung and breast) induced either by doxorubicin chemotherapy drug or by autologous tumor-infiltrating cytotoxic T lymphocytes (CTL). A live fluorescent dye (red) is used to selectively pre-stain the cancer cells before co-cultures and a live fluorescent reporter for caspase activity (green) is used to monitor apoptotic cell death. The here described open-source computational method, named STAMP (<span style="text-decoration: underline">s</span>patio<span style="text-decoration: underline">t</span>emporal <span style="text-decoration: underline">a</span>poptosis <span style="text-decoration: underline">m</span>a<span style="text-decoration: underline">p</span>per), extracts the temporal kinetics and the spatial maps of cancer death, by localizing and tracking cancer cells in the red channel, and by counting the red to green transition signals, over 2–3 days. The robustness and versatility of the method is demonstrated by its application to different cell models and co-culture combinations. Noteworthy, this approach reveals the strong contribution of primary cancer-associated fibroblasts (CAFs) to breast cancer chemo-resistance, proving to be a powerful strategy to investigate intercellular cross-talks and drug resistance mechanisms. Moreover, we defined a new parameter, the ‘potential of death induction’, which is computed in time and in space to quantify the impact of dying cells on neighbor cells. We found that, contrary to natural death, cancer death induced by chemotherapy or by CTL is transmissible, in that it promotes the death of nearby cancer cells, suggesting the release of diffusible factors which amplify the initial cytotoxic stimulus.</p><p class="para" id="N65542">The tumor microenvironment (TME) is a very complex cellular ecosystem, composed of the cancer cells (carrying the disease-causing genetic alterations), immune cells and other stromal cells (such as fibroblasts), which contribute to disease progression and drug responses. Here, we investigated these complex cellular dynamics by reconstituting the tumor ecosystems in a very controlled manner within microfluidic devices, with multiple cell populations, generating the so-called ‘tumors-on-chip’, which can be visualized by video-microscopy and treated with anti-cancer drugs. The resulting videos contain a huge amount of information that requires advanced computational approaches to be extracted. In this work, we developed a novel method, named STAMP, that precisely measures the kinetics and the spatial maps of cancer cell deaths within tumor-on-chip. Two case studies are presented: breast cancer cells upon chemotherapy treatment (doxorubicin) and lung cancer cells upon killing by specific immune cells (tumor-infiltrating cytotoxic T lymphocytes). We generated spatio-temporal maps on cancer death uncovering unsuspected relations between death events. This indicates that dying cancer cells might release soluble factors that induce death of neighbor cancer cells. The STAMP method was suitable to study the capacity of fibroblasts to promote resistance of cancer cells to chemotherapy.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cold stress triggers premature fruit abscission through ABA-dependent signal transduction in early developing apple]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766023827876-4a4fe8b4-5dee-4908-b416-ca0110b4df5c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0249975</link>
            <description><![CDATA[<p class="para" id="N65539">Fruit abscission is a complex physiological process that is regulated by internal and environmental factors. During early development, apple fruit are exposed to extreme temperature fluctuations that are associated with premature fruit drop; however, their effect on fruit abscission is largely unknown. We hypothesized that fruit abscission is triggered by cold stress and investigated the molecular basis of premature fruit drop using RNA-Seq and metabolomics data from apple fruit undergoing abscission following cold stress in the field. Genes responsive to abscisic acid signaling and cell wall degradation were upregulated during abscission, consistent with the increased abscisic acid concentrations detected by liquid chromatography-mass spectrometry. We performed <i>ex vivo</i> cold shock experiments with excised tree subunits consisting of a branch, pedicel, and fruit. Abscission induction occurred in the cold-stressed subunits with concurrent upregulation of abscisic acid biosynthesis (<i>MdNCED1</i>) and metabolism (<i>MdCYP707A</i>) genes, and ethylene biosynthesis (<i>MdACS1</i>) and receptor (<i>MdETR2</i>) genes in the pedicel. Another key finding was the activation of cytoplasmic streaming in abscission-zone cells detected by electron microscopy. Our results provide a novel insight into the molecular basis of fruit abscission physiology in response to cold stress in apple.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Distant activation of Notch signaling induces stem cell niche assembly]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766023212634-64715d22-35e5-453d-829e-0e98a844e869/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009489</link>
            <description><![CDATA[<p class="para" id="N65539">Here we show that multiple modes of Notch signaling activation specify the complexity of spatial cellular interactions necessary for stem cell niche assembly. In particular, we studied the formation of the germline stem cell niche in <i>Drosophila</i> ovaries, which is a two-step process whereby terminal filaments are formed first. Then, terminal filaments signal to the adjacent cap cell precursors, resulting in Notch signaling activation, which is necessary for the lifelong acquisition of stem cell niche cell fate. The genetic data suggest that in order to initiate the process of stem cell niche assembly, Notch signaling is activated among non-equipotent cells via distant induction, where germline Delta is delivered to somatic cells located several diameters away via cellular projections generated by primordial germ cells. At the same time, to ensure the robustness of niche formation, terminal filament cell fate can also be induced by somatic Delta via <i>cis-</i> or <i>trans-</i>inhibition. This exemplifies a double security mechanism that guarantees that the germline stem cell niche is formed, since it is indispensable for the adjacent germline precursor cells to acquire and maintain stemness necessary for successful reproduction. These findings contribute to our understanding of the formation of stem cell niches in their natural environment, which is important for stem cell biology and regenerative medicine.</p><p class="para" id="N65542">Adult organs often contain a stem cell niche that maintains stem cells necessary for the replenishment of different types of terminally differentiated cells that are continuously lost. This study reveals that various modes of Notch signaling activation induce the formation of the germline stem cell niche in <i>Drosophila</i>. We show for the first time that even among non-equipotent cells, Notch signaling can be <i>trans-</i>activated via distant induction mode, where the ligand Delta is delivered via cellular protrusions to the somatic stem cell niche precursors located several cell diameters away. Moreover, there is a second security mechanism controlled by the soma that additionally ensures that the stem cell niche is formed. In the stem cell niche precursors, Notch signaling can be locally inhibited by the somatic Delta. While Notch signaling <i>trans-</i>inhibition has been proposed via mathematical modelling, our findings show that a group of cells that have high Delta can be seen in a living organism, confirming that this mode of Notch signaling inhibition by <i>trans-</i>Delta exists <i>in vivo</i>. This work provides significant advances in the understanding of Notch signaling and the stem cell niche formation, which is important for the fields of stem cell biology and regenerative medicine.</p>]]></description>
            <pubDate><![CDATA[2021-03-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Reward signalling in brainstem nuclei under fluctuating blood glucose]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766023007992-8e10b410-29b8-408f-9775-5f426efc0642/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0243899</link>
            <description><![CDATA[<p class="para" id="N65539">Phasic dopamine release from mid-brain dopaminergic neurons is thought to signal errors of reward prediction (RPE). If reward maximisation is to maintain homeostasis, then the value of primary rewards should be coupled to the homeostatic errors they remediate. This leads to the prediction that RPE signals should be configured as a function of homeostatic state and thus diminish with the attenuation of homeostatic error. To test this hypothesis, we collected a large volume of functional MRI data from five human volunteers on four separate days. After fasting for 12 hours, subjects consumed preloads that differed in glucose concentration. Participants then underwent a Pavlovian cue-conditioning paradigm in which the colour of a fixation-cross was stochastically associated with the delivery of water or glucose via a gustometer. This design afforded computation of RPE separately for better- and worse-than expected outcomes during ascending and descending trajectories of serum glucose fluctuations. In the parabrachial nuclei, regional activity coding positive RPEs scaled positively with serum glucose for both ascending and descending glucose levels. The ventral tegmental area and substantia nigra became more sensitive to negative RPEs when glucose levels were ascending. Together, the results suggest that RPE signals in key brainstem structures are modulated by homeostatic trajectories of naturally occurring glycaemic flux, revealing a tight interplay between homeostatic state and the neural encoding of primary reward in the human brain.</p>]]></description>
            <pubDate><![CDATA[2021-04-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[IKAROS is required for the measured response of NOTCH target genes upon external NOTCH signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766022343015-d6a3cf5d-283e-4be7-b762-9bfce338ca34/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009478</link>
            <description><![CDATA[<p class="para" id="N65539">The tumor suppressor IKAROS binds and represses multiple NOTCH target genes. For their induction upon NOTCH signaling, IKAROS is removed and replaced by NOTCH Intracellular Domain (NICD)-associated proteins. However, IKAROS remains associated to other NOTCH activated genes upon signaling and induction. Whether IKAROS could participate to the induction of this second group of NOTCH activated genes is unknown. We analyzed the combined effect of IKAROS abrogation and NOTCH signaling on the expression of NOTCH activated genes in erythroid cells. In IKAROS-deleted cells, we observed that many of these genes were either overexpressed or no longer responsive to NOTCH signaling. IKAROS is then required for the organization of bivalent chromatin and poised transcription of NOTCH activated genes belonging to either of the aforementioned groups. Furthermore, we show that IKAROS-dependent poised organization of the NOTCH target <i>Cdkn1a</i> is also required for its adequate induction upon genotoxic insults. These results highlight the critical role played by IKAROS in establishing bivalent chromatin and transcriptional poised state at target genes for their activation by NOTCH or other stress signals.</p><p class="para" id="N65542">NOTCH1 deregulation can favor hematological malignancies. In addition to RBP-Jκ/NICD/MAML1, other regulators are required for the measured activation of NOTCH target genes. IKAROS is a known repressor of many NOTCH targets. Since it can also favor transcriptional activation and control gene expression levels, we questioned whether IKAROS could participate to the activation of specific NOTCH target genes. We are reporting that upon NOTCH induction, the absence of IKAROS impairs the measured activation of two groups of NOTCH target genes: (i) those overexpressed and characterized by an additive effect imposed by the absence of IKAROS and NOTCH induction; and (ii) those ‘desensitized’ and no more activated by NOTCH. At genes of both groups, IKAROS controls the timely recruitment of the chromatin remodelers CHD4 and BRG1. IKAROS then influences the activation of these genes through the organization of chromatin and poised transcription or through transcriptional elongation control. The importance of the IKAROS controlled and measured activation of genes is not limited to NOTCH signaling as it also characterizes <i>Cdkn1a</i> expression upon genotoxic stress. Thus, these results provide a new perspective on the importance of IKAROS for the adequate cellular response to stress, whether imposed by NOTCH or genotoxic insults.</p>]]></description>
            <pubDate><![CDATA[2021-03-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Identifying treatment options for <i>BRAF</i><sup>V600</sup> wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766022285247-46bd87bb-f215-48fe-ad0a-fbe9d4eb75a6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0248097</link>
            <description><![CDATA[<p class="para" id="N65539">Although combination BRAF and MEK inhibitors are highly effective for the 40–50% of cutaneous metastatic melanomas harboring <i>BRAF</i><sup>V600</sup> mutations, targeted agents have been ineffective for <i>BRAF</i><sup>V600</sup>wild-type (wt) metastatic melanomas. The SU2C Genomics-Enabled Medicine for Melanoma Trial utilized a Simon two-stage optimal design to assess whether comprehensive genomic profiling improves selection of molecular-based therapies for <i>BRAF</i><sup>V600</sup>wt metastatic melanoma patients who had progressed on standard-of-care therapy, which may include immunotherapy. Of the response-evaluable patients, binimetinib was selected for 20 patients randomized to the genomics-enabled arm, and nine were treated on the alternate treatment arm. Response rates for 27 patients treated with targeted recommendations included one (4%) partial response, 18 (67%) with stable disease, and eight (30%) with progressive disease. Post-trial genomic and protein pathway activation mapping identified additional drug classes that may be considered for future studies. Our results highlight the complexity and heterogeneity of metastatic melanomas, as well as how the lack of response in this trial may be associated with limitations including monotherapy drug selection and the dearth of available single and combination molecularly-driven therapies to treat <i>BRAF</i><sup>V600</sup>wt metastatic melanomas.</p>]]></description>
            <pubDate><![CDATA[2021-04-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766022263284-20cba701-8692-4970-bfa2-624f411bd52e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009471</link>
            <description><![CDATA[<p class="para" id="N65539">Platelet-derived growth factor receptor alpha (PDGFRα) serves as an entry receptor for the human cytomegalovirus (HCMV), and soluble PDGFRα-Fc can neutralize HCMV at a half-maximal effective concentration (EC50) of about 10 ng/ml. While this indicates a potential for usage as an HCMV entry inhibitor PDGFRα-Fc can also bind the physiological ligands of PDGFRα (PDGFs), which likely interferes with the respective signaling pathways and represents a potential source of side effects. Therefore, we tested the hypothesis that interference with PDGF signaling can be prevented by mutations in PDGFRα-Fc or combinations thereof, without losing the inhibitory potential for HCMV. To this aim, a targeted mutagenesis approach was chosen. The mutations were quantitatively tested in biological assays for interference with PDGF-dependent signaling as well as inhibition of HCMV infection and biochemically for reduced affinity to PDGF-BB, facilitating quantification of PDGFRα-Fc selectivity for HCMV inhibition. Mutation of Ile 139 to Glu and Tyr 206 to Ser strongly reduced the affinity for PDGF-BB and hence interference with PDGF-dependent signaling. Inhibition of HCMV infection was less affected, thus increasing the selectivity by factor 4 and 8, respectively. Surprisingly, the combination of these mutations had an additive effect on binding of PDGF-BB but not on inhibition of HCMV, resulting in a synergistic 260fold increase of selectivity. In addition, a recently reported mutation, Val 242 to Lys, was included in the analysis. PDGFRα-Fc with this mutation was fully effective at blocking HCMV entry and had a drastically reduced affinity for PDGF-BB. Combining Val 242 to Lys with Ile 139 to Glu and/or Tyr 206 to Ser further reduced PDGF ligand binding beyond detection. In conclusion, this targeted mutagenesis approach identified combinations of mutations in PDGFRα-Fc that prevent interference with PDGF-BB but maintain inhibition of HCMV, which qualifies such mutants as candidates for the development of HCMV entry inhibitors.</p><p class="para" id="N65542">Human cytomegalovirus is a major cause of congenital birth defects. Yet, currently the best way to avoid cytomegalovirus disease is to prevent infection of pregnant women through hygiene measures. Once the mother is infected there is no approved treatment to block transmission to the fetus. One intensively researched option is to neutralize the virus produced by the infected mother with anti-HCMV antibodies. Yet, as the efficiency of this approach remains to be demonstrated, alternative approaches need to be considered. Similar to antibodies, PDGFRα-Fc binds to the virus and blocks infection, but it is more potent and has a broader activity of inhibition which makes it a promising alternative. A problem however is that PDGFRα-Fc can not only bind to the virus but also to PDGFs which are important growth factors involved in cell-cycle regulation and tissue development. The results of this study offer a solution. Combinations of mutations were identified that can be introduced in PDGFRα-Fc to abrogate sequestration of PDGFs. Thus, the potential side effects of PDGFRα-Fc can be circumvented while it remains active against HCMV. These results pave the way for development of PDGFRα-Fc as a promising HCMV inhibitor.</p>]]></description>
            <pubDate><![CDATA[2021-03-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Small extracellular vesicles secreted by vaginal fibroblasts exert inhibitory effect in female stress urinary incontinence through regulating the function of fibroblasts]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766022071758-51710013-5f94-4307-943c-1139f65c37da/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0249977</link>
            <description><![CDATA[<p class="para" id="N65539">Stress urinary incontinence (SUI) is a common condition in women and associated with extra-cellular matrix (ECM) reconstruction, which is mainly regulated by fibroblasts. However, the underlying mechanism remains obscure. Small extracellular vesicles (sEVs) play fundamental biological roles in various cellular functions. Some studies suggested that the sEVs were involved in the metabolism of ECM and the function of fibroblasts. The purpose of our study was to investigate the effect of sEVs secreted by vaginal fibroblasts on the pathogenesis of SUI. We showed that the fibroblasts of female anterior vaginal wall secreted sEVs. Moreover, fibroblasts of females with SUI had significantly elevated secretion of sEVs. The collagen contents, proliferation and migration capacity of fibroblasts were decreased when fibroblasts were co-cultured with fibroblasts-derived sEVs (fibroblast-sEVs) from SUI patients. Proteomic analysis revealed that fibroblast-sEVs contained various differentially expressed proteins including TIMP2, TGF-β and ABCC4, which were involved in signaling pathways of fibroblasts regulation. Therefore, we suggested that fibroblast-sEVs contributed to the pathogenesis of SUI through various proteins including TIMP2, TGF-β and ABCC4.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The capacity of origins to load MCM establishes replication timing patterns]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021416088-262da021-9a5e-4a6c-9b3a-29a4558a3f3f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009467</link>
            <description><![CDATA[<p class="para" id="N65539">Loading of the MCM replicative helicase at origins of replication is a highly regulated process that precedes DNA replication in all eukaryotes. The stoichiometry of MCM loaded at origins has been proposed to be a key determinant of when those origins initiate replication during S phase. Nevertheless, the genome-wide regulation of MCM loading stoichiometry and its direct effect on replication timing remain unclear. In order to investigate why some origins load more MCM than others, we perturbed MCM levels in budding yeast cells and, for the first time, directly measured MCM levels and replication timing in the same experiment. Reduction of MCM levels through degradation of Mcm4, one of the six obligate components of the MCM complex, slowed progression through S phase and increased sensitivity to replication stress. Reduction of MCM levels also led to differential loading at origins during G1, revealing origins that are sensitive to reductions in MCM and others that are not. Sensitive origins loaded less MCM under normal conditions and correlated with a weak ability to recruit the origin recognition complex (ORC). Moreover, reduction of MCM loading at specific origins of replication led to a delay in their replication during S phase. In contrast, overexpression of MCM had no effects on cell cycle progression, relative MCM levels at origins, or replication timing, suggesting that, under optimal growth conditions, cellular MCM levels are not limiting for MCM loading. Our results support a model in which the loading capacity of origins is the primary determinant of MCM stoichiometry in wild-type cells, but that stoichiometry is controlled by origins’ ability to recruit ORC and compete for MCM when MCM becomes limiting.</p><p class="para" id="N65542">The coordinated replication of complex eukaryotic genomes is primarily regulated at the level of replication initiation. Therefore, how initiation is regulated in time and space is an active field of research. A leading hypothesis is that the stoichiometry of MCM, the replicative helicase, at replication origins is a significant determinant of initiation timing. However, how MCM stoichiometry at origins is regulated is unknown. We tested two hypothetical mechanisms for the control of MCM stoichiometry: Origin capacity, in which MCM stoichiometry is constrained by the varying capacity of individual origins to load MCM, and ORC activity, in which MCM stoichiometry is regulated by the varying activity of ORC, the MCM loader, at individual origins. We find that neither mechanism is consistent with our data, but that a hybrid of the two mechanisms is.</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Electrical signalling on Bt and non-Bt cotton plants under stress by <i>Aphis gossypii</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766008998541-6010c600-368b-4185-b8ae-5571f6c1af19/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0249699</link>
            <description><![CDATA[<p class="para" id="N65539">Plants have developed various mechanisms to respond specifically to each biotrophic attack. It has been shown that the electrical signals emitted by plants are associated with herbivory stress responses and can lead to the activation of multiple defences. Bt cotton is a genetically modified pest-resistant plant that produces an insecticide from <i>Bacillus thuringiensis</i> (Bt) to control Lepidopteran species. Surprisingly, there is no study–yet, that characterizes the signalling mechanisms in transgenic cotton plants attacked by non-target insects, such as aphids. In this study, we characterized the production of electrical signals on Bt and non-Bt cotton plants infested with <i>Aphis gossypii</i> and, in addition, we characterized the dispersal behaviour of aphids to correlate this behaviour to plant signalling responses. Electrical signalling of the plants was recorded with an extracellular measurement technique. Impressively, our results showed that both Bt and non-Bt cotton varieties, when attacked by <i>A</i>. <i>gossypii</i>, emitted potential variation-type electrical signals and clearly showed the presence of distinct responses regarding their perception and the behaviour of aphids, with evidence of delay, in terms of signal amount, and almost twice the amount of Cry1F protein was observed on Bt cotton plants at the highest density of insects/plant. We present in our article some hypotheses that are based on plant physiology and insect behaviour to explain the responses found on Bt cotton plants under aphid stress.</p>]]></description>
            <pubDate><![CDATA[2021-04-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766005633606-9f74f563-227c-455c-b78e-e33ef29f08d9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0249558</link>
            <description><![CDATA[<p class="para" id="N65539">Inhibins and activins are dimeric ligands belonging to the TGFβ superfamily with emergent roles in cancer. Inhibins contain an α-subunit (<i>INHA</i>) and a β-subunit (either <i>INHBA</i> or <i>INHBB</i>), while activins are mainly homodimers of either β<sub>A</sub> (<i>INHBA</i>) or β<sub>B</sub> (<i>INHBB</i>) subunits. Inhibins are biomarkers in a subset of cancers and utilize the coreceptors betaglycan (<i>TGFBR3</i>) and endoglin (<i>ENG</i>) for physiological or pathological outcomes. Given the array of prior reports on inhibin, activin and the coreceptors in cancer, this study aims to provide a comprehensive analysis, assessing their functional prognostic potential in cancer using a bioinformatics approach. We identify cancer cell lines and cancer types most dependent and impacted, which included p53 mutated breast and ovarian cancers and lung adenocarcinomas. Moreover, <i>INHA</i> itself was dependent on <i>TGFBR3</i> and <i>ENG/CD105</i> in multiple cancer types. <i>INHA</i>, <i>INHBA</i>, <i>TGFBR3</i>, and <i>ENG</i> also predicted patients’ response to anthracycline and taxane therapy in luminal A breast cancers. We also obtained a gene signature model that could accurately classify 96.7% of the cases based on outcomes. Lastly, we cross-compared gene correlations revealing <i>INHA</i> dependency to <i>TGFBR3</i> or <i>ENG</i> influencing different pathways themselves. These results suggest that inhibins are particularly important in a subset of cancers depending on the coreceptor <i>TGFBR3</i> and <i>ENG</i> and are of substantial prognostic value, thereby warranting further investigation.</p>]]></description>
            <pubDate><![CDATA[2021-04-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Rapamycin inhibits pathogen transmission in mosquitoes by promoting immune activation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765999764816-42ce53d8-0bd4-47d5-af0d-f1685678b98d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009353</link>
            <description><![CDATA[<p class="para" id="N65539">Repeated blood meals provide essential nutrients for mosquito egg development and routes for pathogen transmission. The target of rapamycin, the TOR pathway, is essential for vitellogenesis. However, its influence on pathogen transmission remains to be elucidated. Here, we show that rapamycin, an inhibitor of the TOR pathway, effectively suppresses <i>Plasmodium berghei</i> infection in <i>Anopheles stephensi</i>. <i>An</i>. <i>stephensi</i> injected with rapamycin or feeding on rapamycin-treated mice showed increased resistance to <i>P</i>. <i>berghei</i> infection. Exposing <i>An</i>. <i>stephensi</i> to a rapamycin-coated surface not only decreased the numbers of both oocysts and sporozoites but also impaired mosquito survival and fecundity. Transcriptome analysis revealed that the inhibitory effect of rapamycin on parasite infection was through the enhanced activation of immune responses, especially the NF-κB transcription factor REL2, a regulator of the immune pathway and complement system. Knockdown of <i>REL2</i> in rapamycin-treated mosquitoes abrogated the induction of the complement-like proteins <i>TEP1</i> and <i>SPCLIP1</i> and abolished rapamycin-mediated refractoriness to <i>Plasmodium</i> infection. Together, these findings demonstrate a key role of the TOR pathway in regulating mosquito immune responses, thereby influencing vector competence.</p><p class="para" id="N65542">Anautogenous mosquitoes must consume vertebrate blood meals to complete oogenesis. Repeated blood feeding makes the mosquitoes efficient disease-transmitting vectors. The TOR pathway activated by ingested blood is known as an important regulator for vitellogenesis in mosquitoes. Herein, we show that the protein kinase TOR is involved in the regulation of mosquitoes’ susceptibility to <i>Plasmodium</i> infection. Inhibition of the TOR pathway by rapamycin upregulates the expression of REL2, a transcription factor controlling the expression of a variety of immune effectors. The enhanced immune responses in turn promote parasite elimination. Therefore, the TOR pathway plays a dual role in not only regulating mosquito reproduction but also in their vector potential.</p>]]></description>
            <pubDate><![CDATA[2021-02-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765998662384-b9892870-55ea-4b27-8325-7cf9ec336310/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001113</link>
            <description><![CDATA[<p class="para" id="N65539">Transforming growth factor-β (TGF-β) signaling plays a critical role in promoting epithelial-to-mesenchymal transition (EMT), cell migration, invasion, and tumor metastasis. ΔNp63α, the major isoform of p63 protein expressed in epithelial cells, is a key transcriptional regulator of cell adhesion program and functions as a critical metastasis suppressor. It has been documented that the expression of ΔNp63α is tightly controlled by oncogenic signaling and is frequently reduced in advanced cancers. However, whether TGF-β signaling regulates ΔNp63α expression in promoting metastasis is largely unclear. In this study, we demonstrate that activation of TGF-β signaling leads to stabilization of E3 ubiquitin ligase FBXO3, which, in turn, targets ΔNp63α for proteasomal degradation in a Smad-independent but Erk-dependent manner. Knockdown of FBXO3 or restoration of ΔNp63α expression effectively rescues TGF-β-induced EMT, cell motility, and tumor metastasis in vitro and in vivo. Furthermore, clinical analyses reveal a significant correlation among TGF-β receptor I (TβRI), FBXO3, and p63 protein expression and that high expression of TβRI/FBXO3 and low expression of p63 are associated with poor recurrence-free survival (RFS). Together, these results demonstrate that FBXO3 facilitates ΔNp63α degradation to empower TGF-β signaling in promoting tumor metastasis and that the TβRI-FBXO3-ΔNp63α axis is critically important in breast cancer development and clinical prognosis. This study suggests that FBXO3 may be a potential therapeutic target for advanced breast cancer treatment.</p><p class="para" id="N65540">TGF-β signaling is critical for promoting cancer metastasis, primarily via Smad-dependent regulation of the epithelial-mesenchymal transition; this study reveals that non-canonical TGF-β signaling stabilizes the E3 ubiquitin ligase FBXO3 to target ΔNp63α for degradation, resulting in downregulation of adhesion molecules and promotion of breast cancer metastasis.</p>]]></description>
            <pubDate><![CDATA[2021-02-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765998647362-f4c632c0-7f84-4e1b-8e92-95ea1907879e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0248103</link>
            <description><![CDATA[<p class="para" id="N65539">The incidence of endometrial cancer (EC) has increased over the past years and mainly affects women above the age of 45 years. Metabolic diseases such as obesity and type II diabetes mellitus as well as associated conditions like polycystic ovary syndrome (PCOS), insulin resistance and hyperinsulinemia lead to elevated levels of circulating estrogens. Increased estrogen concentrations, in turn, further trigger the proliferation of endometrial cells and thus promote EC development and progression, especially in the absence of progesterone as seen in postmenopausal women. Elevated blood glucose levels in diabetic patients further contribute to the risk of EC development. Metformin is an insulin-sensitizing biguanide drug, commonly used in the treatment of type II diabetes mellitus, especially in obese patients. Besides its effects on glucose metabolism, metformin displayed anti-cancer effects in various cancer types, including EC. Direct anti-cancer effects of metformin target signaling pathways that are involved in cellular growth and proliferation, e.g. the AKT/PKB/mTOR pathway. Further proteins and pathways have been suggested as potential targets, but the underlying mechanism of action of metformin’s anti-cancer activity is still not completely understood. In the present study, the effects of metformin on protein expression were investigated in the human EC cell line HEC-1A using an affinity proteomic approach. Cells were treated with 0.5 mmol/L metformin over a period of 7 days and changes in the expression pattern of 1,300 different proteins were compared to the expression in untreated control cells as well as insulin-treated cells. Insulin treatment (100 ng/mL) was incorporated into the study in order to implement a model for insulin resistance and associated hyperinsulinemia, conditions that are often observed in obese and diabetic patients. Furthermore, the culture medium was supplemented with 10 nmol/L ß-estradiol (E2) during treatments to mimic increased estrogen levels, a common risk factor for EC development. Based on the most prominent and significant changes in expression, a set of 80 proteins was selected and subjected to a more detailed analysis. The data revealed that metformin and insulin targeted similar pathways in the present study and mostly acted on proteins related to proliferation, migration and tumor immune response. These pathways may be affected in a tumor-promoting as well as a tumor-suppressing way by either metformin treatment or insulin supplementation. The consequences for the cells resulting from the detected expression changes were discussed in detail for several proteins. The presented data helps identify potential targets affected by metformin treatment in EC and allows for a better understanding of the mechanism of action of the biguanide drug’s anti-cancer activity. However, further investigations are necessary to confirm the observations and conclusions drawn from the presented data after metformin administration, especially for proteins that were regulated in a favorable way, i.e. AKT3, CCND2, CD63, CD81, GFAP, IL5, IL17A, IRF4, PI3, and VTCN1. Further proteins might be of interest, where metformin counteracted unfavorable effects that have been induced by hyperinsulinemia.</p>]]></description>
            <pubDate><![CDATA[2021-03-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Immune gene expression networks in sepsis: A network biology approach]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765994992573-fbbdafd8-7cfc-4ce8-8235-fc82d761ae1c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247669</link>
            <description><![CDATA[<p class="para" id="N65539">To study the dysregulated host immune response to infection in sepsis, gene expression profiles from the Gene Expression Omnibus (GEO) datasets GSE54514, GSE57065, GSE64456, GSE95233, GSE66099 and GSE72829 were selected. From the Kyoto Encyclopedia of Genes and Genomes (KEGG) immune system pathways, 998 unique genes were selected, and genes were classified as follows based on gene annotation from KEGG, Gene Ontology, and Reactome: adaptive immunity, antigen presentation, cytokines and chemokines, complement, hematopoiesis, innate immunity, leukocyte migration, NK cell activity, platelet activity, and signaling. After correlation matrix formation, correlation coefficient of 0.8 was selected for network generation and network analysis. Total transcriptome was analyzed for differentially expressed genes (DEG), followed by gene set enrichment analysis. The network topological structure revealed that adaptive immunity tended to form a prominent and isolated cluster in sepsis. Common genes within the cluster from the 6 datasets included <i>CD247</i>, <i>CD8A</i>, <i>ITK</i>, <i>LAT</i>, and <i>LCK</i>. The clustering coefficient and modularity parameters were increased in 5/6 and 4/6 datasets in the sepsis group that seemed to be associated with functional aspect of the network. GSE95233 revealed that the nonsurvivor group showed a prominent and isolated adaptive immunity cluster, whereas the survivor group had isolated complement-coagulation and platelet-related clusters. T cell receptor signaling (TCR) pathway and antigen processing and presentation pathway were down-regulated in 5/6 and 4/6 datasets, respectively. Complement and coagulation, Fc gamma, epsilon related signaling pathways were up-regulated in 5/6 datasets. Altogether, network and gene set enrichment analysis showed that adaptive-immunity-related genes along with TCR pathway were down-regulated and isolated from immune the network that seemed to be associated with unfavorable prognosis. Prominence of platelet and complement-coagulation-related genes in the immune network was associated with survival in sepsis. Complement-coagulation pathway was up-regulated in the sepsis group that was associated with favorable prognosis. Network and gene set enrichment analysis supported elucidation of sepsis pathogenesis.</p>]]></description>
            <pubDate><![CDATA[2021-03-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765993677673-bf748ce2-a350-4d1a-ad33-381b80fd271b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246828</link>
            <description><![CDATA[<p class="para" id="N65539">Phenotype Prediction Scores (PPS) might be powerful tools to predict traits or the efficacy of treatments based on combinations of Single-Nucleotide Polymorphism <i>(</i>SNPs) in large samples. We developed a novel method to produce PPS models for small samples sizes. The set of SNPs is first filtered on those known to be relevant in biological pathways involved in a clinical condition, and then further filtered repeatedly in a survival strategy to select stabile positive/negative risk alleles. This method is applied on Female Sexual Interest/Arousal Disorder (FSIAD), for which two subtypes has been proposed: 1) a relatively insensitive excitatory system in the brain for sexual cues, and 2) a dysfunctional activation of brain mechanisms for sexual inhibition. A double-blind, randomized, placebo-controlled cross-over experiment was conducted on 129 women with FSIAD. The women received three different on-demand drug-combination treatments during 3 two-week periods: testosterone (0.5 mg) + sildenafil (50 mg), testosterone (0.5 mg) + buspirone (10 mg), or matching placebos. The resulted PPS were independently validated on patient-level and group-level. The AUC scores for T+S of the derivation set was 0.867 (95% CI = 0.796–0.939; p&lt;0.001) and was 0.890 (95% CI = 0.778–1.000; p&lt;0.001) on the validation set. For T+B the AUC of the derivation set was 0.957 (95% CI = 0.921–0.992; p&lt;0.001) and 0.869 (95% CI = 0.746–0.992; p&lt;0.001) for the validation set. Both formulas could reliably predict for each drug who benefit from the on-demand drugs and could therefore be useful in clinical practice.</p>]]></description>
            <pubDate><![CDATA[2021-03-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Calcium-vesicles perform active diffusion in the sea urchin embryo during larval biomineralization]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765992653965-4947c946-4750-4530-91f0-22efa9932898/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008780</link>
            <description><![CDATA[<p class="para" id="N65539">Biomineralization is the process by which organisms use minerals to harden their tissues and provide them with physical support. Biomineralizing cells concentrate the mineral in vesicles that they secret into a dedicated compartment where crystallization occurs. The dynamics of vesicle motion and the molecular mechanisms that control it, are not well understood. Sea urchin larval skeletogenesis provides an excellent platform for investigating the kinetics of mineral-bearing vesicles. Here we used lattice light-sheet microscopy to study the three-dimensional (3D) dynamics of calcium-bearing vesicles in the cells of normal sea urchin embryos and of embryos where skeletogenesis is blocked through the inhibition of Vascular Endothelial Growth Factor Receptor (VEGFR). We developed computational tools for displaying 3D-volumetric movies and for automatically quantifying vesicle dynamics. Our findings imply that calcium vesicles perform an active diffusion motion in both, calcifying (skeletogenic) and non-calcifying (ectodermal) cells of the embryo. The diffusion coefficient and vesicle speed are larger in the mesenchymal skeletogenic cells compared to the epithelial ectodermal cells. These differences are possibly due to the distinct mechanical properties of the two tissues, demonstrated by the enhanced f-actin accumulation and myosinII activity in the ectodermal cells compared to the skeletogenic cells. Vesicle motion is not directed toward the biomineralization compartment, but the vesicles slow down when they approach it, and probably bind for mineral deposition. VEGFR inhibition leads to an increase of vesicle volume but hardly changes vesicle kinetics and doesn’t affect f-actin accumulation and myosinII activity. Thus, calcium vesicles perform an active diffusion motion in the cells of the sea urchin embryo, with diffusion length and speed that inversely correlate with the strength of the actomyosin network. Overall, our studies provide an unprecedented view of calcium vesicle 3D-dynamics and point toward cytoskeleton remodeling as an important effector of the motion of mineral-bearing vesicles.</p><p class="para" id="N65542">Biomineralization is a widespread, fundamental process by which organisms use minerals to harden their tissues. Mineral-bearing vesicles were observed in biomineralizing cells and play an essential role in biomineralization, yet little is known about their three-dimensional (3D) dynamics. Here we quantify 3D-vesicle-dynamics during calcite skeleton formation in sea urchin larvae, using lattice-light-sheet microscopy. We discover that calcium vesicles perform a diffusive motion in both calcifying and non-calcifying cells of the embryo. The diffusion coefficient and vesicle speed are higher in the mesenchymal skeletogenic cells compared to the epithelial ectodermal cells. This difference is possibly due to the higher rigidity of the ectodermal cells as demonstrated by the enhanced signal of f-actin and myosinII activity in these cells compared to the skeletogenic cells. The motion of the vesicles in the skeletogenic cells, is not directed toward the biomineralization compartment but the vesicles slow down near it, possibly to deposit their content. Blocking skeletogenesis through the inhibition of Vascular Endothelial Growth Factor Receptor (VEGFR), increases vesicle volume but doesn’t change the diffusion mode and the cytoskeleton markers in the cells. Our studies reveal the active diffusive motion of mineral bearing vesicles that is apparently defined by the mechanical properties of the cells.</p>]]></description>
            <pubDate><![CDATA[2021-02-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A mathematical model of the role of aggregation in sonic hedgehog signalling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765991258829-ae2873ca-1ce2-41b8-951e-de1e24c7502c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008562</link>
            <description><![CDATA[<p class="para" id="N65539">Effective regulation of the sonic hedgehog (Shh) signalling pathway is essential for normal development in a wide variety of species. Correct Shh signalling requires the formation of Shh aggregates on the surface of producing cells. Shh aggregates subsequently diffuse away and are recognised in receiving cells located elsewhere in the developing embryo. Various mechanisms have been postulated regarding how these aggregates form and what their precise role is in the overall signalling process. To understand the role of these mechanisms in the overall signalling process, we formulate and analyse a mathematical model of Shh aggregation using nonlinear ordinary differential equations. We consider Shh aggregate formation to comprise of multimerisation, association with heparan sulfate proteoglycans (HSPG) and binding with lipoproteins. We show that the size distribution of the Shh aggregates formed on the producing cell surface resembles an exponential distribution, a result in agreement with experimental data. A detailed sensitivity analysis of our model reveals that this exponential distribution is robust to parameter changes, and subsequently, also to variations in the processes by which Shh is recruited by HSPGs and lipoproteins. The work demonstrates the time taken for different sized Shh aggregates to form and the important role this likely plays in Shh diffusion.</p><p class="para" id="N65542">The sonic hedgehog (Shh) pathway is vital for normal development in a wide variety of species and its activity is strictly regulated to ensure correct spatiotemporal patterning of numerous developing tissues. Shh signalling requires the formation of Shh aggregates, formed on producing cells via a range of different mechanisms, that then diffuse to receiving cells. We formulate and analyse a mathematical model of the most well described mechanisms, namely monomer multimerisation, and recruitment of Shh by heparan sulfate proteoglycans and lipoproteins. Our results illustrate a distribution of the size and quantities of aggregates formed by these mechanisms. We found that as a consequence of competition between the mechanisms for Shh monomers the shape distribution of Shh aggregates resembles an exponential distribution. We also found the distribution to be robust to both parameter changes and variations to the processes by which mechanisms recruit Shh. We report that our approach and subsequent results demonstrate that these mechanisms act in synergy allowing Shh to aggregate in various quantities with diverse diffusive abilities. We postulate that this regulation contributes significantly to aid precision in signalling for Shh in areas of development.</p>]]></description>
            <pubDate><![CDATA[2021-02-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765990333835-4239d78a-c5a5-47dd-bd53-3a7c2fe74bb0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247752</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Background/aims</h3><p class="para" id="N65543">Isoalantolactone (IATL) is one of multiple isomeric sesquiterpene lactones and is isolated from inula helenium. IATL has multiple functions such as antibacterial, antihelminthic and antiproliferative activities. IATL also inhibits pancreatic cancer proliferation and induces apoptosis by increasing ROS production. However, the detailed mechanism of IATL-mediated pancreatic cancer apoptosis remains largely unknown.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">In current study, pancreatic carcinoma cell lines (PANC-1, AsPC-1, BxPC-3) and a mouse xenograft model were used to determine the mechanism of IATL-mediated toxic effects.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">IATL (20μM) inhibited pancreatic adenocarcinoma cell lines proliferation in a time-dependent way; while scratch assay showed that IATL significantly inhibited PANC-1 scratch closure (P&lt;0.05); Invasion assays indicated that IATL significantly attenuated pancreatic adenocarcinoma cell lines invasion on matrigel. Signal analysis showed that IATL inhibited pancreatic adenocarcinoma cell proliferation by blocking EGF-PI3K-Skp2-Akt signal axis. Moreover, IATL induced pancreatic adenocarcinoma cell apoptosis by increasing cytosolic Caspase3 and Box expression. This apoptosis was mediated by inhibition of canonical wnt signal pathway. Finally, xenograft studies showed that IATL also significantly inhibited pancreatic adenocarcinoma cell proliferation and induced pancreatic adenocarcinoma cell apoptosis <i>in vivo</i>.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusions</h3><p class="para" id="N65564">IATL inhibits pancreatic cancer proliferation and induces apoptosis on cellular and <i>in vivo</i> models. Signal pathway studies reveal that EGF-PI3K-Skp2-Akt signal axis and canonical wnt pathway are involved in IATL-mediated cellular proliferation inhibition and apoptosis. These studies indicate that IATL may provide a future potential therapy for pancreatic cancer.</p></div>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765989260440-6239126b-9039-4bc1-a78d-218dbfe3a364/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247858</link>
            <description><![CDATA[<p class="para" id="N65539">Myeloproliferative neoplasms (MPNs) cause the over-production of blood cells such as erythrocytes (polycythemia vera) or platelets (essential thrombocytosis). JAK2 V617F is the most prevalent somatic mutation in many MPNs, but previous modeling of this mutation in mice relied on transgenic overexpression and resulted in diverse phenotypes that were in some cases attributed to expression level. CRISPR-Cas9 engineering offers new possibilities to model and potentially cure genetically encoded disorders via precise modification of the endogenous locus in primary cells. Here we develop “scarless” Cas9-based reagents to create and reverse the JAK2 V617F mutation in an immortalized human erythroid progenitor cell line (HUDEP-2), CD34+ adult human hematopoietic stem and progenitor cells (HSPCs), and immunophenotypic long-term hematopoietic stem cells (LT-HSCs). We find no overt <i>in vitro</i> increase in proliferation associated with an endogenous JAK2 V617F allele, but co-culture with wild type cells unmasks a competitive growth advantage provided by the mutation. Acquisition of the V617F allele also promotes terminal differentiation of erythroid progenitors, even in the absence of hematopoietic cytokine signaling. Taken together, these data are consistent with the gradually progressive manifestation of MPNs and reveals that endogenously acquired JAK2 V617F mutations may yield more subtle phenotypes as compared to transgenic overexpression models.</p>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765988638168-98663488-e3a0-47f7-a87c-2f0e17c90c29/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247817</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65543">Pancreatic adenocarcinoma (PAAD) is a pancreatic disease with a high mortality rate in the world. This present research intends to identify the function of lncRNA LINC00857/miR-340-5p/Transforming growth factor alpha (TGFA) in the progression of PAAD.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">Bioinformatics analysis was used to explore the differentially expressed lncRNA/miRNA/mRNA and analyze the relationship between lncRNA/miRNA/mRNA expression and prognosis of PAAD by enquiring TCGA, GEO and GTE<sub>X</sub>. KEGG pathway analysis and GO enrichment analysis were implemented to annotate the crucial genes regulated by LINC00857. The biological behaviors of PAAD cells were detected by CCK-8, colony formation and transwell assays. Interactive associations between LINC00857 and miR-340-5p, as well as miR-340-5p and TGFA were analyzed by dual luciferase assay.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65558">By enquiring TCGA database, we got that LINC00857 was highly expressed in patients with PAAD and positively associated with worse prognosis in PAAD patients. Moreover, LINC00857 upregulation promoted the proliferation and clone formation abilities of PAAD cells. Afterwards, the downstream miRNA and mRNA targets of LINC00857 were picked up to construct a ceRNA network. Further study revealed that TGFA expression was positively regulated by LINC00857 and negatively regulated by miR-340-5p. Besides that, the inhibitory effect of miR-340-5p on PAAD cells growth and movement can be blocked by LINC00857 upregulation. While, the malignant behavior of PAAD cells induced by TGFA overexpression can be eliminated by LINC00857 knockdown.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusions</h3><p class="para" id="N65564">Upregulation of LINC00857 improved growth, invasion and migration abilities of PAAD cells by modulation of miR-340-5p/TGFA, affording potential targets and biomarkers for the clinical diagnosis and treatment.</p></div>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Margination and adhesion dynamics of tumor cells in a real microvascular network]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765981999366-1f3c5589-79d6-4069-8926-558a69a911b8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008746</link>
            <description><![CDATA[<p class="para" id="N65539">In tumor metastasis, the margination and adhesion of tumor cells are two critical and closely related steps, which may determine the destination where the tumor cells extravasate to. We performed a direct three-dimensional simulation on the behaviors of the tumor cells in a real microvascular network, by a hybrid method of the smoothed dissipative particle dynamics and immersed boundary method (SDPD-IBM). The tumor cells are found to adhere at the microvascular bifurcations more frequently, and there is a positive correlation between the adhesion of the tumor cells and the wall-directed force from the surrounding red blood cells (RBCs). The larger the wall-directed force is, the closer the tumor cells are marginated towards the wall, and the higher the probability of adhesion behavior happen is. A relatively low or high hematocrit can help to prevent the adhesion of tumor cells, and similarly, increasing the shear rate of blood flow can serve the same purpose. These results suggest that the tumor cells may be more likely to extravasate at the microvascular bifurcations if the blood flow is slow and the hematocrit is moderate.</p><p class="para" id="N65542">Cancer is one of leading causes of death in the world, but unfortunately, the mechanism of tumor metastasis remains unclear so far. Intuitively, the tumor metastasis starts from a tumor cell migrating towards the vessel wall (namely margination), then adhering to the vessel wall (namely adhesion), and finally extravasating from where it adheres onto. Hence, it is important to investigate the margination and adhesion of tumor cells for understanding the tumor metastasis. We implemented a three-dimensional simulation to directly reproduce these two processes at a cellular scale, where the dynamic behaviors, such as deformation, aggregation and adhesion, of a lot of cells in a very complex microvascular network are taken into account. The results suggest that the tumor cells may be prone to adhere at the microvascular bifurcations with low shear rate and moderate hematocrit, because of a high wall-directed force from the surrounding RBCs. This implies that the tumor may be more likely to extravasate at the microvascular bifurcations if the blood flow is slow and the hematocrit is moderate. Our work may provide new insights into the cancer pathophysiology and its diagnosis and therapy.</p>]]></description>
            <pubDate><![CDATA[2021-02-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Up-down biphasic volume response of human red blood cells to PIEZO1 activation during capillary transits]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765981824364-19e7f0ef-a369-4ef2-81f0-294ac70b1dc8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008706</link>
            <description><![CDATA[<p class="para" id="N65539">In this paper we apply a novel JAVA version of a model on the homeostasis of human red blood cells (RBCs) to investigate the changes RBCs experience during single capillary transits. In the companion paper we apply a model extension to investigate the changes in RBC homeostasis over the approximately 200000 capillary transits during the ~120 days lifespan of the cells. These are topics inaccessible to direct experimentation but rendered mature for a computational modelling approach by the large body of recent and early experimental results which robustly constrain the range of parameter values and model outcomes, offering a unique opportunity for an in depth study of the mechanisms involved. Capillary transit times vary between 0.5 and 1.5s during which the red blood cells squeeze and deform in the capillary stream transiently opening stress-gated PIEZO1 channels allowing ion gradient dissipation and creating minuscule quantal changes in RBC ion contents and volume. Widely accepted views, based on the effects of experimental shear stress on human RBCs, suggested that quantal changes generated during capillary transits add up over time to develop the documented changes in RBC density and composition during their long circulatory lifespan, the quantal hypothesis. Applying the new red cell model (RCM) we investigated here the changes in homeostatic variables that may be expected during single capillary transits resulting from transient PIEZO1 channel activation. The predicted quantal volume changes were infinitesimal in magnitude, biphasic in nature, and essentially irreversible within inter-transit periods. A sub-second transient PIEZO1 activation triggered a sharp swelling peak followed by a much slower recovery period towards lower-than-baseline volumes. The peak response was caused by net CaCl<sub>2</sub> and fluid gain via PIEZO1 channels driven by the steep electrochemical inward Ca<sup>2+</sup> gradient. The ensuing dehydration followed a complex time-course with sequential, but partially overlapping contributions by KCl loss via Ca<sup>2+</sup>-activated Gardos channels, restorative Ca<sup>2+</sup> extrusion by the plasma membrane calcium pump, and chloride efflux by the Jacobs-Steward mechanism. The change in relative cell volume predicted for single capillary transits was around 10<sup>−5</sup>, an infinitesimal volume change incompatible with a functional role in capillary flow. The biphasic response predicted by the RCM appears to conform to the quantal hypothesis, but whether its cumulative effects could account for the documented changes in density during RBC senescence required an investigation of the effects of myriad transits over the full four months circulatory lifespan of the cells, the subject of the next paper.</p><p class="para" id="N65542">Each human red blood cell traverses narrow capillaries about 1000 to 2000 times per day. Cell deformability is essential for smooth transits and this requires tight control of cell volume well below spherical maxima. The pump-leak ion-flux balance controlling red cell volume involves sodium-potassium and calcium pumps and a constellation of passive membrane transporters. PIEZO1, a mechanosensitive ion channel plays a central role, activating transiently during capillary transits. The main question, not accessible to direct experimentation, is what happens to red cell volume and composition <i>in vivo</i> during each capillary transit. We attempted answering this question by applying novel extensions to a tried and tested model of red cell homeostasis that encodes the current knowledge on the subject. The results revealed an unexpected up-down biphasic volume response characterized by a sharp initial surge caused by CaCl<sub>2</sub> influx via PIEZO1, associated with osmotic fluid gain, followed by a slow reversal, a prediction in conflict with prevailing views. The infinitesimal amplitude of the predicted volume changes precludes them playing a significant role in flow dynamics. In the following paper we explore how the biphasic response helps explain the age-related changes red cells experience during their long circulatory lifespan.</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Fruitless decommissions regulatory elements to implement cell-type-specific neuronal masculinization]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765980627984-65fd55a4-0d2c-4f47-bf0c-77dc4f2d5ace/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009338</link>
            <description><![CDATA[<p class="para" id="N65539">In the fruit fly <i>Drosophila melanogaster</i>, male-specific splicing and translation of the Fruitless transcription factor (Fru<sup>M</sup>) alters the presence, anatomy, and/or connectivity of &gt;60 types of central brain neurons that interconnect to generate male-typical behaviors. While the indispensable function of Fru<sup>M</sup> in sex-specific behavior has been understood for decades, the molecular mechanisms underlying its activity remain unknown. Here, we take a genome-wide, brain-wide approach to identifying regulatory elements whose activity depends on the presence of Fru<sup>M</sup>. We identify 436 high-confidence genomic regions differentially accessible in male <i>fruitless</i> neurons, validate candidate regions as bona fide, differentially regulated enhancers, and describe the particular cell types in which these enhancers are active. We find that individual enhancers are not activated universally but are dedicated to specific <i>fru</i><sup>+</sup> cell types. Aside from <i>fru</i> itself, genes are not dedicated to or common across the <i>fru</i> circuit; rather, Fru<sup>M</sup> appears to masculinize each cell type differently, by tweaking expression of the same effector genes used in other circuits. Finally, we find Fru<sup>M</sup> motifs enriched among regulatory elements that are open in the female but closed in the male. Together, these results suggest that Fru<sup>M</sup> acts cell-type-specifically to decommission regulatory elements in male <i>fruitless</i> neurons.</p><p class="para" id="N65542">Courtship behavior in male <i>Drosophila melanogaster</i> is controlled by a well-defined neural circuit that is labeled by the male-specific transcription factor Fruitless (Fru<sup>M</sup>). While Fru<sup>M</sup> is known to change the number, anatomy and connectivity of neurons which comprise the circuit and has been suggested to repress the expression of a few gene targets, the mechanism of how Fru<sup>M</sup> regulates genes across many different kinds of neurons is unknown. Using an approach to identify gene regulatory elements based on their chromatin accessibility states (ATAC-seq), we identified a large set of chromatin accessibility changes downstream of Fruitless. By examining the activity of these regulatory elements <i>in vivo</i>, we found that their activity was 1) sexually dimorphic and 2) specific to a single class of Fru<sup>M</sup> neurons, suggesting that Fru<sup>M</sup> acts on different chromatin targets in different neuron classes comprising the courtship circuit. Further, we found a known Fru<sup>M</sup>-regulated enhancer of the Fru<sup>M</sup>-repressed gene <i>Lgr3</i> to have closed chromatin specifically in Fru<sup>M</sup> neurons. Combined with an enrichment of Fru<sup>M</sup> motifs in regions which are closed in Fru<sup>M</sup> neurons, we present a mechanism where Fru<sup>M</sup> directs the decommissioning of sex-shared regulatory elements to masculinize neurons in a cell-type specific manner.</p>]]></description>
            <pubDate><![CDATA[2021-02-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[mTORC1 activity is supported by spatial association with focal adhesions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765980400477-2066f8e8-c92d-4dd4-bdcc-268c7ef75e0d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202004010</link>
            <description><![CDATA[<p class="para" id="N65540">Rabanal-Ruiz and Byron et al. present a novel mechanism of nutrient signaling that identifies FAs as key cellular hubs that coordinate growth factor signaling and amino acid input into the cell and are required for efficient downstream activation of mTORC1.</p><p class="para" id="N65539">The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogenic and stress signals to control growth and metabolism. Activation of mTORC1 by amino acids and growth factors involves recruitment of the complex to the lysosomal membrane and is further supported by lysosome distribution to the cell periphery. Here, we show that translocation of lysosomes toward the cell periphery brings mTORC1 into proximity with focal adhesions (FAs). We demonstrate that FAs constitute discrete plasma membrane hubs mediating growth factor signaling and amino acid input into the cell. FAs, as well as the translocation of lysosome-bound mTORC1 to their vicinity, contribute to both peripheral and intracellular mTORC1 activity. Conversely, lysosomal distribution to the cell periphery is dispensable for the activation of mTORC1 constitutively targeted to FAs. This study advances our understanding of spatial mTORC1 regulation by demonstrating that the localization of mTORC1 to FAs is both necessary and sufficient for its activation by growth-promoting stimuli.</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SNX25 regulates proinflammatory cytokine expression via the NF-κB signal in macrophages]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765979294022-90757419-fc5c-4255-a5ca-404b589ffdde/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247840</link>
            <description><![CDATA[<p class="para" id="N65539">Innate immunity is the first line of defense against bacterial infection and is initiated by macrophages. Sorting nexin 25 (SNX25) is an SNX family member and is reported to negatively regulate TGF-β signaling by enhancing TGF receptor degradation. However, few studies have focused on the relationship between SNX25 and the immune system. We knocked down SNX25 expression in macrophages and examined inflammatory cytokine expression, a hallmark of innate immunity, after lipopolysaccharide stimulation. SNX25 knockdown increased proinflammatory cytokine expression in RAW 264.7 cells. In addition, SNX25 knockdown activated the NF-κB signal by promoting ubiquitination of IκBα. These results suggest that SNX25 inhibits the NF-κB signal and thereby regulates proinflammatory cytokine expression in macrophages.</p>]]></description>
            <pubDate><![CDATA[2021-03-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Lhx6 regulates canonical Wnt signaling to control the fate of mesenchymal progenitor cells during mouse molar root patterning]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765977723617-292307c7-e3b9-44eb-9254-95375f131db7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009320</link>
            <description><![CDATA[<p class="para" id="N65539">Mammalian tooth crown formation has long served as a model for investigating how patterning and morphogenesis are orchestrated during development. However, the mechanism underlying root patterning and morphogenesis remains poorly understood. In this study, we find that Lhx6 labels a subpopulation of root progenitor cells in the apical dental mesenchyme, which is closely associated with furcation development. Loss of Lhx6 leads to furcation and root number defects, indicating that Lhx6 is a key root patterning regulator. Among the multiple cellular events regulated by Lhx6 is the odontoblast fate commitment of progenitor cells, which it controls in a cell-autonomous manner. Specifically, <i>Lhx6</i> loss leads to elevated expression of the Wnt antagonist <i>Sfrp2</i> and down-regulation of Wnt signaling in the furcation region, while overactivation of Wnt signaling in Lhx6+ progenitor cells partially restore the furcation defects in <i>Lhx6</i><sup><i>-/-</i></sup> mice. Collectively, our findings have important implications for understanding organ morphogenesis and future strategies for tooth root regeneration.</p><p class="para" id="N65542">In the mammalian dentition, the number of the tooth roots varies in a manner that is finely tailored to the physiological function of each tooth type. Specifically, the anterior incisors and canines, which are mainly responsible for lower occlusal pressure movements such as cutting or shearing, are single-rooted, while the more posterior premolars and molars are multi-rooted and used for motions that require higher bite force such as chewing, crushing and grinding. So far, we have very limited understanding of the molecular mechanism that precisely determines the number of tooth roots. The multi-rooted mouse molar presents an excellent model for us to study this question. Here, we show that the gene <i>Lhx6</i> is a key determinant of mouse molar root number, as the absence of this gene results in the transformation of multi-rooted mouse molars into single-rooted ones. We further show how this gene achieves its functional specificity in determining the tooth root number by controlling the region-specific fate determination of progenitor cells. This finding not only provides clues that could inform future tooth regeneration strategies, but also serves to illustrate developmental processes shared with other mammalian organs.</p>]]></description>
            <pubDate><![CDATA[2021-02-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[EGF receptor–mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765973921329-6d50d241-4740-4c7a-8c04-cebd0c004ab8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202001120</link>
            <description><![CDATA[<p class="para" id="N65540">Chiusa et al. show that the RNA-DNA binding protein FUS plays a profibrotic role by binding to the collagen IV gene promoter and commencing its transcription. Reducing nuclear FUS inhibits collagen IV transcription, suggesting that targeting FUS offers a new antifibrotic therapy.</p><p class="para" id="N65539">Excessive accumulation of collagen leads to fibrosis. Integrin α1β1 (Itgα1β1) prevents kidney fibrosis by reducing collagen production through inhibition of the EGF receptor (EGFR) that phosphorylates cytoplasmic and nuclear proteins. To elucidate how the Itgα1β1/EGFR axis controls collagen synthesis, we analyzed the levels of nuclear tyrosine phosphorylated proteins in WT and Itgα1-null kidney cells. We show that the phosphorylation of the RNA-DNA binding protein fused in sarcoma (FUS) is higher in Itgα1-null cells. FUS contains EGFR-targeted phosphorylation sites and, in Itgα1-null cells, activated EGFR promotes FUS phosphorylation and nuclear translocation. Nuclear FUS binds to the collagen IV promoter, commencing gene transcription that is reduced by inhibiting EGFR, down-regulating FUS, or expressing FUS mutated in the EGFR-targeted phosphorylation sites. Finally, a cell-penetrating peptide that inhibits FUS nuclear translocation reduces FUS nuclear content and collagen IV transcription. Thus, EGFR-mediated FUS phosphorylation regulates FUS nuclear translocation and transcription of a major profibrotic collagen gene. Targeting FUS nuclear translocation offers a new antifibrotic therapy.</p>]]></description>
            <pubDate><![CDATA[2020-07-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PTEN dephosphorylates Abi1 to promote epithelial morphogenesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765973891214-1391e6b4-99a8-4ec6-afeb-ecd99ce6d0c9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201910041</link>
            <description><![CDATA[<p class="para" id="N65540">The tumor suppressor PTEN is essential for epithelial morphogenesis. Qi et al. identify Abi1, a core adaptor protein in the WAVE regulatory complex, as a new PTEN substrate. PTEN dephosphorylates Abi1 and causes Abi1 degradation through calpains and thus down-regulates the WAVE regulatory complex to induce epithelial differentiation and polarization.</p><p class="para" id="N65539">The tumor suppressor PTEN is essential for early development. Its lipid phosphatase activity converts PIP<sub>3</sub> to PIP<sub>2</sub> and antagonizes the PI3K–Akt pathway. In this study, we demonstrate that PTEN’s protein phosphatase activity is required for epiblast epithelial differentiation and polarization. This is accomplished by reconstitution of PTEN-null embryoid bodies with PTEN mutants that lack only PTEN’s lipid phosphatase activity or both PTEN’s lipid and protein phosphatase activities. Phosphotyrosine antibody immunoprecipitation and mass spectrometry were used to identify Abi1, a core component of the WASP-family verprolin homologous protein (WAVE) regulatory complex (WRC), as a new PTEN substrate. We demonstrate that PTEN dephosphorylation of Abi1 at Y213 and S216 results in Abi1 degradation through the calpain pathway. This leads to down-regulation of the WRC and reorganization of the actin cytoskeleton. The latter is critical to the transformation of nonpolar pluripotent stem cells into the polarized epiblast epithelium. Our findings establish a link between PTEN and WAVE-Arp2/3–regulated actin cytoskeletal dynamics in epithelial morphogenesis.</p>]]></description>
            <pubDate><![CDATA[2020-07-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Long noncoding RNA amplified in lung cancer rewires cancer pathways]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765973877511-a5d0dc16-d66e-46f5-b51a-9817c02f45a2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202007098</link>
            <description><![CDATA[<p class="para" id="N65540">Martínez-Terroba and Dimitrova preview work from Athie et al., which demonstrates that the lncRNA <i>ALAL-1</i> promotes lung cancer cell proliferation and immune evasion.</p><p class="para" id="N65539">Athie et al. (2020. <i>J. Cell Biol</i>. https://doi.org/10.1083/jcb.201908078) identify <i>ALAL-1</i>, a lncRNA frequently amplified or overexpressed in lung cancer, as an oncogenic driver, capable of promoting the proliferation and altering the immunogenicity of lung cancer cells.</p>]]></description>
            <pubDate><![CDATA[2020-08-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cancer cells educate natural killer cells to a metastasis-promoting cell state]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765973519468-4aa6322e-f091-48c9-86ec-460e2d302df2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202001134</link>
            <description><![CDATA[<p class="para" id="N65540">Chan et al. show that natural killer (NK) cells can be reprogrammed by breast cancer cells to promote metastasis. Reprogramming can be blocked by targeting NK cell inhibitory receptors TIGIT or KLRG1 or inhibiting DNA methyltransferases, which suggests new approaches to prevent or treat metastasis.</p><p class="para" id="N65539">Natural killer (NK) cells have potent antitumor and antimetastatic activity. It is incompletely understood how cancer cells escape NK cell surveillance. Using ex vivo and in vivo models of metastasis, we establish that keratin-14<sup>+</sup> breast cancer cells are vulnerable to NK cells. We then discovered that exposure to cancer cells causes NK cells to lose their cytotoxic ability and promote metastatic outgrowth. Gene expression comparisons revealed that healthy NK cells have an active NK cell molecular phenotype, whereas tumor-exposed (teNK) cells resemble resting NK cells. Receptor–ligand analysis between teNK cells and tumor cells revealed multiple potential targets. We next showed that treatment with antibodies targeting TIGIT, antibodies targeting KLRG1, or small-molecule inhibitors of DNA methyltransferases (DMNT) each reduced colony formation. Combinations of DNMT inhibitors with anti-TIGIT or anti-KLRG1 antibodies further reduced metastatic potential. We propose that NK-directed therapies targeting these pathways would be effective in the adjuvant setting to prevent metastatic recurrence.</p>]]></description>
            <pubDate><![CDATA[2020-07-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Transcriptome analysis of the role of autophagy in plant response to heat stress]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765969262882-07d1e27b-8859-4394-87e3-3ff1e82a543a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247783</link>
            <description><![CDATA[<p class="para" id="N65539">Autophagy plays a critical role in plant heat tolerance in part by targeting heat-induced nonnative proteins for degradation. Autophagy also regulates metabolism, signaling and other processes and it is less understood how the broad function of autophagy affects plant heat stress responses. To address this issue, we performed transcriptome profiling of Arabidopsis wild-type and autophagy-deficient <i>atg5</i> mutant in response to heat stress. A large number of differentially expressed genes (DEGs) were identified between wild-type and <i>atg5</i> mutant even under normal conditions. These DEGs are involved not only in metabolism, hormone signaling, stress responses but also in regulation of nucleotide processing and DNA repair. Intriguingly, we found that heat treatment resulted in more robust changes in gene expression in wild-type than in the <i>atg5</i> mutant plants. The dampening effect of autophagy deficiency on heat-regulated gene expression was associated with already altered expression of many heat-regulated DEGs prior to heat stress in the <i>atg5</i> mutant. Altered expression of a large number of genes involved in metabolism and signaling in the autophagy mutant prior to heat stress may affect plant response to heat stress. Furthermore, autophagy played a positive role in the expression of defense- and stress-related genes during the early stage of heat stress responses but had little effect on heat-induced expression of heat shock genes. Taken together, these results indicate that the broad role of autophagy in metabolism, cellular homeostasis and other processes can also potentially affect plant heat stress responses and heat tolerance.</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[On the preservation of vessel bifurcations during flow-mediated angiogenic remodelling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765968967106-7b755378-f3ff-491b-baa9-3cd7b7a96b91/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1007715</link>
            <description><![CDATA[<p class="para" id="N65539">During developmental angiogenesis, endothelial cells respond to shear stress by migrating and remodelling the initially hyperbranched plexus, removing certain vessels whilst maintaining others. In this study, we argue that the key regulator of vessel preservation is cell decision behaviour at bifurcations. At flow-convergent bifurcations where migration paths diverge, cells must finely tune migration along both possible paths if the bifurcation is to persist. Experiments have demonstrated that disrupting the cells’ ability to sense shear or the junction forces transmitted between cells impacts the preservation of bifurcations during the remodelling process. However, how these migratory cues integrate during cell decision making remains poorly understood. Therefore, we present the first agent-based model of endothelial cell flow-mediated migration suitable for interrogating the mechanisms behind bifurcation stability. The model simulates flow in a bifurcated vessel network composed of agents representing endothelial cells arranged into a lumen which migrate against flow. Upon approaching a bifurcation where more than one migration path exists, agents refer to a stochastic bifurcation rule which models the decision cells make as a combination of flow-based and collective-based migratory cues. With this rule, cells favour branches with relatively larger shear stress or cell number. We found that cells must integrate both cues nearly equally to maximise bifurcation stability. In simulations with stable bifurcations, we found competitive oscillations between flow and collective cues, and simulations that lost the bifurcation were unable to maintain these oscillations. The competition between these two cues is haemodynamic in origin, and demonstrates that a natural defence against bifurcation loss during remodelling exists: as vessel lumens narrow due to cell efflux, resistance to flow and shear stress increases, attracting new cells to enter and rescue the vessel from regression. Our work provides theoretical insight into the role of junction force transmission has in stabilising vasculature during remodelling and as an emergent mechanism to avoid functional shunting.</p><p class="para" id="N65542">When new blood vessels are created, the endothelial cells that make up these vessels migrate and rearrange in response to blood flow to remodel and optimise the vessel network. An essential part of this process is maintaining the branched structure of the network; however, it is unclear what cues cells consider at regions where vessels branch (i.e., bifurcations). In this research, we present a computer model of cell migration to interrogate the process of preserving bifurcations during remodelling. In this model, cells at bifurcations are influenced by both flow and force transmitted from neighbouring cells. We found that both cues (flow-based and collective-based) must be considered equally in order to preserve branching in the vessel network. In simulations with stable bifurcations, we demonstrated that these cues oscillate: a strong signal in one was accompanied by a weak signal in the other. Furthermore, we found that these cues naturally compete with each other due to the coupling between blood flow and the size of the blood vessels, i.e. larger vessels with more cells produce less flow signals and vice versa. Our research provides insight into how forces transmitted between neighbouring cells stabilise and preserve branching during remodelling, as well as implicates the disruption of this force transmission as a potential mechanism when remodelling goes wrong as in the case of vascular malformation.</p>]]></description>
            <pubDate><![CDATA[2021-02-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Current understanding of the interplays between host hormones and plant viral infections]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949239435-a88649da-cb22-4de0-827d-9d3fdbcb5f34/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009242</link>
            <description><![CDATA[<p class="para" id="N65539">Phytohormones mediate plant development and responses to stresses caused by biotic agents or abiotic factors. The functions of phytohormones in responses to viral infection have been intensively studied, and the emerging picture of complex mechanisms provides insights into the roles that phytohormones play in defense regulation as a whole. These hormone signaling pathways are not simple linear or isolated cascades, but exhibit crosstalk with each other. Here, we summarized the current understanding of recent advances for the classical defense hormones salicylic acid (SA), jasmonic acid (JA), and ethylene (ET) and also the roles of abscisic acid (ABA), auxin, gibberellic acid (GA), cytokinins (CKs), and brassinosteroids (BRs) in modulating plant–virus interactions.</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[State-dependent protein-lipid interactions of a pentameric ligand-gated ion channel in a neuronal membrane]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948227101-6efc7a83-0f3c-4110-aad7-410c3ed8b01b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1007856</link>
            <description><![CDATA[<p class="para" id="N65539">Pentameric ligand-gated ion channels (pLGICs) are receptor proteins that are sensitive to their membrane environment, but the mechanism for how lipids modulate function under physiological conditions in a state dependent manner is not known. The glycine receptor is a pLGIC whose structure has been resolved in different functional states. Using a realistic model of a neuronal membrane coupled with coarse-grained molecular dynamics simulations, we demonstrate that some key lipid-protein interactions are dependent on the receptor state, suggesting that lipids may regulate the receptor’s conformational dynamics. Comparison with existing structural data confirms known lipid binding sites, but we also predict further protein-lipid interactions including a site at the communication interface between the extracellular and transmembrane domain. Moreover, in the active state, cholesterol can bind to the binding site of the positive allosteric modulator ivermectin. These protein-lipid interaction sites could in future be exploited for the rational design of lipid-like allosteric drugs.</p><p class="para" id="N65542">Ion channels are proteins that control the flow of ions into the cell. The family of ion channels known as the pentameric ligand gated ion channels (pLGICS) open in response to the binding of a neurotransmitter, moving the channel from a resting state to an open state. The glycine receptor is a pLGIC whose structure has been resolved in different functional states. It is also known that the response of pLGICs can also be modified by different types of lipids found within the membrane itself but exactly how is unclear. Here, we used a realistic model of a neuronal membrane and performed molecular dynamics simulations to show various lipid-protein interactions that are dependent on the channel state. Our work also reveals previously unconsidered protein-lipid interactions at a key junction of the channel known to be critical for the transmission of the opening process. We also demonstrate that cholesterol interacts with the protein at a site already known to bind to another compound that modulates the channel, called ivermectin. The work should be useful for future design of allosteric modulators.</p>]]></description>
            <pubDate><![CDATA[2021-02-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Berberine ameliorates vascular dysfunction by a global modulation of lncRNA and mRNA expression profiles in hypertensive mouse aortae]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935870262-9ea642d7-65aa-4bcc-8e75-3710ac36a89c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247621</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">The current study investigated the mechanism underlying the therapeutic effects of berberine in the vasculature in hypertension.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">Angiotensin II (Ang II)-loaded osmotic pumps were implanted in C57BL/6J mice with or without berberine administration. Mouse aortae were suspended in myograph for force measurement. Microarray technology were performed to analyze expression profiles of lncRNAs and mRNAs in the aortae. These dysregulated expressions were then validated by qRT-PCR. LncRNA-mRNA co-expression network was constructed to reveal the specific relationships.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">Ang Ⅱ resulted in a significant increase in the blood pressure of mice, which was suppressed by berberine. The impaired endothelium-dependent aortic relaxation was restored in hypertensive mice. Microarray data revealed that 578 lncRNAs and 554 mRNAs were up-regulated, while 320 lncRNAs and 377 mRNAs were down-regulated in the aortae by Ang Ⅱ; both were reversed by berberine treatment. qRT-PCR validation results of differentially expressed genes (14 lncRNAs and 6 mRNAs) were completely consistent with the microarray data. GO analysis showed that these verified differentially expressed genes were significantly enriched in terms of “cellular process”, “biological regulation” and “regulation of biological process”, whilst KEGG analysis identified vascular function-related pathways including cAMP signaling pathway, cGMP-PKG signaling pathway, and calcium signaling pathway etc. Importantly, we observed that lncRNA ENSMUST00000144849, ENSMUST00000155383, and AK041185 were majorly expressed in endothelial cells.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusion</h3><p class="para" id="N65561">The present results suggest that the five lncRNAs ENSMUST00000144849, NR_028422, ENSMUST00000155383, AK041185, and uc.335+ might serve critical regulatory roles in hypertensive vasculature by targeting pivotal mRNAs and subsequently affecting vascular function-related pathways. Moreover, these lncRNAs were modulated by berberine, therefore providing the novel potential therapeutic targets of berberine in hypertension. Furthermore, lncRNA ENSMUST00000144849, ENSMUST00000155383, and AK041185 might be involved in the preservation of vascular endothelial cell function.</p></div>]]></description>
            <pubDate><![CDATA[2021-02-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A versatile workflow to integrate RNA-seq genomic and transcriptomic data into mechanistic models of signaling pathways]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935754829-10efe022-623d-4fae-ab72-f7d9036fbb39/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008748</link>
            <description><![CDATA[<p class="para" id="N65539">MIGNON is a workflow for the analysis of RNA-Seq experiments, which not only efficiently manages the estimation of gene expression levels from raw sequencing reads, but also calls genomic variants present in the transcripts analyzed. Moreover, this is the first workflow that provides a framework for the integration of transcriptomic and genomic data based on a mechanistic model of signaling pathway activities that allows a detailed biological interpretation of the results, including a comprehensive functional profiling of cell activity. MIGNON covers the whole process, from reads to signaling circuit activity estimations, using state-of-the-art tools, it is easy to use and it is deployable in different computational environments, allowing an optimized use of the resources available.</p><p class="para" id="N65542">Currently, RNA massive sequencing RNA-seq is the most extensively used technique for gene expression profiling in a single assay. The output of RNA-seq experiments contains millions of sequences, generated from cDNA libraries produced by the retro-transcription of RNA samples, that need to be processed by computational methods to be transformed into meaningful biological information. Thus, a number of bioinformatic workflows and pipelines have been proposed to produce different types of gene expression measurements, including in some cases, functional annotations to facilitate biological interpretation. While most pipelines focus exclusively on transcriptional data, the ultimate activity of the resulting gene product also depends critically on its integrity. Although traditional hybridization-based transcriptomics methodologies (microarrays) miss this information, RNA-seq data also contains information on variants present in the transcripts that can affect the function of the gene product, which is systematically ignored by current RNA-seq pipelines. MIGNON is the first workflow able to perform an integrative analysis of transcriptomic and genomic data in the proper functional context, provided by a mechanistic model of signaling pathway activity, making thus the most of the information contained in RNA-Seq data. MIGNON is easy to use and to deploy and may become a valuable asset in fields such as personalized medicine.</p>]]></description>
            <pubDate><![CDATA[2021-02-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Association of proangiogenic and profibrotic serum markers with lung function and quality of life in sarcoidosis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935428503-cac56776-e3e2-4944-bf63-0cb8dd390ae9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247197</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65543">Sarcoidosis is a systemic inflammatory granulomatous disease, frequently affecting the lung. If left untreated, it may end in lung fibrosis. Proangiogenic and profibrotic vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-β1, fibroblast growth factor (FGF)-2 and platelet-derived growth factor (PDGF)-AB are a known therapeutical target in pulmonary fibrosing diseases, e.g. IPF, but there is no targeted therapy option for pulmonary fibrosis in sarcoidosis.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65549">The aim of our study was to determine the association of these markers’ serum levels on lung function and the patients’ quality of life in a long-term follow-up of sarcoidosis patients, to provide further information for finding targeted therapy options for pulmonary sarcoidosis.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65555">54 patients with sarcoidosis underwent blood sampling, pulmonary function testing and answered the King’s Brief Interstitial Lung Disease (K-BILD) questionnaire at baseline and at three-years follow-up. Serum levels of profibrotic and angiogenic markers were assessed at baseline by enzyme-linked immunosorbent assay.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65561">Between 2015 and 2018, 54 patients with biopsy proven sarcoidosis were enrolled. Throughout the observation period, there was a significant decrease in the diffusion capacity for carbon monoxide (DLCO) [%] (-6.5504 ± 13,39, p = 0.001) and forced expiratory volume in one second predicted (FEV1) [%] (-6.07 ± 12.09, p = 0.001). Patients with greater impairment of forced vital capacity (FVC) did have significantly higher serum levels of VEGF (p = 0.03) and PDGF-AB (p&lt;0.001). The K-BILD questionnaire did not change significantly during follow-up. However, patients with worsening K-BILD scores did have significantly higher serum-levels of PDGF-AB (2.67 pg/ml ± 0.93 vs. 1.88 pg/ml ± 0.60, p = 0.004) at baseline, compared to those with unchanged or increasing K-BILD scores.</p></div><div class="section" id="sec005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65567">Among patients with pulmonary sarcoidosis, baseline serum levels of VEGF and PDGF-AB were associated with pulmonary function impairment. Furthermore, PDGF-AB was associated with worsening K-BILD scores. No such association was observed for FGF-2 and TGF-ß1. VEGF and PDGF-AB may be possible prognostic and therapeutic targets in sarcoidosis as a fibrosing ILD beyond IPF.</p></div>]]></description>
            <pubDate><![CDATA[2021-02-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[VER/VEGF receptors regulate AMPA receptor surface levels and glutamatergic behavior]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934577078-da488934-a6c7-4659-be0b-d5290729fdc4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009375</link>
            <description><![CDATA[<p class="para" id="N65539">Several intracellular trafficking pathways contribute to the regulation of AMPA receptor (AMPAR) levels at synapses and the control of synaptic strength. While much has been learned about these intracellular trafficking pathways, a major challenge is to understand how extracellular factors, such as growth factors, neuropeptides and hormones, impinge on specific AMPAR trafficking pathways to alter synaptic function and behavior. Here, we identify the secreted ligand PVF-1 and its cognate VEGF receptor homologs, VER-1 and VER-4, as regulators of glutamate signaling in <i>C</i>. <i>elegans</i>. Loss of function mutations in <i>ver-1</i>, <i>ver-4</i>, or <i>pvf-1</i>, result in decreased cell surface levels of the AMPAR GLR-1 and defects in glutamatergic behavior. Rescue experiments indicate that PVF-1 is expressed and released from muscle, whereas the VERs function in GLR-1-expressing neurons to regulate surface levels of GLR-1 and glutamatergic behavior. Additionally, <i>ver-4</i> is unable to rescue glutamatergic behavior in the absence of <i>pvf-1</i>, suggesting that VER function requires endogenous PVF-1. Inducible expression of a <i>pvf-1</i> rescuing transgene suggests that PVF-1 can function in the mature nervous system to regulate GLR-1 signaling. Genetic double mutant analysis suggests that the VERs act together with the VPS-35/retromer recycling complex to promote cell surface levels of GLR-1. Our data support a genetic model whereby PVF-1/VER signaling acts with retromer to promote recycling and cell surface levels of GLR-1 to control behavior.</p><p class="para" id="N65542">Sensation, behavior, and cognition all depend on the proper function of neuronal connections called synapses. Synapses that use the neurotransmitter glutamate to signal between nerve cells are the most abundant type in our brain. Presynaptic neurons release glutamate, which activates glutamate receptors on postsynaptic neurons. Dysfunction of glutamate synapses leads to several neurological disorders, and changing their strength–in part by altering glutamate receptors numbers on the surface of the postsynaptic cell—provides the cellular basis of learning and memory. Much remains to be learned about how factors released from other cell types affects synaptic communication. We took advantage of light-activated molecular switches engineered into specific sensory neurons of <i>C</i>. <i>elegans</i> worms to trigger a behavioral reflex that depends on glutamate synapses. Using this behavior, we identified proteins called VER-1 and VER-4 as important for glutamate synapse function. We found that worms missing these VER proteins or their activator PVF-1 have reduced levels of glutamate receptors at the postsynaptic surface and defects in glutamate-dependent behaviors. Our results suggest that inter-tissue cross-talk between muscle PVF-1 and neuronal VERs is important for controlling the number of glutamate receptors at the cell surface, robust neuronal communication and behavioral responses.</p>]]></description>
            <pubDate><![CDATA[2021-02-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765925413295-20256ec7-7b73-4ad9-b408-c10d1094be1e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246695</link>
            <description><![CDATA[<p class="para" id="N65539">Bovine Respiratory Syncytial virus (BRSV) is one of the major infectious agents in the etiology of the bovine respiratory disease complex. BRSV causes a respiratory syndrome in calves, which is associated with severe bronchiolitis. In this study we describe the effect of treatment with antiviral fusion protein inhibitor (FPI) and ibuprofen, on gene expression in lung tissue of calves infected with BRSV. Calves infected with BRSV are an excellent model of human RSV in infants: we hypothesized that FPI in combination with ibuprofen would provide the best therapeutic intervention for both species. The following experimental treatment groups of BRSV infected calves were used: 1) ibuprofen day 3–10, 2) ibuprofen day 5–10, 3) placebo, 4) FPI day 5–10, 5) FPI and ibuprofen day 5–10, 6) FPI and ibuprofen day 3–10. All calves were infected with BRSV on day 0. Daily clinical evaluation with monitoring of virus shedding by qRT-PCR was conducted. On day10 lung tissue with lesions (LL) and non-lesional (LN) was collected at necropsy, total RNA extracted, and RNA sequencing performed. Differential gene expression analysis was conducted with Gene ontology (GO) and KEGG pathway enrichment analysis. The most significant differential gene expression in BRSV infected lung tissues was observed in the comparison of LL with LN; oxidative stress and cell damage was especially noticeable. Innate and adaptive immune functions were reduced in LL. As expected, combined treatment with FPI and Ibuprofen, when started early, made the most difference in gene expression patterns in comparison with placebo, especially in pathways related to the innate and adaptive immune response in both LL and LN. Ibuprofen, when used alone, negatively affected the antiviral response and caused higher virus loads as shown by increased viral shedding. In contrast, when used with FPI Ibuprofen enhanced the specific antiviral effect of FPI, due to its ability to reduce the damaging effect of prostanoids and oxidative stress.</p>]]></description>
            <pubDate><![CDATA[2021-02-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Systemic and local effect of the <i>Drosophila headcase</i> gene and its role in stress protection of Adult Progenitor Cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765925364837-0ea8090e-5b8f-40b3-ae2b-430f12913a84/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009362</link>
            <description><![CDATA[<p class="para" id="N65539">During the development of a holometabolous insect such as <i>Drosophila</i>, specific group of cells in the larva survive during metamorphosis, unlike the other larval cells, and finally give rise to the differentiated adult structures. These cells, also known as Adult Progenitor Cells (APCs), maintain their multipotent capacity, differentially respond to hormonal and nutritional signals, survive the intrinsic and environmental stress and respond to the final differentiation cues. However, not much is known about the specific molecular mechanisms that account for their unique characteristics. Here we show that a specific <i>Drosophila</i> APC gene, <i>headcase</i> (<i>hdc</i>), has a dual role in the normal development of these cells. It acts at a systemic level by controlling the hormone ecdysone in the prothoracic gland and at the same time it acts locally as a tissue growth suppressor in the APC clusters, where it modulates the activity of the TOR pathway and promotes their survival by contributing in the regulation of the Unfolded Protein Response. We also show that <i>hdc</i> provides protection against stress in the APCs and that its ectopic expression in cells that do not usually express <i>hdc</i> can confer these cells with an additional stress protection. Hdc is the founding member of a group of homolog proteins identified from <i>C</i>. <i>elegans</i> to humans, where has been found associated with cancer progression. The finding that the <i>Drosophila hdc</i> is specifically expressed in progenitor cells and that it provides protection against stress opens up a new hypothesis to be explored regarding the role of the human Heca and its contribution to carcinogenesis.</p><p class="para" id="N65542">In all organisms there are sets of “reserve” cells that have the capacity to self-renew and eventually differentiate to repair or provide new structures. Here we report that the <i>Drosophila headcase</i> gene provides such kinds of cells with a stress protective mechanism. Interestingly, <i>headcase</i> is also involved in providing such “reserve” cells with the signal required for initiating their differentiation into new structures. Thus, <i>headcase</i> establishes a fine equilibrium between differentiation and stress protection of these “reserve” cells. Of note <i>headcase</i> is the founding member of a group of homolog proteins identified in many animals. In humans, the <i>headcase</i> homolog is associated with different kinds of cancers but its function and role remains unknown. The finding that the <i>Drosophila headcase</i> confers stress protection opens up a new way to be explored regarding the role of the human Headcase as it could also act as a stress protector and its drop-off may induce stress conditions favouring the initiation and progression of tumorigenesis.</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Subcellular localization of glypican-5 is associated with dynamic motility of the human mesenchymal stem cell line U3DT]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765923699375-a7b996b1-424f-4d31-b98d-d669ae8ad7b9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0226538</link>
            <description><![CDATA[<p class="para" id="N65539">Glypican-5 (GPC5) is a heparan sulfate proteoglycan (HSPG) localized to the plasma membrane. We previously reported that in the human mesenchymal stem cell line UE6E7T-3, GPC5 is overexpressed in association with transformation and promotes cell proliferation by acting as a co-receptor for Sonic hedgehog signaling. In this study, we found using immunofluorescence microscopy that in transformed cells (U3DT), GPC5 localized not only at primary cilia on the cell surface, but also at the leading edge of migrating cells, at the intercellular bridge and blebs during cytokinesis, and in extracellular vesicles. In each subcellular region, GPC5 colocalized with fibroblast growth factor receptor (FGFR) and the small GTPases Rab11 and ARF6, indicating that GPC5 is delivered to these regions by Rab11-associated recycling endosomes. These colocalizations suggest that GPC5 plays an important role in FGF2 stimulation of cell migration, which was abrogated by knockdown of GPC5. Our findings indicate that GPC5 plays a role in regulation of U3DT cell migration and provides several insights into the functions of GPC5 that could be elucidated by future studies.</p>]]></description>
            <pubDate><![CDATA[2021-02-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Transcriptomic analysis elucidates the molecular processes associated with hydrogen peroxide-induced diapause termination in <i>Artemia</i>-encysted embryos]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765923678340-e52a0928-6ea7-4f4b-8dde-dc39e6c6ef82/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0247160</link>
            <description><![CDATA[<p class="para" id="N65539">Treatment with hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) raises the hatching rate through the development and diapause termination of <i>Artemia</i> cysts. To comprehend the upstream genetic regulation of diapause termination activated by exterior H<sub>2</sub>O<sub>2</sub> elements, an Illumina RNA-seq analysis was performed to recognize and assess comparative transcript amounts to explore the genetic regulation of H<sub>2</sub>O<sub>2</sub> in starting the diapause termination of cysts in <i>Artemia salina</i>. We examined three groupings treated with no H<sub>2</sub>O<sub>2</sub> (control), 180 μM H<sub>2</sub>O<sub>2</sub> (low) and 1800 μM H<sub>2</sub>O<sub>2</sub> (high). The results showed a total of 114,057 unigenes were identified, 41.22% of which were functionally annotated in at least one particular database. When compared to control group, 34 and 98 differentially expressed genes (DEGs) were upregulated in 180 μM and 1800 μM H<sub>2</sub>O<sub>2</sub> treatments, respectively. On the other hand, 162 and 30 DEGs were downregulated in the 180 μM and 1800 μM H<sub>2</sub>O<sub>2</sub> treatments, respectively. Cluster analysis of DEGs demonstrated significant patterns among these types of 3 groups. GO and KEGG enrichment analysis showed the DEGs involved in the regulation of blood coagulation (GO: 0030193; GO: 0050818), regulation of wound healing (GO:0061041), regulation of hemostasis (GO: 1900046), antigen processing and presentation (KO04612), the Hippo signaling pathway (KO04391), as well as the MAPK signaling pathway (KO04010). This research helped to define the diapause-related transcriptomes of <i>Artemia</i> cysts using RNA-seq technology, which might fill up a gap in the prevailing body of knowledge.</p>]]></description>
            <pubDate><![CDATA[2021-02-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Inferring the structures of signaling motifs from paired dynamic traces of single cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906884511-c098e6ad-23af-4690-ab3a-4e8fa8f35af3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008657</link>
            <description><![CDATA[<p class="para" id="N65539">Individual cells show variability in their signaling dynamics that often correlates with phenotypic responses, indicating that cell-to-cell variability is not merely noise but can have functional consequences. Based on this observation, we reasoned that cell-to-cell variability under the same treatment condition could be explained in part by a single signaling motif that maps different upstream signals into a corresponding set of downstream responses. If this assumption holds, then repeated measurements of upstream and downstream signaling dynamics in a population of cells could provide information about the underlying signaling motif for a given pathway, even when no prior knowledge of that motif exists. To test these two hypotheses, we developed a computer algorithm called MISC (Motif Inference from Single Cells) that infers the underlying signaling motif from paired time-series measurements from individual cells. When applied to measurements of transcription factor and reporter gene expression in the yeast stress response, MISC predicted signaling motifs that were consistent with previous mechanistic models of transcription. The ability to detect the underlying mechanism became less certain when a cell’s upstream signal was randomly paired with another cell’s downstream response, demonstrating how averaging time-series measurements across a population obscures information about the underlying signaling mechanism. In some cases, motif predictions improved as more cells were added to the analysis. These results provide evidence that mechanistic information about cellular signaling networks can be systematically extracted from the dynamical patterns of single cells.</p><p class="para" id="N65542">Cells use molecular signaling networks to translate dynamically changing stimuli into appropriate downstream responses. Specialized network structures, or motifs, allow cells to properly decode a variety of temporal input signals. In this paper, we present an algorithm that infers signaling motifs from multiple examples of an upstream signal paired with its downstream response in a population of single cells. We compare the predictive power of single-cell versus averaged time-series traces and the incremental benefit of adding more single-cell traces to the algorithm. We use this approach to understand how yeast respond to environmental stresses.</p>]]></description>
            <pubDate><![CDATA[2021-02-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LncRNAs Landscape in the patients of primary gout by microarray analysis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906477346-feae8132-3659-4877-b118-17936d8d21cf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0232918</link>
            <description><![CDATA[<p class="para" id="N65539">To determine the expression profile and clinical significance of long non-coding RNAs (lncRNAs) in peripheral blood mononuclear cells (PBMCs) of patients with primary gout and healthy control subjects. Human lncRNA microarrays were used to identify the differentially expressed lncRNAs and mRNAs in primary gout patients (n = 6) and healthy control subjects (n = 6). Bioinformatics analyses were performed to predict the roles of differently expressed lncRNAs and mRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect the expression levels of 8 lnRNAs in 64 primary gout patients and 32 healthy control subjects. Spearman’s correlation was used to analyze the correlation between these eight lncRNAs and the laboratory values of gout patients. A receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic value of the lncRNAs identified in gout. The microarray analysis identified 1479 differentially expressed lncRNAs (879 more highly expressed and 600 more lowly expressed), 862 differentially expressed mRNAs (390 more highly expressed and 472 more lowly expressed) in primary gout (fold change &gt; 2, P &lt; 0.05), respectively. The bioinformatic analysis indicated that the differentially expressed lncRNAs regulated the abnormally expressed mRNAs, which were involved in the pathogenesis of gout through several different pathways. The expression levels of TCONS_00004393 and ENST00000566457 were significantly increased in the acute gout flare group than those in the intercritical gout group or healthy subjects (P&lt;0.01). Moreover, inflammation indicators were positive correlated with TCONS_00004393 and ENST00000566457 expression levels. The areas under the ROC curve of ENST00000566457 and NR-026756 were 0.868 and 0.948, respectively. Our results provide novel insight into the mechanisms of primary gout, and reveal that TCONS_00004393 and ENST00000566457 might be as candidate targets for the treatment of gout flare; ENST00000566457 and NR-026756 could effectively discriminate between the gout and the healthy control groups.</p>]]></description>
            <pubDate><![CDATA[2021-02-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Histone modification dynamics at H3K27 are associated with altered transcription of <i>in planta</i> induced genes in <i>Magnaporthe oryzae</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765900630464-b9fc33f9-15a7-4f08-8c20-58bd32fdc339/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009376</link>
            <description><![CDATA[<p class="para" id="N65539">Transcriptional dynamic in response to environmental and developmental cues are fundamental to biology, yet many mechanistic aspects are poorly understood. One such example is fungal plant pathogens, which use secreted proteins and small molecules, termed effectors, to suppress host immunity and promote colonization. Effectors are highly expressed <i>in planta</i> but remain transcriptionally repressed <i>ex planta</i>, but our mechanistic understanding of these transcriptional dynamics remains limited. We tested the hypothesis that repressive histone modification at H3-Lys27 underlies transcriptional silencing <i>ex planta</i>, and that exchange for an active chemical modification contributes to transcription of <i>in planta</i> induced genes. Using genetics, chromatin immunoprecipitation and sequencing and RNA-sequencing, we determined that H3K27me3 provides significant local transcriptional repression. We detail how regions that lose H3K27me3 gain H3K27ac, and these changes are associated with increased transcription. Importantly, we observed that many <i>in planta</i> induced genes were marked by H3K27me3 during axenic growth, and detail how altered H3K27 modification influences transcription. ChIP-qPCR during <i>in planta</i> growth suggests that H3K27 modifications are generally stable, but can undergo dynamics at specific genomic locations. Our results support the hypothesis that dynamic histone modifications at H3K27 contributes to fungal genome regulation and specifically contributes to regulation of genes important during host infection.</p><p class="para" id="N65542">Fungal pathogens of crops and humans pose annual threats to our food and health. There are many steps to the host infection process, during which fungal pathogens display unique growth, and use specific genes to cause disease. Despite this knowledge, many aspects of how pathogens regulate their genome to enact this process remain unknown. Here, we demonstrate how chemical modification of lysine residues on the histone H3, which helps organize and control DNA usage, play an important regulatory role in the model fungal pathogen causing rice blast disease. Our analysis shows a significant association between genes important for host infection and H3 lysine 27 methylation. We show that by experimentally changing histone modifications, many fungal genes normally used during plant infection are turned on outside of the host. Furthermore, we detail how histone modifications can change naturally in the fungus during plant infection. These findings help broaden our knowledge of genome regulation for these pathogens, and advances the goal of a more comprehensive understanding of the infection process.</p>]]></description>
            <pubDate><![CDATA[2021-02-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Corticosteroid-binding-globulin (CBG)-deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765899457602-aeb28d1c-0b1f-4d8b-ad64-7617a70274c5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246930</link>
            <description><![CDATA[<p class="para" id="N65539">Corticosteroid-binding globulin (CBG) is the specific carrier of circulating glucocorticoids, but evidence suggests that it also plays an active role in modulating tissue glucocorticoid activity. CBG polymorphisms affecting its expression or affinity for glucocorticoids are associated with chronic pain, chronic fatigue, headaches, depression, hypotension, and obesity with an altered hypothalamic pituitary adrenal axis. CBG has been localized in hippocampus of humans and rodents, a brain area where glucocorticoids have an important regulatory role. However, the specific CBG function in the hippocampus is yet to be established. The aim of this study was to investigate the effect of the absence of CBG on hippocampal glucocorticoid levels and determine whether pathways regulated by glucocorticoids would be altered. We used <i>cbg</i><sup><i>-/-</i></sup> mice, which display low total-corticosterone and high free-corticosterone blood levels at the nadir of corticosterone secretion (morning) and at rest to evaluate the hippocampus for total- and free-corticosterone levels; 11β-hydroxysteroid dehydrogenase expression and activity; the expression of key proteins involved in glucocorticoid activity and insulin signaling; microtubule-associated protein tau phosphorylation, and neuronal and synaptic function markers. Our results revealed that at the nadir of corticosterone secretion in the resting state the <i>cbg</i><sup><i>-/-</i></sup> mouse hippocampus exhibited slightly elevated levels of free-corticosterone, diminished FK506 binding protein 5 expression, increased corticosterone downstream effectors and altered MAPK and PI3K pathway with increased pY216-GSK3β and phosphorylated tau. Taken together, these results indicate that CBG deficiency triggers metabolic imbalance which could lead to damage and long-term neurological pathologies.</p>]]></description>
            <pubDate><![CDATA[2021-02-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Factors influencing estimates of HIV-1 infection timing using BEAST]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765882276438-6b445280-eab5-4efd-8d77-583dc8ac5acb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008537</link>
            <description><![CDATA[<p class="para" id="N65539">While large datasets of HIV-1 sequences are increasingly being generated, many studies rely on a single gene or fragment of the genome and few comparative studies across genes have been done. We performed genome-based and gene-specific Bayesian phylogenetic analyses to investigate how certain factors impact estimates of the infection dates in an acute HIV-1 infection cohort, RV217. In this cohort, HIV-1 diagnosis corresponded to the first RNA positive test and occurred a median of four days after the last negative test, allowing us to compare timing estimates using BEAST to a narrow window of infection. We analyzed HIV-1 sequences sampled one week, one month and six months after HIV-1 diagnosis in 39 individuals. We found that shared diversity and temporal signal was limited in acute infection, and insufficient to allow timing inferences in the shortest HIV-1 genes, thus dated phylogenies were primarily analyzed for <i>env</i>, <i>gag</i>, <i>pol</i> and near full-length genomes. There was no one best-fitting model across participants and genes, though relaxed molecular clocks (73% of best-fitting models) and the Bayesian skyline (49%) tended to be favored. For infections with single founders, the infection date was estimated to be around one week pre-diagnosis for <i>env</i> (IQR: 3–9 days) and <i>gag</i> (IQR: 5–9 days), whilst the genome placed it at a median of 10 days (IQR: 4–19). Multiply-founded infections proved problematic to date. Our ability to compare timing inferences to precise estimates of HIV-1 infection (within a week) highlights that molecular dating methods can be applied to within-host datasets from early infection. Nonetheless, our results also suggest caution when using uniform clock and population models or short genes with limited information content.</p><p class="para" id="N65542">Molecular dating using phylogenetics allows us to estimate the date of an infection from time-stamped within-host sequences alone. There are large datasets of HIV-1 sequences, but genome and gene analyses are not often performed in parallel and rarely with the possibility to compare results against a known narrow window of infection. We showed that all but the longest genes are near-clonal in acute infection, with little information for dating purposes. For infections with single founders, we estimated the eclipse phase—the time between HIV-1 exposure and the first positive diagnostic test—to last between one and two weeks using <i>env</i>, <i>gag</i>, <i>pol</i> and near full-length genomes. This approach could be used to narrow the date of suspected infection in ongoing clinical trials for the prevention of HIV-1 infection.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Oscillating and stable genome topologies underlie hepatic physiological rhythms during the circadian cycle]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765881820415-421b3d5f-83de-42cd-8f33-3af09c62702e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009350</link>
            <description><![CDATA[<p class="para" id="N65539">The circadian clock drives extensive temporal gene expression programs controlling daily changes in behavior and physiology. In mouse liver, transcription factors dynamics, chromatin modifications, and RNA Polymerase II (PolII) activity oscillate throughout the 24-hour (24h) day, regulating the rhythmic synthesis of thousands of transcripts. Also, 24h rhythms in gene promoter-enhancer chromatin looping accompany rhythmic mRNA synthesis. However, how chromatin organization impinges on temporal transcription and liver physiology remains unclear. Here, we applied time-resolved chromosome conformation capture (4C-seq) in livers of WT and arrhythmic <i>Bmal1</i> knockout mice. In WT, we observed 24h oscillations in promoter-enhancer loops at multiple loci including the core-clock genes <i>Period1</i>, <i>Period2</i> and <i>Bmal1</i>. In addition, we detected rhythmic PolII activity, chromatin modifications and transcription involving stable chromatin loops at clock-output gene promoters representing key liver function such as glucose metabolism and detoxification. Intriguingly, these contacts persisted in clock-impaired mice in which both PolII activity and chromatin marks no longer oscillated. Finally, we observed chromatin interaction hubs connecting neighbouring genes showing coherent transcription regulation across genotypes. Thus, both clock-controlled and clock-independent chromatin topology underlie rhythmic regulation of liver physiology.</p><p class="para" id="N65542">In the eukaryotic cell nucleus, DNA loops bring together gene promoters and distal regulatory elements to tune gene expression. To adapt to the 24h periodic changes in the environment, such as light-dark cycles, many organisms on the planet adopted an internal circadian clock encoded genetically. Thus, animal physiology resonates with external cycles. In mouse liver, thousands of genes, including ones belonging to the central clock, lipid and glucose metabolism, as well as detoxification are expressed with a 24h period. Here, we monitored DNA contacts across the circadian cycle involving the promoters of genes playing key roles in the daily physiology of the mouse liver. While the dynamics of some loops oscillates in sync with gene expression along the 24h day, other loops connected daily active regulatory elements to target gene promoters stably over time. Using arrhythmic mutant animals, we demonstrated that the maintenance of such stable loops goes beyond the circadian clock function. Also, we discovered a set of frequently interacting genes having coherent temporal expression regulation in wild type and clock impaired animals. Thus, both dynamic and static DNA contacts underlie the circadian transcription of mouse liver physiology.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Steroid hormone ecdysone deficiency stimulates preparation for photoperiodic reproductive diapause]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765880358179-60c59700-cd58-442f-8056-3ca21f5bc82e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009352</link>
            <description><![CDATA[<p class="para" id="N65539">Diapause, a programmed developmental arrest primarily induced by seasonal environmental changes, is very common in the animal kingdom, and found in vertebrates and invertebrates alike. Diapause provides an adaptive advantage to animals, as it increases the odds of surviving adverse conditions. In insects, individuals perceive photoperiodic cues and modify endocrine signaling to direct reproductive diapause traits, such as ovary arrest and increased fat accumulation. However, it remains unclear as to which endocrine factors are involved in this process and how they regulate the onset of reproductive diapause. Here, we found that the long day-mediated drop in the concentration of the steroid hormone ecdysone is essential for the preparation of photoperiodic reproductive diapause in <i>Colaphellus bowringi</i>, an economically important cabbage beetle. The diapause-inducing long-day condition reduced the expression of ecdysone biosynthetic genes, explaining the drop in the titer of 20-hydroxyecdysone (20E, the active form of ecdysone) in female adults. Application of exogenous 20E induced vitellogenesis and ovarian development but reduced fat accumulation in the diapause-destined females. Knocking down the <i>ecdysone receptor</i> (<i>EcR</i>) in females destined for reproduction blocked reproductive development and induced diapause traits. RNA-seq and hormone measurements indicated that 20E stimulates the production of juvenile hormone (JH), a key endocrine factor in reproductive diapause. To verify this, we depleted three ecdysone biosynthetic enzymes via RNAi, which confirmed that 20E is critical for JH biosynthesis and reproductive diapause. Importantly, impairing <i>Met</i> function, a component of the JH intracellular receptor, partially blocked the 20E-regulated reproductive diapause preparation, indicating that 20E regulates reproductive diapause in both JH-dependent and -independent manners. Finally, we found that 20E deficiency decreased ecdysis-triggering hormone signaling and reduced JH production, thereby inducing diapause. Together, these results suggest that 20E signaling is a pivotal regulator that coordinates reproductive plasticity in response to environmental inputs.</p><p class="para" id="N65542">Developmental arrest pervades organismal development and physiology where it facilitates an enormous range of adaptive responses to stressful conditions. Many animals exhibit various forms of developmental arrest that ensures survival under the most adverse environments. Reproductive diapause occurs when adults temporarily suspend reproduction in response to environmental stress and has been documented for a variety of invertebrates, particularly insects. Endocrine signals play a central role in translating environmental cues such as photoperiod into reproductive diapause-related physiology and behavior. However, it has been an unresolved issue as to which endocrine factors can respond to photoperiodic inputs and regulate diapause outputs. In this study, we found that a decrease in ecdysone levels is critical for reproductive diapause to occur. Also, ecdysone could interact with juvenile hormone to regulate the occurrence of reproductive diapause in response to photoperiodic cues. Our findings provide new insight into endocrine mechanisms of photoperiodic reproductive diapause and an example of phenotypic plasticity in animals.</p>]]></description>
            <pubDate><![CDATA[2021-02-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Anti-epileptic drug topiramate upregulates TGFβ1 and SOX9 expression in primary embryonic palatal mesenchyme cells: Implications for teratogenicity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765880266567-4eb14be5-1bb7-4538-aafe-e9371e54c443/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246989</link>
            <description><![CDATA[<p class="para" id="N65539">Topiramate is an anti-epileptic drug that is commonly prescribed not just to prevent seizures but also migraine headaches, with over 8 million prescriptions dispensed annually. Topiramate use during pregnancy has been linked to significantly increased risk of babies born with orofacial clefts (OFCs). However, the exact molecular mechanism of topiramate teratogenicity is unknown. In this study, we first used an unbiased antibody array analysis to test the effect of topiramate on human embryonic palatal mesenchyme (HEPM) cells. This analysis identified 40 differentially expressed proteins, showing strong connectivity to known genes associated with orofacial clefts. However, among known OFC genes, only TGFβ1 was significantly upregulated in the antibody array analysis. Next, we validated that topiramate could increase expression of TGFβ1 and of downstream target phospho-SMAD2 in primary mouse embryonic palatal mesenchyme (MEPM) cells. Furthermore, we showed that topiramate treatment of primary MEPM cells increased expression of SOX9. SOX9 overexpression in chondrocytes is known to cause cleft palate in mouse. We propose that topiramate mediates upregulation of TGFβ1 signaling through activation of γ-aminobutyric acid (GABA) receptors in the palate. TGFβ1 and SOX9 play critical roles in orofacial morphogenesis, and their abnormal overexpression provides a plausible etiologic molecular mechanism for the teratogenic effects of topiramate.</p>]]></description>
            <pubDate><![CDATA[2021-02-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Viral growth factor- and STAT3 signaling-dependent elevation of the TCA cycle intermediate levels during vaccinia virus infection]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765879249241-badeb049-b4c0-4cbd-b03f-3c56782e04db/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009303</link>
            <description><![CDATA[<p class="para" id="N65539">Metabolism is a crucial frontier of host-virus interaction as viruses rely on their host cells to provide nutrients and energy for propagation. Vaccinia virus (VACV) is the prototype poxvirus. It makes intensive demands for energy and macromolecules in order to build hundreds and thousands of viral particles in a single cell within hours of infection. Our comprehensive metabolic profiling reveals profound reprogramming of cellular metabolism by VACV infection, including increased levels of the intermediates of the tri-carboxylic acid (TCA) cycle independent of glutaminolysis. By investigating the level of citrate, the first metabolite of the TCA cycle, we demonstrate that the elevation of citrate depends on VACV-encoded viral growth factor (VGF), a viral homolog of cellular epidermal growth factor. Further, the upregulation of citrate is dependent on STAT3 signaling, which is activated non-canonically at the serine727 upon VACV infection. The STAT3 activation is dependent on VGF, and VGF-dependent EGFR and MAPK signaling. Together, our study reveals a novel mechanism by which VACV manipulates cellular metabolism through a specific viral factor and by selectively activating a series of cellular signaling pathways.</p><p class="para" id="N65542">Vaccinia virus (VACV) is a large DNA virus with an acute and increasing demand for energy and macromolecules to build hundreds and thousands of viral particles in a single cell within hours of infection. The demand postulates reprogramming of the TCA cycle, as it is the central metabolic hub of a cell that generates metabolites for energy production and macromolecule synthesis. We show that VACV infection reprograms cellular metabolism globally, elevating the TCA cycle intermediate levels and modulating related cell metabolism. The elevation of the TCA cycle intermediates depends on the virus-encoded growth factor that stimulates non-canonical STAT3 signaling during VACV infection. Our results provide the metabolic foundation of viral growth factor to boost VACV infection.</p>]]></description>
            <pubDate><![CDATA[2021-02-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Personalized logical models to investigate cancer response to BRAF treatments in melanomas and colorectal cancers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765872985256-b8c9eb41-9bcc-43ff-ab70-81fa9ec4d210/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1007900</link>
            <description><![CDATA[<p class="para" id="N65539">The study of response to cancer treatments has benefited greatly from the contribution of different omics data but their interpretation is sometimes difficult. Some mathematical models based on prior biological knowledge of signaling pathways facilitate this interpretation but often require fitting of their parameters using perturbation data. We propose a more qualitative mechanistic approach, based on logical formalism and on the sole mapping and interpretation of omics data, and able to recover differences in sensitivity to gene inhibition without model training. This approach is showcased by the study of BRAF inhibition in patients with melanomas and colorectal cancers who experience significant differences in sensitivity despite similar omics profiles.</p><p class="para" id="N65541">We first gather information from literature and build a logical model summarizing the regulatory network of the mitogen-activated protein kinase (MAPK) pathway surrounding BRAF, with factors involved in the BRAF inhibition resistance mechanisms. The relevance of this model is verified by automatically assessing that it qualitatively reproduces response or resistance behaviors identified in the literature. Data from over 100 melanoma and colorectal cancer cell lines are then used to validate the model’s ability to explain differences in sensitivity. This generic model is transformed into personalized cell line-specific logical models by integrating the omics information of the cell lines as constraints of the model. The use of mutations alone allows personalized models to correlate significantly with experimental sensitivities to BRAF inhibition, both from drug and CRISPR targeting, and even better with the joint use of mutations and RNA, supporting multi-omics mechanistic models. A comparison of these untrained models with learning approaches highlights similarities in interpretation and complementarity depending on the size of the datasets.</p><p class="para" id="N65543">This parsimonious pipeline, which can easily be extended to other biological questions, makes it possible to explore the mechanistic causes of the response to treatment, on an individualized basis.</p><p class="para" id="N65542">We constructed a logical model to study, from a dynamical perspective, the differences between melanomas and colorectal cancers that share the same BRAF mutations but exhibit different sensitivities to anti-BRAF treatments. The model was built from the literature and completed from existing pathway databases. The model encompasses the key proteins of the MAPK pathway and was made specific to each cancer cell line (100 melanoma and colorectal cell lines from public database) using available omics data, including mutations and RNAseq data. It can simulate the effect of drugs and show high correlation with experimental results. Moreover, the structure of the network confirms both the importance of the reactivation of the MAPK pathway through CRAF and the involvement of PI3K/AKT pathway in the mechanisms of resistance to BRAF inhibition.</p><p class="para" id="N65544">The study shows that, because of the low number of samples, the mechanistic approach that we propose provides different insights than powerful standard machine learning methodologies would, showing the complementarity between the two approaches. An important aspect to mention is that the mechanistic approach presented here does not rely on training datasets but directly interprets and maps data on the model to simulate drug responses.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765872953863-b75b2942-a10b-45fc-8227-02a7a501868c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009275</link>
            <description><![CDATA[<p class="para" id="N65539">Filoviruses, such as the Ebola virus (EBOV) and Marburg virus (MARV), are causative agents of sporadic outbreaks of hemorrhagic fevers in humans. To infect cells, filoviruses are internalized via macropinocytosis and traffic through the endosomal pathway where host cathepsin-dependent cleavage of the viral glycoproteins occurs. Subsequently, the cleaved viral glycoprotein interacts with the late endosome/lysosome resident host protein, Niemann-Pick C1 (NPC1). This interaction is hypothesized to trigger viral and host membrane fusion, which results in the delivery of the viral genome into the cytoplasm and subsequent initiation of replication. Some studies suggest that EBOV viral particles activate signaling cascades and host-trafficking factors to promote their localization with host factors that are essential for entry. However, the mechanism through which these activating signals are initiated remains unknown. By screening a kinase inhibitor library, we found that receptor tyrosine kinase inhibitors potently block EBOV and MARV GP-dependent viral entry. Inhibitors of epidermal growth factor receptor (EGFR), tyrosine protein kinase Met (c-Met), and the insulin receptor (InsR)/insulin like growth factor 1 receptor (IGF1R) blocked filoviral GP-mediated entry and prevented growth of replicative EBOV in Vero cells. Furthermore, inhibitors of c-Met and InsR/IGF1R also blocked viral entry in macrophages, the primary targets of EBOV infection. Interestingly, while the c-Met and InsR/IGF1R inhibitors interfered with EBOV trafficking to NPC1, virus delivery to the receptor was not impaired in the presence of the EGFR inhibitor. Instead, we observed that the NPC1 positive compartments were phenotypically altered and rendered incompetent to permit viral entry. Despite their different mechanisms of action, all three RTK inhibitors tested inhibited virus-induced Akt activation, providing a possible explanation for how EBOV may activate signaling pathways during entry. In sum, these studies strongly suggest that receptor tyrosine kinases initiate signaling cascades essential for efficient post-internalization entry steps.</p><p class="para" id="N65542">Ebola virus (EBOV) and Marburg virus (MARV) are zoonotic pathogens that can cause severe hemorrhagic fevers in humans and non-human primates. They are members of the growing <i>Filoviridae</i> family that also includes three other species of Ebolaviruses known to be highly pathogenic in humans. While vaccines for EBOV are being deployed and showed high efficacy, pan-filoviral treatment is still lacking. To infect cells, EBOV requires the endosomal/lysosomal resident protein Niemann-Pick C1 (NPC1). Accordingly, viral particles require extensive trafficking within endosomal pathways for entry and delivery of the viral genome into the host cell cytoplasm. Here, we used chemical biology to reveal that EBOV triggers receptor tyrosine kinase (RTK)-dependent signaling to traffic to intracellular vesicles that contain the receptor and are conducive to entry. The characterization of host trafficking factors and signaling pathways that are potentially triggered by the virus are important as these could be targeted for antiviral therapies. In our study, we identified several RTK inhibitors, some of which are FDA-approved drugs, that potently block EBOV infection. Since all filoviruses known to date, even Měnglà virus that was recently discovered in bats in China, use NPC1 as their entry receptor, these inhibitors have the potential to be effective pan-filovirus antivirals.</p>]]></description>
            <pubDate><![CDATA[2021-01-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Unraveling ChR2-driven stochastic Ca<sup>2+</sup> dynamics in astrocytes: A call for new interventional paradigms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765872492780-e3d8ad69-0734-4acf-99e7-6dd6a24065b9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008648</link>
            <description><![CDATA[<p class="para" id="N65539">Optogenetic targeting of astrocytes provides a robust experimental model to differentially induce Ca<sup>2+</sup> signals in astrocytes <i>in vivo</i>. However, a systematic study quantifying the response of optogenetically modified astrocytes to light is yet to be performed. Here, we propose a novel stochastic model of Ca<sup>2+</sup> dynamics in astrocytes that incorporates a light sensitive component—channelrhodopsin 2 (ChR2). Utilizing this model, we investigated the effect of different light stimulation paradigms on cells expressing select variants of ChR2 (wild type, ChETA, and ChRET/TC). Results predict that depending on paradigm specification, astrocytes might undergo drastic changes in their basal Ca<sup>2+</sup> level and spiking probability. Furthermore, we performed a global sensitivity analysis to assess the effect of variation in parameters pertinent to the shape of the ChR2 photocurrent on astrocytic Ca<sup>2+</sup> dynamics. Results suggest that directing variants towards the first open state of the ChR2 photocycle (o<sub>1</sub>) enhances spiking activity in astrocytes during optical stimulation. Evaluation of the effect of Ca<sup>2+</sup> buffering and coupling coefficient in a network of ChR2-expressing astrocytes demonstrated basal level elevations in the stimulated region and propagation of calcium activity to unstimulated cells. Buffering reduced the diffusion range of Ca<sup>2+</sup> within the network, thereby limiting propagation and influencing the activity of astrocytes. Collectively, the framework presented in this study provides valuable information for the selection of light stimulation paradigms that elicit desired astrocytic activity using existing ChR2 constructs, as well as aids in the engineering of future application-oriented optogenetic variants.</p><p class="para" id="N65542">Optogenetics is a novel technique involving the targeted delivery of light-sensitive ion channels like Channelrhodopsin-2 (ChR2) to cells. Recently, this technique has been expanded to non-neuronal cell types, e.g., astrocytes. Optogenetic control of astrocytes <i>in vivo</i> can aid in further understanding the intricacies of their debated roles in the brain. Here, using a mathematical model, we evaluate the effect of short and long-term light stimulation of ChR2-expressing astrocytes on their Ca<sup>2+</sup> spiking activity and basal level. We further investigate how ChR2 gating dynamics, buffering, and coupling coefficient of Ca<sup>2+</sup> influence astrocytic activity in a single cell and a network. Results of our study can serve as a tool for experimental design and engineering of new application-oriented optogenetic constructs targeting astrocytes.</p>]]></description>
            <pubDate><![CDATA[2021-02-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comparative transcriptome analysis of leaves during early stages of chilling stress in two different chilling-tolerant brown-fiber cotton cultivars]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765872393776-81653ae5-f222-47e3-872c-7a0bcbc75479/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246801</link>
            <description><![CDATA[<p class="para" id="N65539">Chilling stress generates significant inhibition of normal growth and development of cotton plants and lead to severe reduction of fiber quality and yield. Currently, little is known for the molecular mechanism of brown-fiber cotton (BFC) to respond to chilling stress. Herein, RNA-sequencing (RNA-seq)-based comparative analysis of leaves under 4°C treatment in two different-tolerant BFC cultivars, chilling-sensitive (CS) XC20 and chilling-tolerant (CT) Z1612, was performed to investigate the response mechanism. A total of 72650 unigenes were identified with eight commonly used databases. Venn diagram analysis identified 1194 differentially expressed genes (DEGs) with significant up-regulation in all comparison groups. Furthermore, enrichment analyses of COG and KEGG, as well as qRT-PCR validation, indicated that 279 genes were discovered as up-regulated DEGs (UDEGs) with constant significant increased expression in CT cultivar Z1612 groups at the dimensions of both each comparison group and treatment time, locating in the enriched pathways of signal transduction, protein and carbohydrate metabolism, and cell component. Moreover, the comprehensive analyses of gene expression, physiological index and intracellular metabolite detections, and ascorbate antioxidative metabolism measurement validated the functional contributions of these identified candidate genes and pathways to chilling stress. Together, this study for the first time report the candidate key genes and metabolic pathways responding to chilling stress in BFC, and provide the effective reference for understanding the regulatory mechanism of low temperature adaptation in cotton.</p>]]></description>
            <pubDate><![CDATA[2021-02-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A multiscale model of complex endothelial cell dynamics in early angiogenesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765852643505-98e78760-0469-4e38-b9c6-74458cab78e0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008055</link>
            <description><![CDATA[<p class="para" id="N65539">We introduce a hybrid two-dimensional multiscale model of angiogenesis, the process by which endothelial cells (ECs) migrate from a pre-existing vascular bed in response to local environmental cues and cell-cell interactions, to create a new vascular network. Recent experimental studies have highlighted a central role of cell rearrangements in the formation of angiogenic networks. Our model accounts for this phenomenon via the heterogeneous response of ECs to their microenvironment. These cell rearrangements, in turn, dynamically remodel the local environment. The model reproduces characteristic features of angiogenic sprouting that include branching, chemotactic sensitivity, the brush border effect, and cell mixing. These properties, rather than being hardwired into the model, emerge naturally from the gene expression patterns of individual cells. After calibrating and validating our model against experimental data, we use it to predict how the structure of the vascular network changes as the baseline gene expression levels of the VEGF-Delta-Notch pathway, and the composition of the extracellular environment, vary. In order to investigate the impact of cell rearrangements on the vascular network structure, we introduce the mixing measure, a scalar metric that quantifies cell mixing as the vascular network grows. We calculate the mixing measure for the simulated vascular networks generated by ECs of different lineages (wild type cells and mutant cells with impaired expression of a specific receptor). Our results show that the time evolution of the mixing measure is directly correlated to the generic features of the vascular branching pattern, thus, supporting the hypothesis that cell rearrangements play an essential role in sprouting angiogenesis. Furthermore, we predict that lower cell rearrangement leads to an imbalance between branching and sprout elongation. Since the computation of this statistic requires only individual cell trajectories, it can be computed for networks generated in biological experiments, making it a potential biomarker for pathological angiogenesis.</p><p class="para" id="N65542">Angiogenesis, the process by which new blood vessels are formed by sprouting from the pre-existing vascular bed, plays a key role in both physiological and pathological processes, including tumour growth. The structure of a growing vascular network is determined by the coordinated behaviour of endothelial cells in response to various signalling cues. Recent experimental studies have highlighted the importance of cell rearrangements as a driver for sprout elongation. However, the functional role of this phenomenon remains unclear. We formulate a new multiscale model of angiogenesis which, by accounting explicitly for the complex dynamics of endothelial cells within growing angiogenic sprouts, is able to reproduce generic features of angiogenic structures (branching, chemotactic sensitivity, cell mixing, etc.) as emergent properties of its dynamics. We validate our model against experimental data and then use it to quantify the phenomenon of cell mixing in vascular networks generated by endothelial cells of different lineages. Our results show that there is a direct correlation between the time evolution of cell mixing in a growing vascular network and its branching structure, thus paving the way for understanding the functional role of cell rearrangements in angiogenesis.</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Calcineurin-dependent regulation of endocytosis by a plasma membrane ubiquitin ligase adaptor, Rcr1]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765851612021-4bb9175d-a3da-4942-8af9-49ed230c53fc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201909158</link>
            <description><![CDATA[<p class="para" id="N65540">Rsp5 is an E3 ubiquitin ligase of the Nedd4 family that regulates many cellular processes in yeast. Zhu et al. show that two paralogous Rsp5 adaptors, Rcr1 and Rcr2, are sorted to distinct locations. Exomer sorts Rcr1 to the plasma membrane via a new sorting motif, and the upregulation of Rcr1 via the calcineurin/Crz1 signaling pathway maintains cell integrity.</p><p class="para" id="N65539">Rsp5, the Nedd4 family member in yeast, is an E3 ubiquitin ligase involved in numerous cellular processes, many of which require Rsp5 to interact with PY-motif containing adaptor proteins. Here, we show that two paralogous transmembrane Rsp5 adaptors, Rcr1 and Rcr2, are sorted to distinct cellular locations: Rcr1 is a plasma membrane (PM) protein, whereas Rcr2 is sorted to the vacuole. Rcr2 is delivered to the vacuole using ubiquitin as a sorting signal. Rcr1 is delivered to the PM by the exomer complex using a newly uncovered PM sorting motif. Further, we show that Rcr1, but not Rcr2, is up-regulated via the calcineurin/Crz1 signaling pathway. Upon exogenous calcium treatment, Rcr1 ubiquitinates and down-regulates the chitin synthase Chs3. We propose that the PM-anchored Rsp5/Rcr1 ubiquitin ligase-adaptor complex can provide an acute response to degrade unwanted proteins under stress conditions, thereby maintaining cell integrity.</p>]]></description>
            <pubDate><![CDATA[2020-05-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pleiotropy and epistasis within and between signaling pathways defines the genetic architecture of fungal virulence]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765851508062-5d5973c3-4c39-4014-a853-0499793dc0f6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009313</link>
            <description><![CDATA[<p class="para" id="N65539">Cryptococcal disease is estimated to affect nearly a quarter of a million people annually. Environmental isolates of <i>Cryptococcus deneoformans</i>, which make up 15 to 30% of clinical infections in temperate climates such as Europe, vary in their pathogenicity, ranging from benign to hyper-virulent. Key traits that contribute to virulence, such as the production of the pigment melanin, an extracellular polysaccharide capsule, and the ability to grow at human body temperature have been identified, yet little is known about the genetic basis of variation in such traits. Here we investigate the genetic basis of melanization, capsule size, thermal tolerance, oxidative stress resistance, and antifungal drug sensitivity using quantitative trait locus (QTL) mapping in progeny derived from a cross between two divergent <i>C. deneoformans</i> strains. Using a “function-valued” QTL analysis framework that exploits both time-series information and growth differences across multiple environments, we identified QTL for each of these virulence traits and drug susceptibility. For three QTL we identified the underlying genes and nucleotide differences that govern variation in virulence traits. One of these genes, <i>RIC8</i>, which encodes a regulator of cAMP-PKA signaling, contributes to variation in four virulence traits: melanization, capsule size, thermal tolerance, and resistance to oxidative stress. Two major effect QTL for amphotericin B resistance map to the genes <i>SSK1</i> and <i>SSK2</i>, which encode key components of the HOG pathway, a fungal-specific signal transduction network that orchestrates cellular responses to osmotic and other stresses. We also discovered complex epistatic interactions within and between genes in the HOG and cAMP-PKA pathways that regulate antifungal drug resistance and resistance to oxidative stress. Our findings advance the understanding of virulence traits among diverse lineages of <i>Cryptococcus</i>, and highlight the role of genetic variation in key stress-responsive signaling pathways as a major contributor to phenotypic variation.</p><p class="para" id="N65542">Different environmental isolates (strains) of the same microbial species can vary greatly in their ability to cause disease, ranging from avirulent to hypervirulent. What makes some strains deadly pathogens, while others are relatively benign? This study describes the characterization of key genetic differences that underlie variation in traits thought to promote virulence in <i>Cryptococcus deneoformans</i>, a wide-spread opportunistic fungal pathogen. Using a combination of quantitative genetic and molecular genetic approaches we dissected the genetic architecture of virulence-related cellular traits (melanin production and the production of a polysaccharide capsule), physiological responses to stress (tolerance of thermal, oxidative, and osmotic stress), and sensitivity to multiple antifungal drugs. Strikingly we find that variation in most of these traits is governed by a small number of genetic differences that modify the function of two major cell signaling networks, cyclic AMP–Protein Kinase A (cAMP-PKA) signaling and a fungal specific MAP-kinase cascade called the high osmolarity glycerol (HOG) pathway. Similar to recent studies in a number of other fungal species, our findings point to an outsize role for a small number of highly pleiotropic signaling pathways in potentiating phenotypic variation both within and between fungal species.</p>]]></description>
            <pubDate><![CDATA[2021-01-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The BMP signaling gradient is interpreted through concentration thresholds in dorsal–ventral axial patterning]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765850957280-4e245e7e-dea1-4d97-b7bb-dc1bbe958f67/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001059</link>
            <description><![CDATA[<p class="para" id="N65539">Bone Morphogenetic Protein (BMP) patterns the dorsal–ventral (DV) embryonic axis in all vertebrates, but it is unknown how cells along the DV axis interpret and translate the gradient of BMP signaling into differential gene activation that will give rise to distinct cell fates. To determine the mechanism of BMP morphogen interpretation in the zebrafish gastrula, we identified 57 genes that are directly activated by BMP signaling. By using Seurat analysis of single-cell RNA sequencing (scRNA-seq) data, we found that these genes are expressed in at least 3 distinct DV domains of the embryo. We distinguished between 3 models of BMP signal interpretation in which cells activate distinct gene expression through interpretation of thresholds of (1) the BMP signaling gradient slope; (2) the BMP signal duration; or (3) the level of BMP signal activation. We tested these 3 models using quantitative measurements of phosphorylated Smad5 (pSmad5) and by examining the spatial relationship between BMP signaling and activation of different target genes at single-cell resolution across the embryo. We found that BMP signaling gradient slope or BMP exposure duration did not account for the differential target gene expression domains. Instead, we show that cells respond to 3 distinct levels of BMP signaling activity to activate and position target gene expression. Together, we demonstrate that distinct pSmad5 threshold levels activate spatially distinct target genes to pattern the DV axis.</p><p class="para" id="N65540">This study tested three models of how a BMP morphogen gradient is translated into differential gene activation that specifies distinct cell fates, finding that BMP signal concentration thresholds, not gradient shape or signal duration, position three distinct gene activation domains.</p>]]></description>
            <pubDate><![CDATA[2021-01-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[New evidence confirming the CD genomic constitutions of the tetraploid <i>Avena</i> species in the section <i>Pachycarpa</i> Baum]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765850585054-5527b412-5f59-4e25-82eb-f7deb88b9528/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0240703</link>
            <description><![CDATA[<p class="para" id="N65539">The tetraploid <i>Avena</i> species in the section <i>Pachycarpa</i> Baum, including <i>A</i>. <i>insularis</i>, <i>A</i>. <i>maroccana</i>, and <i>A</i>. <i>murphyi</i>, are thought to be involved in the evolution of hexaploid oats; however, their genome designations are still being debated. Repetitive DNA sequences play an important role in genome structuring and evolution, so understanding the chromosomal organization and distribution of these sequences in <i>Avena</i> species could provide valuable information concerning genome evolution in this genus. In this study, the chromosomal organizations and distributions of six repetitive DNA sequences (including three SSR motifs (TTC, AAC, CAG), one 5S rRNA gene fragment, and two oat A and C genome specific repeats) were investigated using non-denaturing fluorescence in situ hybridization (ND-FISH) in the three tetraploid species mentioned above and in two hexaploid oat species. Preferential distribution of the SSRs in centromeric regions was seen in the A and D genomes, whereas few signals were detected in the C genomes. Some intergenomic translocations were observed in the tetraploids; such translocations were also detected between the C and D genomes in the hexaploids. These results provide robust evidence for the presence of the D genome in all three tetraploids, strongly suggesting that the genomic constitution of these species is DC and not AC, as had been thought previously.</p>]]></description>
            <pubDate><![CDATA[2021-01-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Crosstalk and ultrasensitivity in protein degradation pathways]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765849810229-1864d96e-f04f-47ad-a1fb-6197123ec778/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008492</link>
            <description><![CDATA[<p class="para" id="N65539">Protein turnover is vital to cellular homeostasis. Many proteins are degraded efficiently only after they have been post-translationally “tagged” with a polyubiquitin chain. Ubiquitylation is a form of Post-Translational Modification (PTM): addition of a ubiquitin to the chain is catalyzed by E3 ligases, and removal of ubiquitin is catalyzed by a De-UBiquitylating enzyme (DUB). Nearly four decades ago, Goldbeter and Koshland discovered that reversible PTM cycles function like on-off switches when the substrates are at saturating concentrations. Although this finding has had profound implications for the understanding of switch-like behavior in biochemical networks, the general behavior of PTM cycles subject to synthesis and degradation has not been studied. Using a mathematical modeling approach, we found that simply introducing protein turnover to a standard modification cycle has profound effects, including significantly reducing the switch-like nature of the response. Our findings suggest that many classic results on PTM cycles may not hold <i>in vivo</i> where protein turnover is ubiquitous. We also found that proteins sharing an E3 ligase can have closely related changes in their expression levels. These results imply that it may be difficult to interpret experimental results obtained from either overexpressing or knocking down protein levels, since changes in protein expression can be coupled via E3 ligase crosstalk. Understanding crosstalk and competition for E3 ligases will be key in ultimately developing a global picture of protein homeostasis.</p><p class="para" id="N65542">Previous work has shown that substrates of Post-Translational Modification (PTM) cycles can have coupled responses if those substrates share enzymes. This implies that modifications leading to substrate degradation (e.g. ubiquitylation by an E3 ligase) could introduce coupling in concentrations of substrates sharing a ligase. Using mathematical models, we found adding protein turnover to a PTM cycle diminishes both sensitivity and ultrasensitivity, particularly in models admitting long ubiquitin chains. We also found that proteins sharing an E3 ligase can indeed have coupled changes in both expression and sensitivity to signals. These results imply that accounting for crosstalk in protein degradation networks is crucial for the interpretation of results from a wide variety of common experimental perturbations to living systems.</p>]]></description>
            <pubDate><![CDATA[2020-12-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765849387733-6d196e13-3c53-47fa-827a-72dd93372f32/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009216</link>
            <description><![CDATA[<p class="para" id="N65539">Intracellular pathogens have evolved to utilize normal cellular processes to complete their replicative cycles. Pathogens that interface with proliferative cell signaling pathways risk infections that can lead to cancers, but the factors that influence malignant outcomes are incompletely understood. Human papillomaviruses (HPVs) predominantly cause benign hyperplasia in stratifying epithelial tissues. However, a subset of carcinogenic or “high-risk” HPV (hr-HPV) genotypes are etiologically linked to nearly 5% of all human cancers. Progression of hr-HPV-induced lesions to malignancies is characterized by increased expression of the E6 and E7 oncogenes and the oncogenic functions of these viral proteins have been widely studied. Yet, the mechanisms that regulate hr-HPV oncogene transcription and suppress their expression in benign lesions remain poorly understood. Here, we demonstrate that EGFR/MEK/ERK signaling, influenced by epithelial contact inhibition and tissue differentiation cues, regulates hr-HPV oncogene expression. Using monolayer cells, epithelial organotypic tissue models, and neoplastic tissue biopsy materials, we show that cell-extrinsic activation of ERK overrides cellular control to promote HPV oncogene expression and the neoplastic phenotype. Our data suggest that HPVs are adapted to use the EGFR/MEK/ERK signaling pathway to regulate their productive replicative cycles. Mechanistic studies show that EGFR/MEK/ERK signaling influences AP-1 transcription factor activity and AP-1 factor knockdown reduces oncogene transcription. Furthermore, pharmacological inhibitors of EGFR, MEK, and ERK signaling quash HPV oncogene expression and the neoplastic phenotype, revealing a potential clinical strategy to suppress uncontrolled cell proliferation, reduce oncogene expression and treat HPV neoplasia.</p><p class="para" id="N65542">Human papillomavirus (HPV) infections occur in differentiating squamous epithelium and induce hyperplasia during the viral replicative cycle. Although HPV oncogene expression is necessary to promote cellular proliferation for viral genome amplification in the middle epithelial layers, oncogene levels are thereafter suppressed to permit differentiation-induced late gene expression in the uppermost epithelial cells. Yet, the mechanisms responsible for controlling HPV oncogene expression are not well understood. Here, we demonstrate that EGFR/MEK/ERK signaling, which is subject to the normal cellular cues of contact inhibition and epithelial tissue differentiation, is a critical regulator of hr-HPV oncogene expression. We found that extrinsic activation of ERK overrides cellular control to promote oncogene expression and the neoplastic phenotype. Many epidemiologically defined risk factors activate the EGFR/MEK/ERK pathway, suggesting a common mechanism whereby they may promote HPV persistence and disease progression. Lastly, we show that HPV oncogene transcription and protein expression remain susceptible to MEK/ERK control in early neoplastic tissues and tumor cells and that targeted inhibition of MEK/ERK signaling might be exploited therapeutically for HPV-induced infections and tumors.</p>]]></description>
            <pubDate><![CDATA[2021-01-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Runx1 is a central regulator of osteogenesis for bone homeostasis by orchestrating BMP and WNT signaling pathways]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765848885305-6caa0993-52ed-45df-a446-dec735ecaedd/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009233</link>
            <description><![CDATA[<p class="para" id="N65539">Runx1 is highly expressed in osteoblasts, however, its function in osteogenesis is unclear. We generated mesenchymal progenitor-specific (<i>Runx1</i><sup><i>f/f</i></sup><i>Twist2-Cre)</i> and osteoblast-specific (<i>Runx1</i><sup><i>f/f</i></sup><i>Col1α1-Cre</i>) conditional knockout (Runx1 CKO) mice. The mutant CKO mice with normal skeletal development displayed a severe osteoporosis phenotype at postnatal and adult stages. Runx1 CKO resulted in decreased osteogenesis and increased adipogenesis. RNA-sequencing analysis, Western blot, and qPCR validation of Runx1 CKO samples showed that Runx1 regulates BMP signaling pathway and Wnt/β-catenin signaling pathway. ChIP assay revealed direct binding of <i>Runx1</i> to the promoter regions of <i>Bmp7</i>, <i>Alk3</i>, and <i>Atf4</i>, and promoter mapping demonstrated that <i>Runx1</i> upregulates their promoter activity through the binding regions. <i>Bmp7</i> overexpression rescued Alk3, Runx2, and Atf4 expression in <i>Runx1</i>-deficient BMSCs. Runx2 expression was decreased while Runx1 was not changed in <i>Alk3</i> deficient osteoblasts. <i>Atf4</i> overexpression in <i>Runx1</i>-deficient BMSCs did not rescue expression of Runx1, Bmp7, and Alk3. Smad1/5/8 activity was vitally reduced in Runx1 CKO cells, indicating <i>Runx1</i> positively regulates the Bmp7/Alk3/Smad1/5/8/Runx2/ATF4 signaling pathway. Notably, Runx1 overexpression in <i>Runx2</i><sup><i>-/-</i></sup> osteoblasts rescued expression of Atf4, OCN, and ALP to compensate <i>Runx2</i> function. <i>Runx1</i> CKO mice at various osteoblast differentiation stages reduced Wnt signaling and caused high expression of C/ebpα and Pparγ and largely increased adipogenesis. Co-culture of <i>Runx1</i>-deficient and wild-type cells demonstrated that <i>Runx1</i> regulates osteoblast−adipocyte lineage commitment both cell-autonomously and non-autonomously. Notably, <i>Runx1</i> overexpression rescued bone loss in OVX-induced osteoporosis. This study focused on the role of Runx1 in different cell populations with regards to BMP and Wnt signaling pathways and in the interacting network underlying bone homeostasis as well as adipogenesis, and has provided new insight and advancement of knowledge in skeletal development. Collectively, <i>Runx1</i> maintains adult bone homeostasis from bone loss though up-regulating Bmp7/Alk3/Smad1/5/8/Runx2/ATF4 and WNT/β-Catenin signaling pathways, and targeting <i>Runx1</i> potentially leads to novel therapeutics for osteoporosis.</p><p class="para" id="N65542">Bone loss in osteoporosis and many other degenerative bone diseases is characterized by decreased bone formation and increased fat accumulation in the bone marrow, especially during aging, and many are suspected to have a genetic basis. Bone marrow mesenchymal stem cells (BMSCs) can differentiate into adipocytes, chondrocytes, and osteoblasts. BMSCs from aging or genetic defect subjects are less likely to differentiate into osteoblasts while more inclined to differentiate into adipocytes. However, the molecular mechanisms remain elusive. Here, we describe a new mutant mice model-<i>Runx1</i> mesenchymal progenitor-specific and osteoblast-specific conditional knockout (<i>Runx1</i> CKO) mice, which showed the severe bone formation defects and adipocytes accumulation. Here, we revealed that <i>Runx1</i> enhances osteoblast lineage commitment promotes bone formation and inhibits adipogenesis by up-regulating the Bmp7/Alk3/Smad1/5/8/Runx2/ATF4 and WNT/β-catenin signaling pathways and orchestrating multiple signaling pathways involved in bone formation. These findings further elucidated the roles of Runx1 in bone homeostasis with implications into development of novel therapeutic strategies for osteoporosis as well as other degenerative bone diseases.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Voting-based integration algorithm improves causal network learning from interventional and observational data: An application to cell signaling network inference]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765848875055-831d3fdd-7b13-4f19-9891-d693197fd6e9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245776</link>
            <description><![CDATA[<p class="para" id="N65539">In order to increase statistical power for learning a causal network, data are often pooled from multiple observational and interventional experiments. However, if the direct effects of interventions are uncertain, multi-experiment data pooling can result in false causal discoveries. We present a new method, “Learn and Vote,” for inferring causal interactions from multi-experiment datasets. In our method, experiment-specific networks are learned from the data and then combined by weighted averaging to construct a consensus network. Through empirical studies on synthetic and real-world datasets, we found that for most of the larger-sized network datasets that we analyzed, our method is more accurate than state-of-the-art network inference approaches.</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Fibroblast Growth Factor 9 (FGF9) negatively regulates the early stage of chondrogenic differentiation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847015648-5742bdad-7692-4e5d-bae2-6d98f315e995/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0241281</link>
            <description><![CDATA[<p class="para" id="N65539">Fibroblast growth factor signaling is essential for mammalian bone morphogenesis and growth, involving membranous ossification and endochondral ossification. FGF9 has been shown to be an important regulator of endochondral ossification; however, its role in the early differentiation of chondrocytes remains unknown. Therefore, in this study, we aimed to determine the role of FGF9 in the early differentiation of chondrogenesis. We found an increase in FGF9 expression during proliferating chondrocyte hypertrophy in the mouse growth plate. Silencing of FGF9 promotes the growth of ATDC5 cells and promotes insulin-induced differentiation of ATDC5 chondrocytes, which is due to increased cartilage matrix formation and type II collagen (col2a1) and X (col10a1), Acan, Ihh, Mmp13 gene expression. Then, we evaluated the effects of AKT, GSK-3β, and mTOR. Inhibition of FGF9 significantly inhibits phosphorylation of AKT and GSK-3β, but does not affected the activation of mTOR. Furthermore, phosphorylation of inhibited AKT and GSK-3β was compensated using the AKT activator SC79, and differentiation of ATDC5 cells was inhibited. In conclusion, our results indicate that FGF9 acts as an important regulator of early chondrogenesis partly through the AKT/GSK-3β pathway.</p>]]></description>
            <pubDate><![CDATA[2021-02-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Systems biology predicts that fibrosis in tuberculous granulomas may arise through macrophage-to-myofibroblast transformation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765846786135-eae976d3-e130-4df9-8d96-7685e8fb11a1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008520</link>
            <description><![CDATA[<p class="para" id="N65539"><i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) infection causes tuberculosis (TB), a disease characterized by development of granulomas. Granulomas consist of activated immune cells that cluster together to limit bacterial growth and restrict dissemination. Control of the TB epidemic has been limited by lengthy drug regimens, antibiotic resistance, and lack of a robustly efficacious vaccine. Fibrosis commonly occurs during treatment and is associated with both positive and negative disease outcomes in TB but little is known about the processes that initiate fibrosis in granulomas. Human and nonhuman primate granulomas undergoing fibrosis can have spindle-shaped macrophages with fibroblast-like morphologies suggesting a relationship between macrophages, fibroblasts, and granuloma fibrosis. This relationship has been difficult to investigate because of the limited availability of human pathology samples, the time scale involved in human TB, and overlap between fibroblast and myeloid cell markers in tissues. To better understand the origins of fibrosis in TB, we used a computational model of TB granuloma biology to identify factors that drive fibrosis over the course of local disease progression. We validated the model with granulomas from nonhuman primates to delineate myeloid cells and lung-resident fibroblasts. Our results suggest that peripheral granuloma fibrosis, which is commonly observed, can arise through macrophage-to-myofibroblast transformation (MMT). Further, we hypothesize that MMT is induced in M1 macrophages through a sequential combination of inflammatory and anti-inflammatory signaling in granuloma macrophages. We predict that MMT may be a mechanism underlying granuloma-associated fibrosis and warrants further investigation into myeloid cells as drivers of fibrotic disease.</p><p class="para" id="N65542">Tuberculosis is a disease caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), a bacterium that infects over a third of the world’s population. The only available vaccine for TB has limited efficacy and drug treatment involves several antibiotics that are taken for several months. These drugs can have significant side-effects and a lack of compliance can lead to drug resistance in <i>Mtb</i>. A hallmark of <i>Mtb</i> infection is the development of clusters of cells that form around infected macrophages to contain the infection called granulomas. Older granulomas, or granulomas in patients treated with antibiotic, often become fibrotic and this can cause chronic lung problems long after the <i>Mtb</i> infection has cleared. The process that drives a fibrotic outcome has been difficult to assess <i>in vivo</i>. Herein we combined wet-lab and computational experimentation to identify a novel mechanism leading to peripheral fibrosis in granulomas. We find that macrophages transforming into myofibroblast-like cells, may be a key pathway to granuloma-associated fibrosis, a phenomena that has not been well characterized <i>in vivo</i>. Further we identified factors that can inhibit fibrosis development during TB that could be therapeutic targets during TB treatment to limit the risk of long-term tissue damage in TB.</p>]]></description>
            <pubDate><![CDATA[2020-12-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Sas4 links basal bodies to cell division via Hippo signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838898969-ef78c738-ee8b-4132-afed-3bcbc4016916/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201906183</link>
            <description><![CDATA[<p class="para" id="N65540">Sas4 is a conserved basal body assembly protein. Here, Ruehle et al. describe a previously unknown link between basal bodies and the control of cell division by Hippo signaling molecules that depends on Sas4.</p><p class="para" id="N65539">Basal bodies (BBs) are macromolecular complexes required for the formation and cortical positioning of cilia. Both BB assembly and DNA replication are tightly coordinated with the cell cycle to ensure their accurate segregation and propagation to daughter cells, but the mechanisms ensuring coordination are unclear. The <i>Tetrahymena</i> Sas4/CPAP protein is enriched at assembling BBs, localizing to the core BB structure and to the base of BB-appendage microtubules and striated fiber. Sas4 is necessary for BB assembly and cortical microtubule organization, and Sas4 loss disrupts cell division furrow positioning and DNA segregation. The Hippo signaling pathway is known to regulate cell division furrow position, and Hippo molecules localize to BBs and BB-appendages. We find that Sas4 loss disrupts localization of the Hippo activator, Mob1, suggesting that Sas4 mediates Hippo activity by promoting scaffolds for Mob1 localization to the cell cortex. Thus, Sas4 links BBs with an ancient signaling pathway known to promote the accurate and symmetric segregation of the genome.</p>]]></description>
            <pubDate><![CDATA[2020-05-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genome-wide prediction of topoisomerase II<i>β</i> binding by architectural factors and chromatin accessibility]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838779416-084549e8-0b4f-4061-882c-4c7f1f5b0ff1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1007814</link>
            <description><![CDATA[<p class="para" id="N65539">DNA topoisomerase II-<i>β</i> (TOP2B) is fundamental to remove topological problems linked to DNA metabolism and 3D chromatin architecture, but its cut-and-reseal catalytic mechanism can accidentally cause DNA double-strand breaks (DSBs) that can seriously compromise genome integrity. Understanding the factors that determine the genome-wide distribution of TOP2B is therefore not only essential for a complete knowledge of genome dynamics and organization, but also for the implications of TOP2-induced DSBs in the origin of oncogenic translocations and other types of chromosomal rearrangements. Here, we conduct a machine-learning approach for the prediction of TOP2B binding using publicly available sequencing data. We achieve highly accurate predictions, with accessible chromatin and architectural factors being the most informative features. Strikingly, TOP2B is sufficiently explained by only three features: DNase I hypersensitivity, CTCF and cohesin binding, for which genome-wide data are widely available. Based on this, we develop a predictive model for TOP2B genome-wide binding that can be used across cell lines and species, and generate virtual probability tracks that accurately mirror experimental ChIP-seq data. Our results deepen our knowledge on how the accessibility and 3D organization of chromatin determine TOP2B function, and constitute a proof of principle regarding the <i>in silico</i> prediction of sequence-independent chromatin-binding factors.</p><p class="para" id="N65542">Type II DNA topoisomerases (TOP2) are a double-edged sword. They solve topological problems in the form of supercoiling, knots and tangles that inevitably accompany genome metabolism, but they do so at the cost of transiently cleaving DNA, with the risk that this entails for genome integrity, and the serious consequences for human health, such as neurodegeneration, developmental disorders or predisposition to cancer. A comprehensive analysis of TOP2 distribution throughout the genome is therefore essential for a deep understanding of its function and regulation, and how this can affect genome dynamics and stability. Here, we use machine learning to thoroughly explore genome-wide binding of TOP2B, a vertebrate TOP2 paralog that has been linked to genome organization and cancer-associated translocations. Our analysis shows that TOP2B-DNA binding can be accurately predicted exclusively using information on DNA accessibility and binding of genome-architecture factors. We show that such information is enough to generate virtual maps of TOP2B binding along the genome, which we validate with <i>de novo</i> experimental data. Our results highlight the importance of TOP2B for accessibility and 3D organization of chromatin, and show that computationally predicted TOP2 maps can be accurately obtained using minimal publicly available datasets, opening the door for their use in different organisms, cell types and conditions with experimental and/or clinical relevance.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A workflow for sizing oligomeric biomolecules based on cryo single molecule localization microscopy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838580311-11a51042-5dbb-4166-810c-3bedcb7e80ce/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245693</link>
            <description><![CDATA[<p class="para" id="N65539">Single molecule localization microscopy (SMLM) has enormous potential for resolving subcellular structures below the diffraction limit of light microscopy: Localization precision in the low digit nanometer regime has been shown to be achievable. In order to record localization microscopy data, however, sample fixation is inevitable to prevent molecular motion during the rather long recording times of minutes up to hours. Eventually, it turns out that preservation of the sample’s ultrastructure during fixation becomes the limiting factor. We propose here a workflow for data analysis, which is based on SMLM performed at cryogenic temperatures. Since molecular dipoles of the fluorophores are fixed at low temperatures, such an approach offers the possibility to use the orientation of the dipole as an additional information for image analysis. In particular, assignment of localizations to individual dye molecules becomes possible with high reliability. We quantitatively characterized the new approach based on the analysis of simulated oligomeric structures. Side lengths can be determined with a relative error of less than 1% for tetramers with a nominal side length of 5 nm, even if the assumed localization precision for single molecules is more than 2 nm.</p>]]></description>
            <pubDate><![CDATA[2021-01-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[<i>Pseudomonas aeruginosa</i> induces p38MAP kinase-dependent IL-6 and CXCL8 release from bronchial epithelial cells via a Syk kinase pathway]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765836554880-c047d05f-ee54-4235-9b1f-8fae1739dbf0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246050</link>
            <description><![CDATA[<p class="para" id="N65539"><i>Pseudomonas aeruginosa</i> (Pa) infection is a major cause of airway inflammation in immunocompromised and cystic fibrosis (CF) patients. Mitogen-activated protein (MAP) and tyrosine kinases are integral to inflammatory responses and are therefore potential targets for novel anti-inflammatory therapies. We have determined the involvement of specific kinases in Pa-induced inflammation. The effects of kinase inhibitors against p38MAPK, MEK 1/2, JNK 1/2, Syk or c-Src, a combination of a p38MAPK with Syk inhibitor, or a novel narrow spectrum kinase inhibitor (NSKI), were evaluated against the release of the proinflammatory cytokine/chemokine, IL-6 and CXCL8 from BEAS-2B and CFBE41o- epithelial cells by Pa. Effects of a Syk inhibitor against phosphorylation of the MAPKs were also evaluated. IL-6 and CXCL8 release by Pa were significantly inhibited by p38MAPK and Syk inhibitors (p&lt;0.05). Phosphorylation of HSP27, but not ERK or JNK, was significantly inhibited by Syk kinase inhibition. A combination of p38MAPK and Syk inhibitors showed synergy against IL-6 and CXCL8 induction and an NSKI completely inhibited IL-6 and CXCL8 at low concentrations. Pa-induced inflammation is dependent on p38MAPK primarily, and Syk partially, which is upstream of p38MAPK. The NSKI suggests that inhibiting specific combinations of kinases is a potent potential therapy for Pa-induced inflammation.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Evaluating Deep Learning models for predicting ALK-5 inhibition]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765824566206-3c0dfd64-61cd-4d5d-b7fc-6ec59c3907d3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246126</link>
            <description><![CDATA[<p class="para" id="N65539">Computational methods have been widely used in drug design. The recent developments in machine learning techniques and the ever-growing chemical and biological databases are fertile ground for discoveries in this area. In this study, we evaluated the performance of Deep Learning models in comparison to Random Forest, and Support Vector Regression for predicting the biological activity (pIC<sub>50</sub>) of ALK-5 inhibitors as candidates to treat cancer. The generalization power of the models was assessed by internal and external validation procedures. A deep neural network model obtained the best performance in this comparative study, achieving a coefficient of determination of 0.658 on the external validation set with mean square error and mean absolute error of 0.373 and 0.450, respectively. Additionally, the relevance of the chemical descriptors for the prediction of biological activity was estimated using Permutation Importance. We can conclude that the forecast model obtained by the deep neural network is suitable for the problem and can be employed to predict the biological activity of new ALK-5 inhibitors.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765824440333-0567683f-812b-4b10-8989-cbb1fafb094a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245209</link>
            <description><![CDATA[<p class="para" id="N65539">Kidneys are one of the targets for SARS-CoV-2, it is reported that up to 36% of patients with SARS-CoV-2 infection would develop into acute kidney injury (AKI). AKI is associated with high mortality in the clinical setting and contributes to the transition of AKI to chronic kidney disease (CKD). Up to date, the underlying mechanisms are obscure and there is no effective and specific treatment for COVID-19-induced AKI. In the present study, we investigated the mechanisms and interactions between Quercetin and SARS-CoV-2 targets proteins by using network pharmacology and molecular docking. The renal protective effects of Quercetin on COVID-19-induced AKI may be associated with the blockade of the activation of inflammatory, cell apoptosis-related signaling pathways. Quercetin may also serve as SARS-CoV-2 inhibitor by binding with the active sites of SARS-CoV-2 main protease 3CL and ACE2, therefore suppressing the functions of the proteins to cut the viral life cycle. In conclusion, Quercetin may be a novel therapeutic agent for COVID-19-induced AKI. Inhibition of inflammatory, cell apoptosis-related signaling pathways may be the critical mechanisms by which Quercetin protects kidney from SARS-CoV-2 injury.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mitochondrial depolarization promotes calcium alternans: Mechanistic insights from a ventricular myocyte model]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765824033630-11adb2f7-e31d-4779-ad7f-be2cc2d3ceeb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008624</link>
            <description><![CDATA[<p class="para" id="N65539">Mitochondria are vital organelles inside the cell and contribute to intracellular calcium (Ca<sup>2+</sup>) dynamics directly and indirectly via calcium exchange, ATP generation, and production of reactive oxygen species (ROS). Arrhythmogenic Ca<sup>2+</sup> alternans in cardiac myocytes has been observed in experiments under abnormal mitochondrial depolarization. However, complex signaling pathways and Ca<sup>2+</sup> cycling between mitochondria and cytosol make it difficult in experiments to reveal the underlying mechanisms of Ca<sup>2+</sup> alternans under abnormal mitochondrial depolarization. In this study, we use a newly developed spatiotemporal ventricular myocyte computer model that integrates mitochondrial Ca<sup>2+</sup> cycling and complex signaling pathways to investigate the mechanisms of Ca<sup>2+</sup> alternans during mitochondrial depolarization. We find that elevation of ROS in response to mitochondrial depolarization plays a critical role in promoting Ca<sup>2+</sup> alternans. Further examination reveals that the redox effect of ROS on ryanodine receptors and sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase synergistically promote alternans. Upregulation of mitochondrial Ca<sup>2+</sup> uniporter promotes Ca<sup>2+</sup> alternans via Ca<sup>2+</sup>-dependent mitochondrial permeability transition pore opening. Due to their relatively slow kinetics, oxidized Ca<sup>2+</sup>/calmodulin-dependent protein kinase II activation and ATP do not play significant roles acutely in the genesis of Ca<sup>2+</sup> alternans after mitochondrial depolarization, but their roles can be significant in the long term, mainly through their effects on sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase activity. In conclusion, mitochondrial depolarization promotes Ca<sup>2+</sup> alternans acutely via the redox effect of ROS and chronically by ATP reduction. It suppresses Ca<sup>2+</sup> alternans chronically through oxidized Ca<sup>2+</sup>/calmodulin-dependent protein kinase II activation.</p><p class="para" id="N65542">Mitochondrial dysfunction has been implicated in life-threatening cardiac arrhythmias. Experimentalists have shown that mitochondrial depolarization could cause period-doubling behavior in cytosolic Ca<sup>2+</sup> transient (i.e., Ca<sup>2+</sup> alternans). However, the underlying mechanisms behind these experimental observations remain unclear. Here, we focus on revealing the underlying mechanisms of cellular Ca<sup>2+</sup> alternans in the context of mitochondrial depolarization. Using our newly developed action potential model that incorporates a 3D network of Ca<sup>2+</sup> release unit with a 3D network of mitochondria, we dissect out individual roles of mitochondrial Ca<sup>2+</sup> and complex signaling pathways (e.g., reactive oxygen species, oxidized Ca<sup>2+</sup>/calmodulin-dependent protein kinase II activation, and ATP) in the genesis of cellular Ca<sup>2+</sup> alternans. The key finding is that mitochondrial depolarization promotes Ca<sup>2+</sup> alternans acutely via the redox effect of ROS and chronically by ATP reduction, and oxidized Ca<sup>2+</sup>/calmodulin-dependent protein kinase II activation may suppress Ca<sup>2+</sup> alternans chronically. We believe that this study reveals insightful information for understanding the mechanisms of the genesis of Ca<sup>2+</sup> alternans in the context of mitochondrial depolarization and provides valuable simulation results to guide future experiments.</p>]]></description>
            <pubDate><![CDATA[2021-01-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A regulatory sub-circuit downstream of Wnt signaling controls developmental transitions in neural crest formation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765823002418-dba03aca-c6c8-46a7-8a7d-867b99bfcd02/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009296</link>
            <description><![CDATA[<p class="para" id="N65539">The process of cell fate commitment involves sequential changes in the gene expression profiles of embryonic progenitors. This is exemplified in the development of the neural crest, a migratory stem cell population derived from the ectoderm of vertebrate embryos. During neural crest formation, cells transition through distinct transcriptional states in a stepwise manner. The mechanisms underpinning these shifts in cell identity are still poorly understood. Here we employ enhancer analysis to identify a genetic sub-circuit that controls developmental transitions in the nascent neural crest. This sub-circuit links Wnt target genes in an incoherent feedforward loop that controls the sequential activation of genes in the neural crest lineage. By examining the cis-regulatory apparatus of Wnt effector gene <i>AXUD1</i>, we found that multipotency factor SP5 directly promotes neural plate border identity, while inhibiting premature expression of specification genes. Our results highlight the importance of repressive interactions in the neural crest gene regulatory network and illustrate how genes activated by the same upstream signal become temporally segregated during progressive fate restriction.</p><p class="para" id="N65542">The neural crest is a migratory stem cell population that plays a crucial role in the development of vertebrate embryos. These cells contribute to multiple tissues and organs, including the craniofacial skeleton, the peripheral nervous system, and the pigmentation of the skin. Neural crest formation requires sequential expression of sets of genes that gradually change the identity of progenitor cells. Here we characterize a gene circuit that plays an important role in these developmental transitions. We show that a pair of transcription factors downstream of the Wingless (Wnt) signaling pathway (<i>SP5</i> and <i>AXUD1</i>) control the temporal activation of neural crest genes. While SP5 drives the expression of genes expressed at gastrula stages, <i>AXUD1</i> promotes neural crest genes transcribed during neurulation. We found that these regulators are linked by inhibitory interactions that prevent overlap between transcriptional states. Our results shed light on how the architecture of gene regulatory circuits underlies the timing of developmental transitions during neural crest development.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822768864-8e9836b9-be02-46f3-bb21-a5f22ac82c3f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245715</link>
            <description><![CDATA[<p class="para" id="N65539">Approximately 500,000 new cases of head and neck squamous cell carcinoma (HNSCC) are reported annually. Radiation therapy is an important treatment for oral squamous cell carcinoma (OSCC). The survival rate of patients with HNSCC remained low (50%) in decades because of radiation therapy failure caused by the radioresistance of HNSCC cells. This study aimed to identify PI3K inhibitors that can enhance radiosensitivity. Results showed that pan-Phosphoinositide 3-kinases (PI3K) inhibitor BKM120 and class I α-specific PI3K inhibitor BYL719 dose-dependently reduced the growth of OSCC cells but not that of radioresistant OML1-R cells. The combination treatment of BKM120 or BYL719 with radiation showed an enhanced inhibitory effect on OSCC cells and radioresistant OML1-R cells. Furthermore, the enhanced inhibitory effect of the combination treatment was confirmed in patient-derived OSCC cells. The triple combination treatment of mTOR inhibitor AZD2014 and BKM120 or AZD2014 and BYL719 with radiation showed a significantly enhanced inhibitory effect on radioresistant OML1-R cells. These results suggest that the PI3K inhibitors are potential therapeutic agents with radiosensitivity for patients with OSCC.</p>]]></description>
            <pubDate><![CDATA[2021-01-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765821620486-8b382187-78c2-4bc3-84cb-6ed1c2bf57ce/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0246116</link>
            <description><![CDATA[<p class="para" id="N65539">Alzheimer’s disease (AD) is a devastating illness affecting over 40 million people worldwide. Intraneuronal rise of amyloid beta in its oligomeric forms (iA<i>β</i>Os), has been linked to the pathogenesis of AD by disrupting cytosolic Ca<sup>2+</sup> homeostasis. However, the specific mechanisms of action are still under debate and intense effort is ongoing to improve our understanding of the crucial steps involved in the mechanisms of A<i>β</i>Os toxicity. We report the development of a mathematical model describing a proposed mechanism by which stimulation of Phospholipase C (PLC) by iA<i>β</i>O, triggers production of IP<sub>3</sub> with consequent abnormal release of Ca<sup>2+</sup> from the endoplasmic reticulum (ER) through activation of IP<sub>3</sub> receptor (IP<sub>3</sub>R) Ca<sup>2+</sup> channels. After validating the model using experimental data, we quantify the effects of intracellular rise in iA<i>β</i>Os on model solutions. Our model validates a dose-dependent influence of iA<i>β</i>Os on IP<sub>3</sub>-mediated Ca<sup>2+</sup> signaling. We investigate Ca<sup>2+</sup> signaling patterns for small and large iA<i>β</i>Os doses and study the role of various parameters on Ca<sup>2+</sup> signals. Uncertainty quantification and partial rank correlation coefficients are used to better understand how the model behaves under various parameter regimes. Our model predicts that iA<i>β</i>O alter IP<sub>3</sub>R sensitivity to IP<sub>3</sub> for large doses. Our analysis also shows that the upstream production of IP<sub>3</sub> can influence A<i>β</i>-driven solution patterns in a dose-dependent manner. Model results illustrate and confirm the detrimental impact of iA<i>β</i>Os on IP<sub>3</sub> signaling.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820878448-0b22dac7-e379-4ec9-8b26-0f2f0749de85/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0244187</link>
            <description><![CDATA[<p class="para" id="N65539">Rheumatoid arthritis (RA) is a systemic and incurable autoimmune disease characterized by chronic inflammation in synovial lining of joints. To identify the signaling pathways involved in RA, its disease activity, and treatment response, we adapted a systems immunology approach to simultaneously quantify 42 signaling nodes in 21 immune cell subsets (e.g., IFNα→p-STAT5 in B cells) in peripheral blood mononuclear cells (PBMC) from 194 patients with longstanding RA (including 98 patients before and after treatment), and 41 healthy controls (HC). We found multiple differences between patients with RA compared to HC, predominantly in cytokine-induced Jak/STAT signaling in many immune cell subsets, suggesting pathways that may be associated with susceptibility to RA. We also found that high RA disease activity, compared to low disease activity, was associated with decreased (e.g., IFNα→p-STAT5, IL-10→p-STAT1) or increased (e.g., IL-6→STAT3) response to stimuli in multiple cell subsets. Finally, we compared signaling in patients with established, refractory RA before and six months after initiation of methotrexate (MTX) or TNF inhibitors (TNFi). We noted significant changes from pre-treatment to post-treatment in IFNα→p-STAT5 signaling and IL-10→p-STAT1 signaling in multiple cell subsets; these changes brought the aberrant RA signaling profiles toward those of HC. This large, comprehensive functional signaling pathway study provides novel insights into the pathogenesis of RA and shows the potential of quantification of cytokine-induced signaling as a biomarker of disease activity or treatment response.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[<i>Ciona Brachyury</i> proximal and distal enhancers have different FGF dose-response relationships]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820715993-cf76200b-ee43-47fc-b2de-952a8615f945/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009305</link>
            <description><![CDATA[<p class="para" id="N65539">Many genes are regulated by two or more enhancers that drive similar expression patterns. Evolutionary theory suggests that these seemingly redundant enhancers must have functionally important differences. In the simple ascidian chordate <i>Ciona</i>, the transcription factor Brachyury is induced exclusively in the presumptive notochord downstream of lineage specific regulators and FGF-responsive Ets family transcription factors. Here we exploit the ability to finely titrate FGF signaling activity via the MAPK pathway using the MEK inhibitor U0126 to quantify the dependence of transcription driven by different <i>Brachyury</i> reporter constructs on this direct upstream regulator. We find that the more powerful promoter-adjacent proximal enhancer and a weaker distal enhancer have fundamentally different dose-response relationships to MAPK inhibition. The Distal enhancer is more sensitive to MAPK inhibition but shows a less cooperative response, whereas the Proximal enhancer is less sensitive and more cooperative. A longer construct containing both enhancers has a complex dose-response curve that supports the idea that the proximal and distal enhancers are moderately super-additive. We show that the overall expression loss from intermediate doses of U0126 is not only a function of the fraction of cells expressing these reporters, but also involves graded decreases in expression at the single-cell level. Expression of the endogenous gene shows a comparable dose-response relationship to the full length reporter, and we find that different notochord founder cells are differentially sensitive to MAPK inhibition. Together, these results indicate that although the two <i>Brachyury</i> enhancers have qualitatively similar expression patterns, they respond to FGF in quantitatively different ways and act together to drive high levels of <i>Brachyury</i> expression with a characteristic input/output relationship. This indicates that they are fundamentally not equivalent genetic elements.</p><p class="para" id="N65542">When and where genes are expressed is controlled by regulatory DNA regions known as enhancers. Genes often have multiple enhancers that control expression in different cell types or embryonic regions, but there are also genes that have multiple enhancers that control near-identical expression patterns. These ‘shadow’ enhancers are common features of many animal genomes, but it is unclear to what extent they are truly identical in function. Here we studied a pair of shadow enhancers for the notochord-specific gene <i>Brachyury</i> in the simple model chordate <i>Ciona</i> that are both directly activated by the same signaling pathway. We titrated the activity of this pathway with graded doses of a pharmacological inhibitor and measured the effects in quantitative enhancer assays. We found that the two enhancers had significant differences in sensitivity and cooperativity to the same shared regulator and are thus not identical in function when assessed quantitatively. We also identified subtle differences in sensitivity to this upstream signal between different notochord precursor cells.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Immunological design of commensal communities to treat intestinal infection and inflammation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765819429685-4880b38c-975a-4092-8bc4-ead4ce199d9f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.ppat.1009191</link>
            <description><![CDATA[<p class="para" id="N65539">The immunological impact of individual commensal species within the microbiota is poorly understood limiting the use of commensals to treat disease. Here, we systematically profile the immunological fingerprint of commensals from the major phyla in the human intestine (Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria) to reveal taxonomic patterns in immune activation and use this information to rationally design commensal communities to enhance antibacterial defenses and combat intestinal inflammation. We reveal that Bacteroidetes and Firmicutes have distinct effects on intestinal immunity by differentially inducing primary and secondary response genes. Within these phyla, the immunostimulatory capacity of commensals from the Bacteroidia class (Bacteroidetes phyla) reflects their robustness of TLR4 activation and Bacteroidia communities rely solely on this receptor for their effects on intestinal immunity. By contrast, within the Clostridia class (Firmicutes phyla) it reflects the degree of TLR2 and TLR4 activation, and communities of Clostridia signal via both of these receptors to exert their effects on intestinal immunity. By analyzing the receptors, intracellular signaling components and transcription factors that are engaged by different commensal species, we identify canonical NF-κB signaling as a critical rheostat which grades the degree of immune stimulation commensals elicit. Guided by this immunological analysis, we constructed a cross-phylum consortium of commensals (<i>Bacteroides uniformis</i>, <i>Bacteroides ovatus</i>, <i>Peptostreptococcus anaerobius</i> and <i>Clostridium histolyticum</i>) which enhances innate TLR, IL6 and macrophages-dependent defenses against intestinal colonization by vancomycin resistant Enterococci, and fortifies mucosal barrier function during pathological intestinal inflammation through the same pathway. Critically, the setpoint of intestinal immunity established by this consortium is calibrated by canonical NF-κB signaling. Thus, by profiling the immunological impact of major human commensal species our work paves the way for rational microbiota reengineering to protect against antibiotic resistant infections and to treat intestinal inflammation.</p><p class="para" id="N65542">The symbiotic bacteria that colonize the human intestine are major regulators of the immune system. While the collective ability of these organisms to shape immune function is clear the individual impact of different symbionts on immunity is poorly delineated. To address this, we have systematically characterized the immunological properties of an extensive panel of commensals from the major taxa in the human intestinal microbiota. We have uncovered the unique complement of pattern recognition receptors, intracellular signaling components and transcription factors through which each symbiotic species exerts their effect on the innate immune system. This allowed us to identify, for the first time, taxonomic patterns of commensal regulation of immunity and uncover a unique role for canonical NF-κB signaling in acting as a rheostat calibrating the degree of immune stimulation symbionts elicit. We used the immunological profiles of these symbionts to guide the construction of therapeutic symbiont communities to combat both AMR infection and pathological intestinal inflammation. Previously, harnessing the power of symbiotic microbes to combat disease was largely a trial-and-error process, and predicting how changes in microbiota composition will impact immunity was almost impossible. Our study addresses both of these challenges and provides a unique scientific resource to guide the rational design of symbiotic microbial communities to treat myriad diseases and reveals how loss of different symbionts will impact host health.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comparative RNA-Seq analysis unfolds a complex regulatory network imparting yellow mosaic disease resistance in mungbean [<i>Vigna radiata</i> (L.) R. Wilczek]]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799315783-8024c950-2e60-45cf-bbef-dcbaea86a788/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0244593</link>
            <description><![CDATA[<p class="para" id="N65539">Yellow Mosaic Disease (YMD) in mungbean [<i>Vigna radiata</i> (L.) R. Wilczek] is one of the most damaging diseases in Asia. In the northern part of India, the YMD is caused by Mungbean Yellow Mosaic India Virus (MYMIV), while in southern India this is caused by Mungbean Yellow Mosaic Virus (MYMV). The molecular mechanism of YMD resistance in mungbean remains largely unknown. In this study, RNA-seq analysis was conducted between a resistant (PMR-1) and a susceptible (Pusa Vishal) mungbean genotype under infected and control conditions to understand the regulatory network operating between mungbean-YMV. Overall, 76.8 million raw reads could be generated in different treatment combinations, while mapping rate per library to the reference genome varied from 86.78% to 93.35%. The resistance to MYMIV showed a very complicated gene network, which begins with the production of general PAMPs (pathogen-associated molecular patterns), then activation of various signaling cascades like kinases, jasmonic acid (JA) and brassinosteroid (BR), and finally the expression of specific genes (like PR-proteins, virus resistance and R-gene proteins) leading to resistance response. The function of WRKY, NAC and MYB transcription factors in imparting the resistance against MYMIV could be established. The string analysis also revealed the role of proteins involved in kinase, viral movement and phytoene synthase activity in imparting YMD resistance. A set of novel stress-related EST-SSRs are also identified from the RNA-Seq data which may be used to find the linked genes/QTLs with the YMD resistance. Also, 11 defence-related transcripts could be validated through quantitative real-time PCR analysis. The identified gene networks have led to an insight about the defence mechanism operating against MYMIV infection in mungbean which will be of immense use to manage the YMD resistance in mungbean.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Devil in the details: Mechanistic variations impact information transfer across models of transcriptional cascades]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765793407307-a14956f2-f7a8-45d0-9f64-433bdca6e931/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245094</link>
            <description><![CDATA[<p class="para" id="N65539">The transcriptional network determines a cell’s internal state by regulating protein expression in response to changes in the local environment. Due to the interconnected nature of this network, information encoded in the abundance of various proteins will often propagate across chains of noisy intermediate signaling events. The data-processing inequality (DPI) leads us to expect that this intracellular game of “telephone” should degrade this type of signal, with longer chains losing successively more information to noise. However, a previous modeling effort predicted that because the steps of these signaling cascades do not truly represent independent stages of data processing, the limits of the DPI could seemingly be surpassed, and the amount of transmitted information could actually <i>increase</i> with chain length. What that work did not examine was whether this regime of growing information transmission was attainable by a signaling system constrained by the mechanistic details of more complex protein-binding kinetics. Here we address this knowledge gap through the lens of information theory by examining a model that explicitly accounts for the binding of each transcription factor to DNA. We analyze this model by comparing stochastic simulations of the fully nonlinear kinetics to simulations constrained by the linear response approximations that displayed a regime of growing information. Our simulations show that even when molecular binding is considered, there remains a regime wherein the transmitted information can grow with cascade length, but ends after a critical number of links determined by the kinetic parameter values. This inflection point marks where correlations decay in response to an oversaturation of binding sites, screening informative transcription factor fluctuations from further propagation down the chain where they eventually become indistinguishable from the surrounding levels of noise.</p>]]></description>
            <pubDate><![CDATA[2021-01-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comparative proteomics analysis reveals the molecular mechanism of enhanced cold tolerance through ROS scavenging in winter rapeseed (<i>Brassica napus</i> L.)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765793210002-07a3ce4d-5188-4562-b59c-823acff2e269/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0243292</link>
            <description><![CDATA[<p class="para" id="N65539">Two winter rapeseed cultivars, “NS” (cold tolerant) and “NF” (cold sensitive), were used to reveal the morphological, physiological, and proteomic characteristics in leaves of plants after treatment at -4°C for 12 h(T1) and 24 h(T2), and at room temperature(T0), to understand the molecular mechanisms of cold tolerance. Antioxidant activity and osmotic adjustment ability were higher, and plasma membrane injury was less obvious, in NS than in NF under cold stress. We detected different abundant proteins (DAPs) related to cold tolerance in winter rapeseed through data-independent acquisition (DIA). Compared with NF, A total of 1,235 and 1,543 DAPs were identified in the NSs under T1 and T2, respectively. Compared with NF, 911 proteins were more abundant in NS only after cold treatment. Some of these proteins were related to ROS scavenging through four metabolic pathways: lysine degradation; phenylalanine, tyrosine, and tryptophan; flavonoid biosynthesis; and ubiquinone and other terpenoid-quinone biosynthesis. Analysis of these proteins in the four candidate pathways revealed that they were rapidly accumulated to quickly enhance ROS scavenging and improve the cold tolerance of NS. These proteins were noticeably more abundant during the early stage of cold stress, which was critical for avoiding ROS damage.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765789911611-ccb11f28-e0fe-49ab-b6cd-890616cb0df5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245204</link>
            <description><![CDATA[<p class="para" id="N65539">Diabetes mellitus is caused by breakdown of blood glucose homeostasis, which is maintained by an exquisite balance between insulin and glucagon produced respectively by pancreatic beta cells and alpha cells. However, little is known about the mechanism of inducing glucagon secretion from human alpha cells. Many methods for generating pancreatic beta cells from human pluripotent stem cells (hPSCs) have been reported, but only two papers have reported generation of pancreatic alpha cells from hPSCs. Because NKX6.1 has been suggested as a very important gene for determining cell fate between pancreatic beta and alpha cells, we searched for the factors affecting expression of NKX6.1 in our beta cell differentiation protocols. We found that BMP antagonism and activation of retinoic acid signaling at stage 2 (from definitive endoderm to primitive gut tube) effectively suppressed NKX6.1 expression at later stages. Using two different hPSCs lines, treatment with BMP signaling inhibitor (LDN193189) and retinoic acid agonist (EC23) at Stage 2 reduced NKX6.1 expression and allowed differentiation of almost all cells into pancreatic alpha cells <i>in vivo</i> after transplantation under a kidney capsule. Our study demonstrated that the cell fate of pancreatic cells can be controlled by adjusting the expression level of NKX6.1 with proper timing of BMP antagonism and activation of retinoic acid signaling during the pancreatic differentiation process. Our method is useful for efficient induction of pancreatic alpha cells from hPSCs.</p>]]></description>
            <pubDate><![CDATA[2021-01-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Reno-protective effect of IL-34 inhibition on cisplatin-induced nephrotoxicity in mice]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765789379963-cf6749ad-9952-41ff-af2f-aa227392b864/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245340</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Introduction</h3><p class="para" id="N65543">Interleukin-34 (IL-34) shares a receptor (cFMS) with colony stimulating factor-1 (CSF-1), and these two ligands mediate macrophage proliferation. However, in contrast to CSF-1, the influence of IL-34 on tubular epithelial cells (TECs) injury remains unclear. We investigated the physiological effects of IL-34 on TEC damage caused by cisplatin nephrotoxicity (CP-N).</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">Mice were administered anti-mouse IL-34 antibody (anti-IL-34 Ab; 400 ng/kg) or vehicle from 1 day before and up to 2 days after CP-N induction. <i>In vitro</i>, mouse renal proximal TECs (MRPTEpiC) were cultured to analyze the inhibitory effects of IL-34 on CP-induced TEC apoptosis.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65558">Compared to vehicle treatment, anti-IL-34 Ab treatment significantly suppressed the intra-renal expression of IL-34 and its two receptors, cFMS and PTP-ζ, and significantly improved renal function, ameliorated tubulointerstitial injury, suppressed macrophage infiltration, and reduced apoptotic cell numbers in CP-N mice. It also significantly reduced the renal transcript levels of Kim-1, MIP-1/CCL3, TNF-α, and Bax in CP-N mice. Furthermore, anti-IL-34 Ab-treated CP-N mice showed less renal infiltration of F4/80<sup>+</sup>TNF-α<sup>+</sup> cells. <i>In vitro</i>, stimulation with CP induced the expression of IL-34 and its two receptors in MRPTEpiC. Anti-IL-34 Ab treatment significantly suppressed CP-induced Bax expression with the degradation of ERK1/2 phosphorylation in damaged MRPTEpiC.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusions</h3><p class="para" id="N65573">IL-34 secreted from damaged TECs appeared to be involved in the progression of CP-N. Inhibition of IL-34 with neutralizing antibody directly prevented CP-induced TEC apoptosis by inhibiting the phosphorylation of ERK 1/2. Blocking of IL-34 appears to suppress the proliferation of cytotoxic macrophages, which indirectly attenuates CP-N. Thus, IL-34 represents a potential therapeutic target for TEC injury, and the inhibition of IL-34 might have a reno-protective effect.</p></div>]]></description>
            <pubDate><![CDATA[2021-01-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Dynamic regulation of CTCF stability and sub-nuclear localization in response to stress]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765767409265-83b10260-855e-4191-becd-b96361ec1e54/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009277</link>
            <description><![CDATA[<p class="para" id="N65539">The nuclear protein CCCTC-binding factor (CTCF) has diverse roles in chromatin architecture and gene regulation. Functionally, CTCF associates with thousands of genomic sites and interacts with proteins, such as cohesin, or non-coding RNAs to facilitate specific transcriptional programming. In this study, we examined CTCF during the cellular stress response in human primary cells using immune-blotting, quantitative real time-PCR, chromatin immunoprecipitation-sequence (ChIP-seq) analysis, mass spectrometry, RNA immunoprecipitation-sequence analysis (RIP-seq), and Airyscan confocal microscopy. Unexpectedly, we found that CTCF is exquisitely sensitive to diverse forms of stress in normal patient-derived human mammary epithelial cells (HMECs). In HMECs, a subset of CTCF protein forms complexes that localize to Serine/arginine-rich splicing factor (SC-35)-containing nuclear speckles. Upon stress, this species of CTCF protein is rapidly downregulated by changes in protein stability, resulting in loss of CTCF from SC-35 nuclear speckles and changes in CTCF-RNA interactions. Our ChIP-seq analysis indicated that CTCF binding to genomic DNA is largely unchanged. Restoration of the stress-sensitive pool of CTCF protein abundance and re-localization to nuclear speckles can be achieved by inhibition of proteasome-mediated degradation. Surprisingly, we observed the same characteristics of the stress response during neuronal differentiation of human pluripotent stem cells (hPSCs). CTCF forms stress-sensitive complexes that localize to SC-35 nuclear speckles during a specific stage of neuronal commitment/development but not in differentiated neurons. We speculate that these particular CTCF complexes serve a role in RNA processing that may be intimately linked with specific genes in the vicinity of nuclear speckles, potentially to maintain cells in a certain differentiation state, that is dynamically regulated by environmental signals. The stress-regulated activity of CTCF is uncoupled in persistently stressed, epigenetically re-programmed “variant” HMECs and certain cancer cell lines. These results reveal new insights into CTCF function in cell differentiation and the stress-response with implications for oxidative damage-induced cancer initiation and neuro-degenerative diseases.</p><p class="para" id="N65542">Our tissues are subject to chronic physiological and environmental damage, yet little is known about how healthy human cells normally respond to stress. We examined the effect of damage on cells obtained from breast tissue of disease-free women. Unexpectedly, we identified a well-known protein regulator of chromosomal function, CTCF, as a robust target of stress signals. In normal mammary cells, a pool of CTCF is localized to large “depots” within the nucleus that regulate RNA processing. Upon cellular damage, CTCF rapidly disappears from nuclear “depots” by stress-inducible protein degradation while genome occupancy by CTCF is relatively unaffected. We observe the same phenomenon in neuronal progenitors differentiated from human pluripotent stem cells. We propose that in specific cell types, stress-sensitive forms of CTCF exist that have a unique function in RNA metabolism potentially by fine-tuning gene expression near nuclear speckles, which may maintain cells in a progenitor or adaptive state. Upon stress, this particular CTCF function is rapidly disabled, which may change the identity of cells most vulnerable to disease in order to safeguard them from becoming dysfunctional. Persistently stressed cells have lost this CTCF function, which may facilitate the genesis of damage-induced cancer initiation and neuro-degeneration.</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose <sup>131</sup>I exposure]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765758970666-c17cf396-e29e-4eac-87cc-43bae21ced99/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0244098</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65543">Radioiodide (<sup>131</sup>I) is commonly used to treat thyroid cancer and hyperthyroidis.<sup>131</sup>I released during nuclear accidents, have resulted in increased incidence of thyroid cancer in children. Therefore, a better understanding of underlying cellular mechanisms behind <sup>131</sup>I exposure is of great clinical and radiation protection interest. The aim of this work was to study the long-term dose-related effects of <sup>131</sup>I exposure in thyroid tissue and plasma in young rats and identify potential biomarkers.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Materials and methods</h3><p class="para" id="N65561">Male Sprague Dawley rats (5-week-old) were i.v. injected with 0.5, 5.0, 50 or 500 kBq <sup>131</sup>I (D<sub>thyroid</sub> ca 1–1000 mGy), and killed after nine months at which time the thyroid and blood samples were collected. Gene expression microarray analysis (thyroid samples) and LC-MS/MS analysis (thyroid and plasma samples) were performed to assess differential gene and protein expression profiles in treated and corresponding untreated control samples. Bioinformatics analyses were performed using the DAVID functional annotation tool and Ingenuity Pathway Analysis (IPA). The gene expression microarray data and LC-MS/MS data were validated using qRT-PCR and ELISA, respectively.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65573">Nine <sup>131</sup>I exposure-related candidate biomarkers (transcripts: <i>Afp</i> and <i>RT1-Bb</i>, and proteins: ARF3, DLD, IKBKB, NONO, RAB6A, RPN2, and SLC25A5) were identified in thyroid tissue. Two dose-related protein candidate biomarkers were identified in thyroid (APRT and LDHA) and two in plasma (DSG4 and TGM3). Candidate biomarkers for thyroid function included the ACADL and SORBS2 (all activities), TPO and TG proteins (low activities). <sup>131</sup>I exposure was shown to have a profound effect on metabolism, immune system, apoptosis and cell death. Furthermore, several signalling pathways essential for normal cellular function (actin cytoskeleton signalling, HGF signalling, NRF2-mediated oxidative stress, integrin signalling, calcium signalling) were also significantly regulated.</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusion</h3><p class="para" id="N65591"><span style="text-decoration: underline">E</span>xposure-related and dose-related effects on gene and protein expression generated few expression patterns useful as biomarkers for thyroid function and cancer.</p></div>]]></description>
            <pubDate><![CDATA[2020-12-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Network pharmacology of bioactives from <i>Sorghum bicolor</i> with targets related to diabetes mellitus]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765757145116-c424fee5-1c32-4483-81ff-7a598b3819e2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0240873</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65543"><i>Sorghum bicolor</i> (SB) is rich in protective phytoconstituents with health benefits and regarded as a promising source of natural anti-diabetic substance. However, its comprehensive bioactive compound(s) and mechanism(s) against type-2 diabetes mellitus (T2DM) have not been exposed. Hence, we implemented network pharmacology to identify its key compounds and mechanism(s) against T2DM.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65551">Compounds in SB were explored through GC-MS and screened by Lipinski’s rule. Genes associated with the selected compounds or T2DM were extracted from public databases, and the overlapping genes between SB-compound related genes and T2DM target genes were identified using Venn diagram. Then, the networking between selected compounds and overlapping genes was constructed, visualized, and analyzed by RStudio. Finally, affinity between compounds and genes was evaluated via molecular docking.</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65557">GC-MS analysis of SB detected a total of 20 compounds which were accepted by the Lipinski’s rule. A total number of 16 compounds-related genes and T2DM-related genes (4,763) were identified, and 81 overlapping genes between them were selected. Gene set enrichment analysis exhibited that the mechanisms of SB against T2DM were associated with 12 signaling pathways, and the key mechanism might be to control blood glucose level by activating PPAR signaling pathway. Furthermore, the highest affinities were noted between four main compounds and six genes (FABP3-Propyleneglyco monoleate, FABP4-25-Oxo-27-norcholesterol, NR1H3-Campesterol, PPARA-β-sitosterol, PPARD-β-sitosterol, and PPARG-β-sitosterol).</p></div><div class="section" id="sec004"><h3 class="BHead" id="nov000-4">Conclusion</h3><p class="para" id="N65563">Our study overall suggests that the four key compounds detected in SB might ameliorate T2DM severity by activating the PPAR signaling pathway.</p></div>]]></description>
            <pubDate><![CDATA[2020-12-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765746930441-2fab36fa-a578-4ab2-a104-6d14a23e8f1a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0243715</link>
            <description><![CDATA[<p class="para" id="N65539">Despite the use of front-line anticancer drugs such as paclitaxel for ovarian cancer treatment, mortality rates have remained almost unchanged for the past three decades and the majority of patients will develop recurrent chemoresistant disease which remains largely untreatable. Overcoming chemoresistance or preventing its onset in the first instance remains one of the major challenges for ovarian cancer research. In this study, we demonstrate a key link between senescence and inflammation and how this complex network involving the biomarkers MAD2, TLR4 and MyD88 drives paclitaxel resistance in ovarian cancer. This was investigated using siRNA knockdown of MAD2, TLR4 and MyD88 in two ovarian cancer cell lines, A2780 and SKOV-3 cells and overexpression of MyD88 in A2780 cells. Interestingly, siRNA knockdown of MAD2 led to a significant increase in TLR4 gene expression, this was coupled with the development of a highly paclitaxel-resistant cell phenotype. Additionally, siRNA knockdown of MAD2 or TLR4 in the serous ovarian cell model OVCAR-3 resulted in a significant increase in TLR4 or MAD2 expression respectively. Microarray analysis of SKOV-3 cells following knockdown of TLR4 or MAD2 highlighted a number of significantly altered biological processes including EMT, complement, coagulation, proliferation and survival, ECM remodelling, olfactory receptor signalling, ErbB signalling, DNA packaging, Insulin-like growth factor signalling, ion transport and alteration of components of the cytoskeleton. Cross comparison of the microarray data sets identified 7 overlapping genes including MMP13, ACTBL2, AMTN, PLXDC2, LYZL1, CCBE1 and CKS2. These results demonstrate an important link between these biomarkers, which to our knowledge has never before been shown in ovarian cancer. In the future, we hope that triaging patients into alterative treatment groups based on the expression of these three biomarkers or therapeutic targeting of the mechanisms they are involved in will lead to improvements in patient outcome and prevent the development of chemoresistance.</p>]]></description>
            <pubDate><![CDATA[2020-12-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Regulation of neovasculogenesis in co-cultures of aortic adventitial fibroblasts and microvascular endothelial cells by cell-cell interactions and TGF-β/ALK5 signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765746918037-b52c9fd1-ee8a-4f2e-b9e3-62212f0f5bd5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0244243</link>
            <description><![CDATA[<p class="para" id="N65539">Adventitial fibroblasts (AFs) are critical mediators of vascular remodeling. However, the contributions of AFs towards development of vasculature and the specific mechanisms by which these cells regulate physiological expansion of the vasa vasorum, the specialized microvasculature that supplies nutrients to the vascular wall, are not well understood. To determine the regulatory role of AFs in microvascular endothelial cell (MVEC) neovasculogenesis and to investigate the regulatory pathways utilized for communication between the two cell types, AFs and MVECs were cultured together in poly(ethylene glycol)-based hydrogels. Following preliminary evaluation of a set of cell adhesion peptides (AG10, AG73, A2G78, YIGSR, RGD), 7.5wt% hydrogels containing 3 mM RGD were selected as these substrates did not initiate primitive tubule structures in 3D MVEC monocultures, thus providing a passive platform to study AF-MVEC interaction. The addition of AFs to hydrogels promoted MVEC viability; however, increasing AF density within hydrogels stimulated MVEC proliferation, increased microvessel density and size, and enhanced deposition of basement membrane proteins, collagen IV and laminin. Importantly, AF-MVEC communication through the transforming growth factor beta (TGF-β)/activin receptor-like kinase 5 (ALK5) signaling pathway was observed to mediate microvessel formation, as inhibition of ALK5 significantly decreased MVEC proliferation, microvessel formation, mural cell recruitment, and basement membrane production. These data indicate that AFs regulate MVEC neovasculogenesis and suggest that therapeutics targeting the TGF-β/ALK5 pathway may be useful for regulation of vasculogenic and anti-vasculogenic responses.</p>]]></description>
            <pubDate><![CDATA[2020-12-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[<i>In vitro</i> and <i>in vivo</i> characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765745654120-45cfc79e-4014-462e-9e81-528274be9814/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0244368</link>
            <description><![CDATA[<p class="para" id="N65539">Achondroplasia is a rare genetic disorder caused by mutations in the Fibroblast Growth Factor receptor 3 (FGFR3). These mutations lead to aberrant increase of inhibitory signaling in proliferating chondrocytes at the growth plate. Recifercept is a potential treatment for this disease using a decoy approach to sequester FGFR3 ligands subsequently normalizing activation of the mutated FGFR3 receptor. Recifercept binds to FGF isoforms <i>in vitro</i> and in cellular model systems and reduces FGFR3 signaling. In addition, in a transgenic mouse model of achondroplasia, Recifercept restores reduced body weight and long bone growth in these mice. These data suggest that Recifercept treatment could lead to clinical benefits in children treated with this molecule.</p>]]></description>
            <pubDate><![CDATA[2020-12-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Development of a hybrid model for a partially known intracellular signaling pathway through correction term estimation and neural network modeling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765744657373-cb3d6aa7-d488-4862-9259-2ddbf464dfc8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008472</link>
            <description><![CDATA[<p class="para" id="N65539">Developing an accurate first-principle model is an important step in employing systems biology approaches to analyze an intracellular signaling pathway. However, an accurate first-principle model is difficult to be developed since it requires in-depth mechanistic understandings of the signaling pathway. Since underlying mechanisms such as the reaction network structure are not fully understood, significant discrepancy exists between predicted and actual signaling dynamics. Motivated by these considerations, this work proposes a hybrid modeling approach that combines a first-principle model and an artificial neural network (ANN) model so that predictions of the hybrid model surpass those of the original model. First, the proposed approach determines an optimal subset of model states whose dynamics should be corrected by the ANN by examining the correlation between each state and outputs through relative order. Second, an L2-regularized least-squares problem is solved to infer values of the correction terms that are necessary to minimize the discrepancy between the model predictions and available measurements. Third, an ANN is developed to generalize relationships between the values of the correction terms and the system dynamics. Lastly, the original first-principle model is coupled with the developed ANN to finalize the hybrid model development so that the model will possess generalized prediction capabilities while retaining the model interpretability. We have successfully validated the proposed methodology with two case studies, simplified apoptosis and lipopolysaccharide-induced NF<i>κ</i>B signaling pathways, to develop hybrid models with <i>in silico</i> and <i>in vitro</i> measurements, respectively.</p><p class="para" id="N65542">An intracellular signaling pathway is often represented by a set of nonlinear ordinary differential equations, which translate our current knowledge about the signaling pathway into a testable mathematical model. However, predictions from such models are often subject to high uncertainty since many signaling pathways are only partially known beforehand. In this study, we propose a systematic approach to develop a hybrid model to improve model accuracy by combining machine learning and the first-principle modeling. Specifically, model correction terms are learned from discrepancy between model predictions and measurements, and these terms are added to the first-principle model to enhance the prediction accuracy. Once these correction terms are learned from the data, an artificial neural network (ANN) model is developed to find an empirical relation between the model and the correction terms so that the developed ANN can be used to posses improved predictive capabilities even in new operating conditions (i.e., generalizability). The final hybrid model is then constructed by coupling the first-principle model with the developed ANN.</p>]]></description>
            <pubDate><![CDATA[2020-12-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765744303296-752234a4-5954-4971-8c64-cd071aad1fd6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0243975</link>
            <description><![CDATA[<p class="para" id="N65539">4-Hexylresorcinol (4HR) is used as a food preservative and an ingredient of toothpaste and cosmetics. The present study was performed using 233 antisera to determine the changes in protein expression induced by 4HR in human umbilical cord vein endothelial cells (HUVECs), and evaluated the 4HR-induced effects in comparison with previous results (Kim et al., 2019). Similar to RAW 264.7 cells, 4HR-treated HUVECs showed decreases in the expression of the proliferation-related proteins, cMyc/MAX/MAD network proteins, p53/RB and Wnt/β-catenin signaling, and they showed inactivation of DNA transcription and protein translation compared to the untreated controls. 4HR upregulated growth factors (TGF-β1, β2, β3, SMAD2/3, SMAD4, HGF-α, Met, IGF-1) and RAS signaling proteins (RAF-B, p38, p-p38, p-ERK-1, and Rab-1), and induced stronger expression of the cellular protection-, survival-, and differentiation-related proteins in HUVECs than in RAW 264.7 cells. 4HR suppressed NFkB signaling in a manner that suggests potential anti-inflammatory and wound healing effects by reducing M1 macrophage polarization and increasing M2 macrophage polarization in both cells. 4HR-treated HUVECs tended to increase the ER stress mediators by upregulating eIF2AK3, ATF4, ATF6, lysozyme, and LC3 and downregulating eIF2α and GADD153 (CHOP), resulting in PARP-1/AIF-mediated apoptosis. These results indicate that 4HR has similar effects on the protein expression of HUVECs and RAW 264.7 cells, but their protein expression levels differ according to cell types. The 4HR-treated cells showed global protein expression characteristic of anticancer and wound healing effects, which could be alleviated simultaneously by other proteins exerting opposite functions. These results suggest that although 4HR has similar effects on the global protein expression of HUVECs and RAW 264.7 cells, the 4HR-induced molecular interferences in those cells are complex enough to produce variable protein expression, leading different cell functions. Moreover, HUVECs have stronger wound healing potential to overcome the impact induced by 4HR than RAW 264.7 cells.</p>]]></description>
            <pubDate><![CDATA[2020-12-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Self-limiting stem-cell niche signaling through degradation of a stem-cell receptor]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765744249853-c9b39a42-f5a6-4220-9e34-b92222badc6a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001003</link>
            <description><![CDATA[<p class="para" id="N65539">Stem-cell niche signaling is short-range in nature, such that only stem cells but not their differentiating progeny receive self-renewing signals. At the apical tip of the <i>Drosophila</i> testis, 8 to 10 germline stem cells (GSCs) surround the hub, a cluster of somatic cells that organize the stem-cell niche. We have previously shown that GSCs form microtubule-based nanotubes (MT-nanotubes) that project into the hub cells, serving as the platform for niche signal reception; this spatial arrangement ensures the reception of the niche signal specifically by stem cells but not by differentiating cells. The receptor Thickveins (Tkv) is expressed by GSCs and localizes to the surface of MT-nanotubes, where it receives the hub-derived ligand Decapentaplegic (Dpp). The fate of Tkv receptor after engaging in signaling on the MT-nanotubes has been unclear. Here we demonstrate that the Tkv receptor is internalized into hub cells from the MT-nanotube surface and subsequently degraded in the hub cell lysosomes. Perturbation of MT-nanotube formation and Tkv internalization from MT-nanotubes into hub cells both resulted in an overabundance of Tkv protein in GSCs and hyperactivation of a downstream signal, suggesting that the MT-nanotubes also serve a second purpose to dampen the niche signaling. Together, our results demonstrate that MT-nanotubes play dual roles to ensure the short-range nature of niche signaling by (1) providing an exclusive interface for the niche ligand-receptor interaction; and (2) limiting the amount of stem cell receptors available for niche signal reception.</p><p class="para" id="N65540">A stem cell niche is the specialized micro-environment that provides the signal to the resident stem cells to support their undifferentiated, self-renewing state. This study shows that the cells that compose the niche do not only provide the signal, but also take up the receptor of stem cells for subsequent lysosomal degradation; this mechanism is essential for restriction of niche signal range.</p>]]></description>
            <pubDate><![CDATA[2020-12-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Coupling of autism genes to tissue-wide expression and dysfunction of synapse, calcium signalling and transcriptional regulation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740448423-3055f913-af19-4202-b7f6-c411806c1e00/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0242773</link>
            <description><![CDATA[<p class="para" id="N65539">Autism Spectrum Disorder (ASD) is a heterogeneous disorder that is often accompanied with many co-morbidities. Recent genetic studies have identified various pathways from hundreds of candidate risk genes with varying levels of association to ASD. However, it is unknown which pathways are specific to the core symptoms or which are shared by the co-morbidities. We hypothesised that critical ASD candidates should appear widely across different scoring systems, and that comorbidity pathways should be constituted by genes expressed in the relevant tissues. We analysed the Simons Foundation for Autism Research Initiative (SFARI) database and four independently published scoring systems and identified 292 overlapping genes. We examined their mRNA expression using the Genotype-Tissue Expression (GTEx) database and validated protein expression levels using the human protein atlas (HPA) dataset. This led to clustering of the overlapping ASD genes into 2 groups; one with 91 genes primarily expressed in the central nervous system (CNS geneset) and another with 201 genes expressed in both CNS and peripheral tissues (CNS+PT geneset). Bioinformatic analyses showed a high enrichment of CNS development and synaptic transmission in the CNS geneset, and an enrichment of synapse, chromatin remodelling, gene regulation and endocrine signalling in the CNS+PT geneset. Calcium signalling and the glutamatergic synapse were found to be highly interconnected among pathways in the combined geneset. Our analyses demonstrate that 2/3 of ASD genes are expressed beyond the brain, which may impact peripheral function and involve in ASD co-morbidities, and relevant pathways may be explored for the treatment of ASD co-morbidities.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739934513-f07c3d3d-c8a6-41bb-a412-401647b441a6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001032</link>
            <description><![CDATA[<p class="para" id="N65539">Despite recent progress in recognizing the importance of mesenchymal cells for the homeostasis of the intestinal system, the current picture of how these cells communicate with the associated epithelial layer remains unclear. To describe the relevant cell populations in an unbiased manner, we carried out a single-cell transcriptome analysis of the adult murine colon, producing a high-quality atlas of matched colonic epithelium and mesenchyme. We identify two crypt-associated colonic fibroblast populations that are demarcated by different strengths of platelet-derived growth factor receptor A (Pdgfra) expression. Crypt-bottom fibroblasts (CBFs), close to the intestinal stem cells, express low levels of Pdgfra and secrete canonical Wnt ligands, Wnt potentiators, and bone morphogenetic protein (Bmp) inhibitors. Crypt-top fibroblasts (CTFs) exhibit high Pdgfra levels and secrete noncanonical Wnts and Bmp ligands. While the Pdgfra<sup>low</sup> cells maintain intestinal stem cell proliferation, the Pdgfra<sup>high</sup> cells induce differentiation of the epithelial cells. Our findings enhance our understanding of the crosstalk between various colonic epithelial cells and their associated mesenchymal signaling hubs along the crypt axis—placing differential Pdgfra expression levels in the spotlight of intestinal fibroblast identity.</p><p class="para" id="N65540">Despite the known importance of mesenchymal cells for the homeostasis of the intestinal system, how these cells communicate with the associated epithelial layer remains unclear. A single cell atlas of matched colonic epithelium and mesenchyme identifies two fibroblast populations that orchestrate maintenance and differentiation of colonic epithelial stem cells.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Jagged1 intracellular domain modulates steroidogenesis in testicular Leydig cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739393090-6ddde13a-256a-4dc1-9488-f024e4f4ea3f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0244553</link>
            <description><![CDATA[<p class="para" id="N65539">Leydig cells represent the steroidogenic lineage of mammalian testis, which produces testosterone. Genetic evidence indicates the requirement of Notch signaling in maintaining a balance between differentiated Leydig cells and their progenitors during fetal development. In primary Leydig cells, Notch1 expression decreases with testicular development, while the expression of its ligand, Jagged1, remains relatively unchanged, suggesting that the roles of Jagged1 extend beyond Notch signaling. In addition, Jagged1 is known to be processed into its intracellular domain, which then translocate to the nucleus. In this study, we investigated the effect of Jagged1 intracellular domain (JICD) on steroidogenesis in Leydig cells. The independent overexpression of JICD in MA-10 Leydig cells was found to inhibit the activity of cAMP-induced Nur77 promoter. In addition, JICD suppressed Nur77 transactivation of the promoter of steroidogenic genes such as <i>P450scc</i>, <i>P450c17</i>, <i>StAR</i>, and <i>3β-HSD</i>. Further, adenovirus-mediated overexpression of JICD in primary Leydig cells repressed the expression of steroidogenic genes, consequently lowering testosterone production. These results collectively suggest that steroidogenesis in testicular Leydig cells, which is regulated by LH/cAMP signaling, is fine-tuned by Jagged1 during testis development.</p>]]></description>
            <pubDate><![CDATA[2020-12-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Context-specific network modeling identifies new crosstalk in β-adrenergic cardiac hypertrophy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739107408-91fc185f-f47a-456f-b8d0-01c62523f986/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pcbi.1008490</link>
            <description><![CDATA[<p class="para" id="N65539">Cardiac hypertrophy is a context-dependent phenomenon wherein a myriad of biochemical and biomechanical factors regulate myocardial growth through a complex large-scale signaling network. Although numerous studies have investigated hypertrophic signaling pathways, less is known about hypertrophy signaling as a whole network and how this network acts in a context-dependent manner. Here, we developed a systematic approach, CLASSED (Context-specific Logic-bASed Signaling nEtwork Development), to revise a large-scale signaling model based on context-specific data and identify main reactions and new crosstalks regulating context-specific response. CLASSED involves four sequential stages with an automated validation module as a core which builds a logic-based ODE model from the interaction graph and outputs the model validation percent. The context-specific model is developed by estimation of default parameters, classified qualitative validation, hybrid Morris-Sobol global sensitivity analysis, and discovery of missing context-dependent crosstalks. Applying this pipeline to our prior-knowledge hypertrophy network with context-specific data revealed key signaling reactions which distinctly regulate cell response to isoproterenol, phenylephrine, angiotensin II and stretch. Furthermore, with CLASSED we developed a context-specific model of β-adrenergic cardiac hypertrophy. The model predicted new crosstalks between calcium/calmodulin-dependent pathways and upstream signaling of Ras in the ISO-specific context. Experiments in cardiomyocytes validated the model’s predictions on the role of CaMKII-Gβγ and CaN-Gβγ interactions in mediating hypertrophic signals in ISO-specific context and revealed a difference in the phosphorylation magnitude and translocation of ERK1/2 between cardiac myocytes and fibroblasts. CLASSED is a systematic approach for developing context-specific large-scale signaling networks, yielding insights into new-found crosstalks in β-adrenergic cardiac hypertrophy.</p><p class="para" id="N65542">Pathological cardiac hypertrophy is a disease in which the heart grows abnormally in response to different motivators such as high blood pressure or variations in hormones and growth factors. The shape of the heart after its growth depends on the context in which it grows. Since cell signaling in the cardiac cells plays a key role in the determination of heart shape, a thorough understanding of cardiac cells signaling in each context enlightens the mechanisms which control response of cardiac cells. However, cell signaling in cardiac hypertrophy comprises a complex web of pathways with numerous interactions, and predicting how these interactions control the hypertrophic signal in each context is not achievable by only experiments or general computational models. To address this need, we developed an approach to bring together the experimental data of each context with a signaling network curated from literature to identify the main players of cardiac cells response in each context and attain the context-specific models of cardiac hypertrophy. By utilizing our approach, we identified the main regulators of cardiac hypertrophy in four important contexts. We developed a network model of β-adrenergic cardiac hypertrophy, and predicted and validated new interactions that regulate cardiac cells response in this context.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Using WGCNA (weighted gene co-expression network analysis) to identify the hub genes of skin hair follicle development in fetus stage of Inner Mongolia cashmere goat]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610336587-de89d2c8-d16a-4547-aec4-18e11a6e5bc6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0243507</link>
            <description><![CDATA[<div class="section" id="sec001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">Mature hair follicles represent an important stage of hair follicle development, which determines the stability of hair follicle structure and its ability to enter the hair cycle. Here, we used weighted gene co-expression network analysis (WGCNA) to identify hub genes of mature skin and hair follicles in Inner Mongolian cashmere goats.</p></div><div class="section" id="sec002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">We used transcriptome sequencing data for the skin of Inner Mongolian cashmere goats from fetal days 45–135 days, and divided the co expressed genes into different modules by WGCNA. Characteristic values were used to screen out modules that were highly expressed in mature skin follicles. Module hub genes were then selected based on the correlation coefficients between the gene and module eigenvalue, gene connectivity, and Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The results were confirmed by quantitative polymerase chain reaction (qPCR).</p></div><div class="section" id="sec003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">Ten modules were successfully defined, of which one, with a total of 3166 genes, was selected as a specific module through sample and gene expression pattern analyses. A total of 584 candidate hub genes in the module were screened by the correlation coefficients between the genes and module eigenvalue and gene connectivity. Finally, GO/KEGG functional enrichment analyses detected WNT10A as a key gene in the development and maturation of skin hair follicles in fetal Inner Mongolian cashmere goats. qPCR showed that the expression trends of 13 genes from seven fetal skin samples were consistent with the sequencing results, indicating that the sequencing results were reliable.n</p></div>]]></description>
            <pubDate><![CDATA[2020-12-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RIM-binding protein couples synaptic vesicle recruitment to release sites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609708732-1c57eb5e-105a-46ba-9640-630f9134c7df/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201902059</link>
            <description><![CDATA[<p class="para" id="N65540">Petzoldt et al. investigate the functional protein architecture at the presynaptic active zone, an elaborate protein scaffold organizing synaptic vesicle (SV) release. They find that the conserved multidomain protein RIM-BP provides a relay to guide SVs during their recruitment into membrane close SV release sites.</p><p class="para" id="N65539">At presynaptic active zones, arrays of large conserved scaffold proteins mediate fast and temporally precise release of synaptic vesicles (SVs). SV release sites could be identified by clusters of Munc13, which allow SVs to dock in defined nanoscale relation to Ca<sup>2+</sup> channels. We here show in <i>Drosophila</i> that RIM-binding protein (RIM-BP) connects release sites physically and functionally to the ELKS family Bruchpilot (BRP)-based scaffold engaged in SV recruitment. The RIM-BP N-terminal domain, while dispensable for SV release site organization, was crucial for proper nanoscale patterning of the BRP scaffold and needed for SV recruitment of SVs under strong stimulation. Structural analysis further showed that the RIM-BP fibronectin domains form a “hinge” in the protein center, while the C-terminal SH3 domain tandem binds RIM, Munc13, and Ca<sup>2+</sup> channels release machinery collectively. RIM-BPs’ conserved domain architecture seemingly provides a relay to guide SVs from membrane far scaffolds into membrane close release sites.</p><p class="para" id="N65542"><div class="section" id="GA"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('GA');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765609708732-1c57eb5e-105a-46ba-9640-630f9134c7df/assets/JCB_201902059_GA.jpg" alt=""/></div></div></div></div></p>]]></description>
            <pubDate><![CDATA[2020-05-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling <i>in vivo</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609563623-bcaf7c4d-970b-474d-b9e2-5ae6586c9d8e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pgen.1009228</link>
            <description><![CDATA[<p class="para" id="N65539">Signal transduction pathways are intricately fine-tuned to accomplish diverse biological processes. An example is the conserved Ras/mitogen-activated-protein-kinase (MAPK) pathway, which exhibits context-dependent signaling output dynamics and regulation. Here, by altering codon usage as a novel platform to control signaling output, we screened the <i>Drosophila</i> genome for modifiers specific to either weak or strong Ras-driven eye phenotypes. Our screen enriched for regions of the genome not previously connected with Ras phenotypic modification. We mapped the underlying gene from one modifier to the ribosomal gene RpS21. In multiple contexts, we show that RpS21 preferentially influences weak Ras/MAPK signaling outputs. These data show that codon usage manipulation can identify new, output-specific signaling regulators, and identify RpS21 as an <i>in vivo</i> Ras/MAPK phenotypic regulator.</p><p class="para" id="N65542">Cellular communication is critical in controlling the growth of organs and must be carefully regulated to prevent disease. The Ras signaling pathway is frequently used for cellular communication of tissue growth regulation but can operate at different signaling strengths. Here, we used a novel strategy to identify genes that specifically tune weak or strong Ras signaling states. We find that the gene RpS21 preferentially tunes weak Ras signaling states.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TNF-α signaling: TACE inhibition to put out the burning heart]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608273742-e7b7d49b-8c7a-4028-b036-fddefa255616/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001037</link>
            <description><![CDATA[<p class="para" id="N65539">More than 20 years ago, Seta and colleagues hypothesized that cytokines, which are activated by myocardial injury, significantly drive heart failure progression and would therefore be effective targets to treat cardiac dysfunction. Unfortunately, several clinical trials inhibiting key cytokines like tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (Il-1β) turned out negative or even revealed adverse clinical effects. Providing a potential mechanistic explanation for the ineffectiveness of TNF-α blockade in heart failure, novel findings demonstrate that the membrane-bound precursor form of TNF-α, transmembrane TNF-α (tmTNF-α), mediates cardioprotective effects during pressure overload-induced cardiac remodeling. This study suggests that preventing tmTNF-α cleavage by targeting the TNF-α converting enzyme (TACE) rather than inhibiting TNF-α signaling altogether might be a valuable therapeutic approach.</p><p class="para" id="N65540">The Yin and Yang of TNF-α signaling in heart failure: this Primer explores the history of failure of TNF-α antagonistic therapy in heart failure and how a recent study suggests that inhibition of TNF-α converting enzyme TACE might be a way out of this dilemma.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The cell biology of inflammation: From common traits to remarkable immunological adaptations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608261606-16dbd9ef-899c-45ef-8480-acaf8dbdf476/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202004003</link>
            <description><![CDATA[<p class="para" id="N65540">Weavers and Martin revisit Metchnikoff’s classic observations of inflammatory cell behavior in damaged tissues and update them with the latest cell biology studies.</p><p class="para" id="N65539">Tissue damage triggers a rapid and robust inflammatory response in order to clear and repair a wound. Remarkably, many of the cell biology features that underlie the ability of leukocytes to home in to sites of injury and to fight infection—most of which are topics of intensive current research—were originally observed in various weird and wonderful translucent organisms over a century ago by Elie Metchnikoff, the “father of innate immunity,” who is credited with discovering phagocytes in 1882. In this review, we use Metchnikoff’s seminal lectures as a starting point to discuss the tremendous variety of cell biology features that underpin the function of these multitasking immune cells. Some of these are shared by other cell types (including aspects of motility, membrane trafficking, cell division, and death), but others are more unique features of innate immune cells, enabling them to fulfill their specialized functions, such as encapsulation of invading pathogens, cell–cell fusion in response to foreign bodies, and their self-sacrifice as occurs during NETosis.</p>]]></description>
            <pubDate><![CDATA[2020-06-15T00:00]]></pubDate>
        </item>
    </channel>
</rss>